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ABSTRACT

The P300 component of the auditory ERP elicited to target stimuli has been
extensively investigated as a potential psychophysiological marker in schizophrenia.
Theoretical and empirical evidence is presented, suggesting the earlier components
(N100, P200) to both target and non-target stimuli may better capture information
processing deficits currently proposed to be central to schizophrenia. The thesis
comprises 4 studies.

Study 1 demonstrated deficits to non-target (reduced N100 amplitude, earlier
P200 latency), in addition to target stimuli (reduced and earlier N100 amplitude,
increased P200 amplitude), in schizophrenia (n = 40) compared with matched normal
controls. The schizophrenia group was also characterised by a lack of differentiation
between ERPs elicited to target and non-target stimuli, in comparison to the normal
control group.

Study 2 confirmed the results of Study 1 in groups of chronic (chronic
schizophrenia, n = 40) and first episode schizophrenia (FESz, n = 40), and
additionally established that in normal controls non-target stimuli occurring
immediately before the target (T-1) generated larger Ni amplitudes than the nontarget after (T+1), a pattern that failed to occur in Chronic schizophrenia and was
minimal in FESz. N100 amplitude deficits to non-target stimuli were also correlated
with clinical symptomatology, particularly with higher levels on the disorganisation
factor. Most importantly, N100 and P200 responses to target and non-target (T+1 &
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T-1) stimuli, were superior predictors in classifying both first episode and chronic
schizophrenia patients than were the more commonly employed P300 measures.

Study 3 examined the effect of certain sequence types on ERPs in FESz
(n =14) and normal controls (n = 14), in order to ascertain whether P300 and
other ERP deficits in schizophrenia could be attributed to impairments on
specific sequence occurrences. Specifically, effects from the discontinuation of a
long series of repetitions (DR-series) and alternations (DA-series) were
examined. In general, patients with FESz demonstrated similar ERPs to controls
to the series examined.

Study 4 demonstrated that the early (N100 and P200) component deficits
to target and non-target stimuli were specific for FESz (n = 20), when compared
to both a clinical (ADHD, n = 20) and normal (n = 20) control group. Finally, a
stepwise discriminant function analysis (Dfa), demonstrated that measures
derived from the early components had better sensitivity and specificity values
(vs. N2, P3) for diagnostic classification when compared with ADHD.

This thesis provides compelling evidence that N100 and P200
components to target and non-target stimuli are impaired in both the early and
chronic manifestations of schizophrenia, and argues that, on account of the
superior sensitivity and specificity values associated with the early components,
they may serve as potentially useful biological markers for the disorder.
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ABBREVIATIONS
Abbreviations used in the text throughout this thesis

Abbreviation

Term

ADHD
ANOVA
ER_P
cf.
CIDI
CRT
CSz
CT
DfA
DA
DR
DSM-IV
FESz
fMRI
ISI
ITI
IQ
MANOVA
1VIRI
ms

Attention Deficit Hyperactivity Disorder
Analysis of Variance
Event related Potential
Compared with
Composite International Diagnostic Interview—Computerised Version
Choice reaction time task
Chronic schizophrenia
Computer Tomography
Discriminant function analysis
Discontinuation of alternations
Discontinuation of repetitions
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition
FESz
functional Magnetic Resonance Imaging
Inter stimulus interval;
Inter target interval
Intelligence Quotient
Multivariate Analysis of Variance
Magnetic Resonance Imaging
Milliseconds
Non-target
number
Positive and Negative Symptom Scale
Positron Emission Tomography
regional Cerebral Blood Flow
Response-stimuli interval
Response Time
Schedule for the assessment of negative symptoms
Schedule for the assessment of positive symptoms
Single Photon Emission Tomography
Target stimuli
Non-target stimuli immediately preceding the target stimuli
Non-target stimuli immediately following the target stimuli
Target to target interval

N
n
PANSS
PET
rCBF
RST
RT
SANS
SAPS
SPECT
T
T-1
T+1
TTI

Note. Abbreviations used in Tables are not given here; all abbreviations will be defined on their first
use in the text.
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1 INTRODUCTION
1.1

RATIONALE FOR AND OVERVIEW OF THE THESIS

The central importance of cognitive deficits to schizophrenia has been
proposed for at least a century (Andreasen, Paradiso & O'Leary, 1998; Blueler,
1950/1911; Braff, 1993; Broadbent, 1958; Frith, 1995; Gray, 1998; Hemsley, 1996;

Kraeplin, 1989/1919). Although there is little doubt about the existence of a
cognitive deficit, the nature of this deficit, its interaction with symptoms, stability
over time, whether it follows a neurodevelopmental or neurodegenerative course, and
the underlying brain dynamics remain unclear (Andreasen, 2000; Frith, 1992;
Goldman Rakic, 1994; Gray, 1998). This primary deficit is seen to underlie
impairments in second order cognitive processes (e.g. attention, memory, language
emotion) and symptoms of schizophrenia.

The development of event related potentials (ERPs) has provided a window for
understanding the neural mechanisms that might underlie this deficit. The
millisecond resolution generated by ERPs time-locked to stimuli in cognitive
paradigms and recorded over the entire scalp provides a spatio-temporal map of
consequent electrical brain activity in the real time of cognition. Understanding the
psychophysiology of such a cognitive deficit has exciting implications, in particular
the possibilities of identifying a biological validation of diagnosis, an endophenotype
for genetic and pharmaceutical research and a biological marker of risk for
schizophrenia. The results of this thesis which includes first episode and chronic
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schizophrenia participants may also inform treatment intervention and the timing of
that intervention and contribute to the understanding of the pathology underlying
schizophrenia.

The P300 component of the ERP to target stimuli in the auditory oddball
paradigm is seen to reflect "the processing of incoming information when it is
incorporated into memory representations of the stimulus and the context in which
the stimulus occurs" (Polich & Herbst, 2000, p4). Research has demonstrated a
widely reproducible, reduced P300 amplitude in schizophrenia (Ford, 1999; Jeon &
Polich, 2000; Pritchard, 1986) which has been suggested as a possible biological
marker of risk for schizophrenia (Bharath, Gangadhar, & Janakiramaiah, 2000;
Blackwood, 2000; Freidman & Squires-Wheeler, 1994). It has been argued that this
reduction represents difficulties in context updating and generation of expectancies
(Donchin & Coles, 1988).

There are several limitations in P300 research (see Chapter 2) suggesting the
need to look beyond the P300 component. Although reduced P300 amplitude is
sensitive for schizophrenia, it is not specific to schizophrenia. Reduced P300
amplitude has also been found in other psychiatric and neurological conditions such
as alcoholism (Pfefferbaum, Ford, White & Mathalon, 1991), depression
(Pfefferbaum, Wenegrat, Ford, Roth & Koppell, 1984), attention deficit hyperactivity
disorder (AMID; Barry, Johnstone & Clarke, 2003), borderline-personality disorder
(Blackwood, Sinclair & Kutcher, 1986); Parkinson's disease (Raudino, Garavaglia,
Beretta & Pellegrino, 1997) and dementia (Goodin, Squires Henderson & Starr,
1978). In addition, theoretical and empirical findings provide some support for the
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notion that a comparator disturbance leading to a failure to make use of context in
information processing might occur 100-200ms post-stimulus and consequently
would be better captured in the differentiation between target and non-target ERP
components, particularly the earlier N100 and P200 components (See Chapter 2.5).
ERP studies in schizophrenia have focused mainly on the P300 component elicited
by target stimuli, many restricting their analysis solely to P300. Less attention has
been given to earlier N100, P200 components to target stimuli and even less to nontarget stimuli (see Chapter 2 for review). Hence, it is theoretically compelling and
clinically relevant to investigate deficits in earlier components, N100 and P200, to
both target and non-target stimuli in schizophrenia. To be valuable, such an
investigation would need to demonstrate the presence of these deficits at onset and
over longer duration of illness and their improved sensitivity and specificity when
compared to the P300.

The thesis is built around four empirical studies and is presented as follows.
Chapter 1 provides a brief outline of the thesis, presenting the clinical picture, a
review of the symptom structure and major models of schizophrenia. Chapter 2
reviews the previous literature on the auditory P300 component in schizophrenia and
presents arguments for the importance of examining ERPs to non-target stimuli in
addition to target stimuli. The focus of Chapter 3 (Study 1) is to examine the
relationship between the ERPs elicited by target and non-target stimuli in an auditory
oddball paradigm. The critical difference between this Study and previous research is
the examination of ERP components to non-target in addition to target stimuli, and
the examination of the difference in ERP responses to non-target and target stimuli
between the schizophrenia and normal control groups.
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Chapter 4 reviews and evaluates the literature germane to Study 2, and
Chapter 5 describes the Study. This Study encompasses several objectives. In order
to exclude the possibility that the deficits identified in Study 1 were a consequence of
chronicity, or it's many consequences, this Study examines the presence of these
deficits in a group of people experiencing their first episode of schizophrenia and
their matched control group and contrasts these with deficits found in a group with
chronic schizophrenia and their matched controls. The focus is on a more finegrained analysis of deficits in ERPs to target and non-target stimuli, sub-averaging
ERPs elicited by non-target stimuli, depending on their sequence - the non-target
occurring immediately preceding (T-1) or following (T+1) the target stimuli. In
addition, the relationship between key symptom clusters and ERP findings are
analysed. Although not major objectives of the Study, age and gender effects were
also briefly examined. The wide age span arising from this design allows for a
comparison of age effects between schizophrenia and normal control groups. Gender
differences in schizophrenia have recently gained theoretical relevance and hence
differential gender effects on ERPs between clinical and control groups are also
investigated.

The interpretation of Study 2 results led to questions regarding sequence
effects on ERPs to target and non-target stimuli in schizophrenia, necessitating the
development of a different paradigm. These questions were investigated in Study 3
(Chapter 6). The improved sensitivity for schizophrenia of N100, P200 components
elicited by target and non-target stimuli versus N200 and P300 to target stimuli also
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lead to a further investigation of the relative specificity of these components in Study
4 (Chapter7).
Chapter 6 introduces and describes Study 3. This Study examined how
sequence effects on ERPs may contribute to an understanding of difficulties with
either the independent processing of target and non-target stimuli and/or the
interrelated processing of these two stimuli in a group with first episode
schizophrenia. The Study focuses on the effects of the discontinuation of alternation
sequence on P300 amplitude, latency and RT, as a possible index of associative
strength. A further aim of this Study was to discriminate between two competing
hypotheses emerging from the results of Study 2 regarding the absence of sequence
effects on the non-target N100 amplitude in schizophrenia.

The final experimental Study (Study 4) is described in Chapter 7 and
examines whether deficits in N100 and P200 components to target and non-target
stimuli, observed in chronic and first episode schizophrenia were specific to this
disorder. As ADHD shares deficits in common cognitive domains (eg. attention,
working memory and inhibitory dysfunction) with schizophrenia (Chapter 7.1) they
provide a useful psychiatric control group for exploring the specificity of ERP
findings in schizophrenia, particularly in a young group with FESz. Hence, Study 4
examined ERPs to target and non-target stimuli (T-1 & T+1) in FESz in comparison
to normal and psychiatric (ADHD) control groups.

Chapter 8 comprises a summary, interpretation and discussion of the four
studies previously conducted. The theoretical and clinical implications are also
discussed, as are the limitations of this thesis and suggestions for further research.
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In summary, this thesis significantly contributes to ERP findings within the
schizophrenia literature and enhances the theoretical understanding of the
mechanisms that may contribute to the psychopathology of this clinical condition.

1.2

SCHIZOPHRENIA - THE CLINICAL PICTURE

1.2.1 Classification and course
There is, as yet, no accepted biological validation for the diagnosis of
schizophrenia, which is a clinical diagnosis based upon the evaluation of reported
and observed symptoms (Sedvall & Terenius, 2000). Diagnosis is made on the basis
of characteristic positive (delusions, hallucinations, disorganized speech or
behaviour) and negative (affective flattening alogia and avolition) symptoms, with
continuous signs of disturbance for at least six months. These symptoms are
accompanied by deteriorating personal, social and occupational functioning and are
not secondary to another disorder e.g. substance abuse (American Psychiatric
Association, 1994). The peak age of onset is in the twenties, with onset generally a
little earlier in males than females (Hafner et al., 1998). Schizophrenia is one of the
most costly mental illnesses in terms of its impact on patients, their families, the
health system and the economy (Langley-Hawthorne, 1997; Andreasen, 1995).
Schizophrenia has a range of courses and outcomes (Gaebel & Frommann, 2000).
Although onset may be abrupt the majority of individuals display some type of prodromal phase which may last a year or more before the onset of overt psychotic
symptoms. Although Kraeplin (1989/1919) conceived dementia praecox as a
deteriorating illness, Bleuler (1950/1911) emphasized that the course could be
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irregular with remissions and intermediate outcomes. Ciompi (1988) suggests the
course of schizophrenia is not always catastrophic, as almost 30% of patients can get
well or have a good remission and in 30% a mild residual symptomatology persists.
DSM IV (American Psychiatric Association, 1994) specifies six main course
patterns: episodic with interepisode residual symptoms, episodic with no interepisode
residual symptoms; continuous, single episode in partial remission, single episode in
full remission and other or unspecified.

Schizophrenia has a similar clinical presentation and prevalence throughout
the world, a lifetime and point prevalence of approximately 1 percent (Sartorius,
Jablensky & Korten, 1986). However, sex differences have been reported with a two
to three-fold increase in the incidence of schizophrenia in males (Hambrecht et al.,
1994; Timms, 1998). Compared with females males have been found to show poorer
premorbid adjustment (Childers & Harding, 1990; Salokangas, 1983), younger age at
onset and at first hospitalization (Hafner et al., 1989; Loranger, 1984; Shtasel, Gur,
Gallacher, Heimberg, & Gur, 1992), more severe symptoms and course of illness
(Angermeyer, Kuhn, & Goldstein,1990; Childers & Harding, 1990; Goldstein, 1988;
Goldstein, Santangelo, Simpson, & Tsuang, 1990; McGlashon & Bardenstein, 1990;
Salongas,1983) worse social and vocational outcome(Childers & Harding, 1990),
greater structural brain anomalies (Gur et al., 2000; Harvey et al.,1990; Leong &
Chue, 2000) and neurological soft signs (Alexander et al., 1994).

1.2.2 Clinical heterogeneity
Schizophrenia has been considered a heterogeneous disorder in terms of both
clinical symptoms and neuropathological findings (Hemsley, 1996). One approach to
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explore this heterogeneity has been the use of categorical subtypesfor
example,paranoid/non paranoid (Kremen, Seidman, Goldstein, Faraone & Tsuang,
1994), thought disorder/no thought disorder (Tallent, Weinberger & Goldberg 2001),
positive/negative (Crow, 1980) or deficit/non-deficit (Carpenter, Heinrichs, &
Wagman, 1988). However one problem with this approach is that individual patients
may have symptoms from more than one category, for example, many patients with
schizophrenia exhibit both positive and negative symptoms. An alternative approach
uses factor analysis to reduce the large number of symptoms into factors that can cooccur in individual patients.

Many factor analytic studies (Andreasen, Arndt, Miller, Flaum & Nopoulos,
1995; Liddle, 1987; Loftus, DeLisi, & Crow, 1998) suggest that three primary
symptom factors account for the interrelationships among the core symptoms of
schizophrenia. The three factors have been characterised by Liddle (1987) as
follows: (1) psychomotor poverty - deficit negative symptoms such as affective
flattening, emotional and social withdrawal, and avolition); (2) reality distortion positive symptoms of hallucinations and delusions; and the (3) disorganisation factor
- positive and negative aspects of thought disorder and attentional problems. These
studies have largely limited factor analysis to the core symptoms of schizophrenia as
measured by the schedule for the assessment of positive symptoms (SAPS), and the
schedule for the assessment of negative symptoms (SANS, Andreasen, Arndt, Miller,
Flaum & Nopoulos, 1995) or the positive and negative sections of the positive and
negative syndrome scale (PANS S, Kay & Opler, 1987). When investigators have
added symptoms of general psychopathology to the factor analysis (usually the
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psychopathology section of the PANSS), they have found that five factors, or more,
are necessary to explain the heterogeneity of symptoms in schizophrenia (Bell,
Lysaker, Beam-Goulet, Milstein, Lindenmayer, 1994; Lancon, Reine, Llorca,
Auquier, 1999; Lindenmayer, Grochowski, & Hyman, 1995). In these studies the
three core factors have largely remained, with the addition of two or more further
factors, although the exact symptoms that comprise these dimensions differ slightly
across studies. The two most common additional factors have been characterised as
excitement and depression/anxiety. Consideration of symptom factors can unlock
significant associations with brain function that can be obscured through traditional
group averaging (Harris, Williams, Gordon, Bahramali & Slewa-Younan, 1999;
Liddle, 1987, 1992; Liddle et al., 1992; Williams, Gordon, Bahramali, Wright &
Meares, 2000). For example, Harris (2004) found increased alpha 2 and beta power
associated with reality distortion (divided into psychotic and paranoid domains)
while finding decreased alpha and beta power associated with the disorganisation
factor. A review of the relationship between symptom factors and cognitive domains,
psychophysiology and imaging factors is presented in Chapter 4.4

1.3

GENETICS

Evidence from many studies demonstrates that genetic factors contribute
substantially to the aetiology of schizophrenia (Gottesman, 1991; Moldin &
Gottsmann, 1997) with epidemiological studies suggesting that additive and
interactive genes, each with small effects, mediate this genetic vulnerability (Joober,
Boksa, Benkelfat, & Rouleau, 2002). Genetic research has led to the questioning of
the usefulness of the DSM IV categorical definition of schizophrenia for genetic
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investigation, while acknowledging its necessity for clinical purposes. The disorder
is unlikely to be caused by one gene that is 100% penetrant and the number of people
that meet the requirements of DSM IV may be only a selected fraction of the total
occurrence of the phenotype (Clonninger, 1994). Strauss (1969) and others (Claridge,
1994; Johns & Van Os, 2001) have suggested that psychosis may exist as a
continuous phenotype in nature. Phenotype incorporates the observable
characteristics of an organism in contrast with genotype, which is an organism's
genetic composition

The most widely accepted model for the transmission of schizophrenia, the
polygenic threshold model (Gottesman & Moldin, 1997; Gottesman & Shields, 1967)
proposes that the liability to develop the disorder is normally distributed in the
population, reflecting the additive effects of several different genes plus
environmental factors. Thus, only those individuals who exceed a certain threshold
of liability would develop the disease. Relatives of schizophrenic patients have, on
average an increased liability compared with the general population because of
predisposing genetic factors, causing more of these relatives to be beyond the
threshold for manifesting the disorder. The strongest evidence for the existence of
schizophrenia susceptibility loci has been found on chromosomes 1, 6, 8, and 13
(Bailer, et al., 2000; Brzustowicz et al., 2000; Gurling et al., 2001; Schwab et al.,
2000 Shaw et al., 1998 Williams et al., 1999). However, statistical evidence is not
strong, and the existence of nonreplications demonstrates that these findings are not
conclusive (National Institute of Mental Health's Genetic workgroup, 1999).
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The problems surrounding the adequacy of the current diagnostic criteria for
schizophrenia, and the heterogeneity of individuals currently classified, contribute to
the importance of identifying biological endophenotypes, as they can identify
relatives of affected individuals who would be considered unaffected with typical
diagnostic systems. They can also identify individuals at risk before the development
of the disease and help to identify a candidate location for illness-susceptibility loci
(Porjesz et al., 2002). Endophenotypes represent measurable characteristics that
reflect an underlying genotype that may be more closely related to that genotype than
the diagnostic category itself. Endophenotypes must be associated with the illness in
the population, heritable, primarily disorder dependant and co-segregate with illness
within families (Gottesmann & Gould, 2003). The heritability of P300 amplitude in
the normal population has been estimated around 60% (van Beijsterveldt & van Baal,
2002; Wright et al., 2001) with highest heritability (79%) from the Minnesota twin
sample (Katsanis, Iacono, Mcue & Carlson, 1997). Very few studies have looked at
the heritability of the N100 and P200 components. Studies which have included
N100 have found both amplitude and latency heritable (Koutchoubei, 1987 orienting task; O'Connor, Mozerati, & Christian, 1994 - oddball; Surwillow, 1980 oddball). O'Connor et al. also found genetic influences in the waveform shape of
ERPs to both target and non-target stimuli. There are few studies that link ERPs to
genetic findings in schizophrenia. Blackwood (2001) has linked P300 amplitude to
chromosome 1. Preliminary findings about the heritability of target and non-target
ERP components suggests their potential as endophenotypes is worthy of further
investigation.
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1.4

MODELS OF SCHIZOPHRENIA

The last one hundred years of schizophrenia research has shown a shift from
viewing schizophrenia as a loosening of association cognitively (Blueler, 1950/1911)
and a neurodegenerative view of its course (Kraeplin, 1896), to a focus on
specialised or focal deficits, and then to a biologically driven focus on disconnection
and a neurodevelopmental hypothesis (Bullmore, Frangou, & Murray, 1997; Friston,
1998; Peled, 1999). Figure 1 is an attempt to integrate some of the major models
with a unified cognitive deficit and pathophysiology into a working model of
schizophrenia.

Comprehensive models of schizophrenia need to account for multiple
aetiologies including genetic contribution, the age of onset, its remitting and
relapsing course, the modulating role of neurotransmitters, the heterogeneity of
symptoms and the difficulty in finding a pathophysiological marker. The stressvulnerability model of schizophrenia (Zubin & Spring, 1977; Nuechterlein &
Dawson, 1984; Clements & Turpin, 1992) provides insight into the remitting and
relapsing course of schizophrenia. This model proposes that a predisposition to
schizophrenia on the basis of genetic vulnerability and ecogenetic effects interacts
dynamically with psychosocial factors in the individual's life such as family
environment, social network and substance abuse to establish a threshold, beyond
which a person may develop schizophrenia or psychosis. This threshold moves as
protective or destructive factors intersect with the person's vulnerability.
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Working Model of Schizophrenia
(A) Etiology: multiple convergent factors
DNA, gene expression, viruses, toxins, birth injury, psychological experiences

g

‘Q,

g g ‘Q,

(B) Neur °developmental contribution

II

Dysplasia during second half of gestation (resulting in abnormal asymmetry and
connectivity of the adult brain); abnormal synaptic pruning at adolescence.

(C) Anatomic and functional disconnection in neuronal connectivity and
communication in the mature brain involving the modulation of long-term changes in

synaptic efficacy by the ascending neurotransmitter systems.

II

(D) Impairment in a fundamental cognitive process

A breakdown in the normal relationship between stored material and current sensory
input or failure to make use of context in information processing
(See Chapter2, Table 2.1)

II
(E) Impairment in one or more second order Cognitive Processes
(E.g. attention, memory, language emotion)

II

(F) Symptoms of Schizophrenia

(Reality distortion, psychomotor poverty, disorganisation, excitement and
depression/anxiety)

Figure 1. 1 A framework for integrating some of the major models of schizophrenia
Note. Figure adapted from Andreasen's (2000, p108) working model. Changes to
Andreasen's model are in blue. Arrows in blue have been made bidirectional to
reflect the possibility of a two rather than one way interaction.
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The disconnection model, suggesting that different neuronal systems in the
brain have become disconnected from each other in schizophrenia (Friston 1998,
1999) has provided the stress-vulnerability model with a plausible
pathophysiological mechanism. Research suggests that perhaps the difficulty in
finding a single pathophysiological marker despite many years of research is because
the pathology in schizophrenia may involve multi-distributed neural circuits and
neurotransmitter systems (Andreasen, Paradiso, & O'Leary, 1998; Bullmore, et al.,
1997; Friston, 1999; Goldman Rakic & Selemon, 1998; McGlashen & Hoffman,
2000; Peled, 1999). Disconnection models have been proposed in different, but
generally compatible versions by several proponents.

Friston (1999) proposes a regionally specific disruption of effective
connectivity within the brain through experience, or activity dependent plasticity in
systems which would only be functionally expressed in the developed brain,
involving ascending modulatry neurotransmitters. The reduced neuropil hypothesis
(Selemon & Goldman-Rakic, 1999) proposes that the reduction of interneuronal
neuropil in the prefrontal cortex is a prominent feature, and suggests a major role for
prefrontal regions and their multiple distributed cortical, thalamic and striatal
connections in schizophrenia. Peled (1999) suggests a disorder of multiple constraint
organisation with specific symptom factors determined by the site and level of the
disconnection. Reality distortion is associated with a breakdown in auditory
unimodal networks and their connections with heteromodal networks, psychomotor
poverty is associated with disturbances in constraint satisfaction of the networks
located at the highest levels of the hierarchy, and disorganisation is associated with
disturbance that encompasses most if not all brain systems.
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Disconnectivity models can also account for the timing of the onset of
schizophrenia through neurodevelopmental hypotheses. These hypotheses argue that
there are two stages in the development of the brain that can be linked to brain
abnormalities that lead to schizophrenia. The first period, the early
neurodevelopmental stage, takes place during the pre-natal and neonatal period. It is
argued that a combination of early brain lesions and environmental factors such as
pre-natal viral infections, obstetric complications and winter or early spring births
may combine together to predispose a person to schizophrenia but that frank
psychosis may not occur until the brain has matured sufficiently. For example,
Bullmore et al. (1997) present evidence that dysplasia during the second half of
gestation would result in abnormal asymmetry and connectivity in the adult brain.

The next period, the late neurodevelopmental stage, is thought to take place
during brain maturation. Here it is argued that schizophrenia may develop as a
consequence of abnormal synaptic pruning occurring during adolescence. Loss of
synaptic density is known to be a feature of neurodevelpomental plasticity, with
upwards of 60% of synapses being pruned in normal CNS development. This process
reaches the prefrontal and association areas relatively late in the developmental
course during mid-adolescence (Huttenlocher & Dabholkar, 1997), at the same time
as the period of greatest risk for schizophrenia. An acceleration of this process of
synaptic loss may underlie the expression of schizophrenia at this stage as well as the
substantial cortical grey matter volume loss in the longitudinal structural magnetic
resonance imaging (sMRI) studies of recent onset schizophrenia (DeLisi et al., 1997;
Rapoport et al., 1999; Lieberman et al., 2001).
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Evidence in support of disconnection models has been found in different
modalities. Several investigators (Woodruff et al., 1997; Bullmore et al., 1998;
Wright et al., 1999) argue that areas that share neurodevelopmental influences
develop in parallel, establishing statistically definable structural interdependencies
that reflect continued connectivity. Structural MRI studies have identified these
dependencies in normal controls, however decreased interregional dependencies
particularly between frontal hippocampal and temporal regions have been found in
people with schizophrenia (Woodruff et al., 1997 Bullmore et al., 1998; Wright et al.,
1999). Studies have also shown low neuropil levels (Lewis et al., 1999)
abnormalities in synaptic, dendritic, axonal, and white matter tract organization, and
abnormalities of glutamatergic neurotransmission, (Garey et al., 1998; Glantz &
Lewis, 2000; Goldman Rakic & Selemon, 1997) which are consistent with disturbed
intracortical connectivity.

It is also possible that disconnectivity is anatomically restricted, rather than
widespread, with certain cortico-cortical and cortical-subcortical connections
particularly vulnerable to disruption in schizophrenia. The strongest evidence to date
has emphasised the disconnectivity between frontal and lateral temporal cortices
(Frith et al., 1995), between the frontal cortex and the hippocampus (Weinberger
Berman & Torrey, 1992); and in both fronto-striatal thalamic (Robbins, 1990) and in
fronto-thalamic-cerebellar (Andreasen et al., 1998) circuits. Gray (1995, 1998)
proposes a specific disconnection, an anatomic abnormality in the limbic forebrain,
affecting the hippocampal formation, amygdala and temporal and frontal neocortex,
leading to a functional neurochemical abnormality, hyperactivity of transmission in
the ascending mesolimbic doperminergic pathway, that disrupts the comparator
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process. The comparator "has the general function of predicting, on a moment by
moment basis, the next perceived state of the world, comparing this to the actual next
perceived state of the world, and determining whether the predicted and actual states
match or mismatch" (Gray 1995, p 680).
The point of entry for this thesis is at level D (see Figure 1.1) the
psychophysiology of the fundamental cognitive deficit - a breakdown in the normal
relationship between stored material and current sensory input or the failure to make
use of context. However, there is also interaction with other levels,for example,E resultant cognitive deficits; F - clinical symptoms; and at levels prior to D, if the
determined deficits are shown to have potential as biological markers for genetic
investigation.
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2 AUDITORY ERPs IN SCHIZOPHRENIA: INTRODUCTION AND
RATIONALE FOR STUDY 1.
2.1

ADVANTAGES OF ERPS FOR INVESTIGATING BRAIN DYSFUNCTION IN
SCHIZOPHRENIA

Neuroimaging technologies for investigating brain dynamics in schizophrenia
include electroencephalogram (EEG), event-related potentials (ERP), positive
emission tomography (PET), functional magnetic resonance imaging (fMRI), and
single photon emission computerized tomography (SPECT). Although PET, SPECT
and fMRI, provide good spatial resolution, these methods do not have the temporal
resolution to investigate cognitive processing in the millisecond domain (Gordon,
2002). Andreasen, Nopoulos, O'Leary, Miller, Wassink and Flaum (1999) claim that
"the rapid constant checking and updating of input and output" occurs "at the
nanosecond level" (p. 911). While the claim for nanoseconds may be taking poetic
license with the physiology of nerve action potential, it nevertheless points to the
advantages of a technique such as the event related potential (ERP) which has
millisecond resolution.

ERPs provide an index of electrical brain activity time-locked to sensory
stimuli and provide a spatiotemporal map of consequent neural events. They are also
able to distinguish processing stages and can clarify the timing, ordering and
interactions of the intermediate processes that are engaged in specific cognitive
activities (Hillyard & Kutas, 1983). An advantage of ERPs is that neural responses
can be measured for all stimuli, regardless of whether an overt response is required.
This makes ERPs ideally suited for the purpose of this Study as they allow us to
assess the extent to which non-targets, which do not require a response are processed.
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In contrast measures of performance such as response time (RT) are less able to
focus on brain activity to non-target stimuli. Additionally, the analytic requirements
of NMI i.e. subtraction of the baseline activation, elicited by non-target stimuli
from the activation elicited by target stimuli also make it difficult to examine and
contrast early (pre N200 & P300) brain activity to target and non-target stimuli.
Several studies have shown a robust within subject test-retest reliability for ERP
components supporting their validity as markers of CNS functioning (Sandman &
Patterson, 2000; Segalowitz & Barnes, 1993; Sinha & Parsons, 1992; Walhovd &
Fell, 2002). Results form these studies have indicated that measures of amplitude
show superior reliability over measures of latency. Other advantages of ERPs are that
they are accessible and non-invasive. Thus ERPs are well suited to the investigation
of cognitive deficits in schizophrenia and particularly to the investigation of the
proposed comparator disturbance.

2.2

THE FUNDAMENTAL COGNITIVE DEFICIT IN SCHIZOPHRENIA

While the capacity to ignore task irrelevant stimuli and optimally process
relevant target information is seminal to normal brain function, early models of
cognitive disturbance in schizophrenia suggested a global failure of this process,
commonly associated with filter disturbances (Broadbent, 1958). Recent models
(Gray, 1998; Gray, Feldon, Rawlins, Hemsley and Smith, 1991; Hemsley, 1996)
propose a core physiological mechanism underlying this process, namely a
disturbance of the comparator process. The Gray-Hemsley model proposes that the
cognitive deficits exhibited by patients with schizophrenia correspond to a
breakdown in the normal relationship between stored material and current sensory
input. Thus, people with schizophrenia fail to establish appropriate response biases
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because they are unable to use stored memories of regularities based on their
previous experience. This model is consistent with Sokolov's (Sokolov, 1963;
Sokolov & Vinograda, 1975) neuronal model, and with aspects of the models
proposed by Andreasen et al. (1998), Frith (1995), and Servan-Schreiber, Cohen,
and Steingard (1996), suggesting a deficit in the co-ordination and expression of
information, a disruption in the monitoring of willed intention, and a failure in the
inhibitory effect of context, respectively. The fundamental cognitive deficit could
thus be seen as a failure to make use of context in information processing Table 2.1).
Table 2.1 Failure to make use of context in information processing, differing
conceptions of a fundamental cognitive deficit.
"It is a weakening of the influence of stored memories of regularities of previous
input on current perception" (Hemsley, 1987, p182). "This stored body of knowledge
normally interacts with the encoding, comprehension and or retrieval of new
information by guiding attention expectancies, interpretation and memory search."
(Hemsley, 1996)
A disturbance of the comparator process which "has the general function of
predicting, on a moment by moment basis, the next perceived state of the world,
comparing this to the actual next perceived state of the world, and determining
whether the predicted and actual states match or fail to do so ("mismatch")". (Gray,
1995, p 680)
"Several schizophrenic deficits could be related to a disturbance in a single
mechanism with pervasive implications for cognition: the representation and
maintenance of context information". (Servan-Schreiber et al., 1996, p 1105)
"An impairment of the neural mechanisms by which symbolic representations are
both retrieved from long-term memory and 'held in mind' to guide behaviour in the
absence of instructive stimuli in the outside world" (Goldman-Rakic & Seleman,
1997, p 437-438)
A disorder of consciousness or self awareness that impairs the ability to think with
"metarepresentations" (higher order abstract concepts that are representations of
mental states) (Frith, 1992)
Cognitive dysmetria "a disruption in the fluid co-ordination of mental activity that is
the hallmark of normal cognition... The basis of the poor co-ordination may be a
defect in timing or sequencing the flow of information" (Andreasen et al., 1999, p
911)
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2.3

THE ODDBALL PARADIGM

The auditory oddball paradigm, also called the P300 paradigm, is one of the earliest
and most extensively researched paradigms for eliciting cognitive ERPs (Ford, 1999;
Picton, 1992), with a body of evidence on functional and clinical implications. In the
`oddball' paradigm, a subject detects and responds to an infrequent but task-relevant
stimulus (target), randomly interspersed among more frequent, standard stimuli (nontarget). These stimuli can be either auditory or visual. Most studies in schizophrenia
have reported the auditory, rather than the visual P300 (Ford, 1999) as P300
abnormalities are more consistently observed in auditory paradigms (Egan et al.,
1994; Ford et al., 1994; Pfefferbaum, Ford, White & Roth, 1989). In the auditory
version of the oddball paradigm, the participant is instructed to listen to a series of
high and low tones, and to respond (e.g. by button press or counting) to one tone
designated the target stimuli. There is thus a string of frequently occurring stimuli
(standards or non-targets) interrupted intermittently by infrequently occurring (rare
or target) stimuli, making the non-targets the context in which the decision 'target' is
made. This comparison between target and non-target stimuli has been likened to the
comparator process (Ford, 1999; Brown, Gonsalvez, Harris, Williams, & Gordon,
2002). Kok (1997) suggests that the primary function of the neural network involved
in target identification in the oddball is to compare stimulus attributes with an
internal representation of the target, or memory-dependant characteristics of the
target. Although more sophisticated paradigms exist for examining the use of context
and selective attention, they are often too complex to use in clinical settings. As
generalised attentional and/or motivational impairments adversely affect
performance on most cognitive tasks in schizophrenia, it is important to have a task
that patients are capable of performing and that does not require training. The
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auditory oddball has the advantage of being a simple task which can be performed by
most subjects. Thus an ERP deficit elicited by such a task is likely to reflect
mechanisms implicated in the processing requirements of the task, rather than
secondary reactions to the level of difficulty or incorrect performance on the task.
Notably, a disturbance at this level may underpin disturbances found in more
complex paradigms. A review of P300 findings in schizophrenia, indicates the
contribution the oddball paradigm has made to our understanding of the cognitive
disturbance in schizophrenia, along with the limitations of this research, and some
questions that arise from it.

2.4

AUDITORY P300 FINDINGS IN SCHIZOPHRENIA

Roth and Cannon (1972) and Levit, Sutton and Zubin (1973) were the first to
use the auditory oddball paradigm with people with schizophrenia, both finding
reduced P300 amplitude to target stimuli. These studies utilised the oddball paradigm
in the passive condition, where subjects ignore the tones. Most subsequent studies
have used the attend paradigm, where subjects either count or press a button to
targets. Roth and Cannon's study is particularly relevant, as it was the only study
found which examined the non-target before and after the target stimuli separately, in
schizophrenia, apart from the Studies 2 and 4 in the current thesis.

The P300 deficit has been reproduced widely (Ford, 1999; Jeon & Polich,
2000; Pritchard, 1986) making it "perhaps the most replicable biological reflection of
schizophrenia" (Ford, 1999, p 668). Most oddball studies have concentrated on the
P300 component to the target stimuli, as the P300 component was seen as
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endogenous, or sensitive to cognitive determinants. The earlier components, N100
and P200 which occur in both target and non-target stimuli, were seen to be more
exogenous, or sensitive to manipulations of sensory characteristics (Van Der Stalt,
1999). The interpretation of the reduced P300 in schizophrenia has led to a number
of hypotheses which have generated a large area of research. Important issues
arising from this research are explored below.

2.4.1 Neuroleptic medication and P300
A common limitation of many P300 studies in schizophrenia is the use of
medicated patients as subjects. As untreated psychosis has undesirable outcomes,
both in the short and long term, withdrawing a patient from medication or delaying
the introduction of medication raises important ethical questions. However, the
possibility that medication may influence ERP findings needs to be considered. As it
is a variable occurring in the clinical and not in the control group, it is necessary to
demonstrate that the differences between groups are not attributable to medication.
This is especially important, as several neuroleptic medications also have
anticholinergic effects, and specific anticholinergics are used to control
extrapyramidal symptoms. However, cholinergic suppression has been shown to
reduce P300 amplitude in healthy individuals (Hammond, Meador, Aung-Din, &
Wilder, 1987; Meador et al 1987; Meador et al 1988 and Meador et al 1989).

The possibility that reduced P300 in schizophrenia could be a medication
artefact has been addressed by several studies which have found reduced P300 in
patients with schizophrenia who have been withdrawn from neuroleptic medication

36

(Coburn et al., 1998; Ford et al., 1994, Laurent et al., 1999; Ogura et al., 1991) and in
a neuroleptic—naive sample (Hirayasu et al., 1998).

More recently, several studies have examined the interaction of medication
and P300 from the alternative view, the possibility that neuroleptic medicine could
normalize the P300 reduction in schizophrenia. While traditional antipsychotic
medications do not appear to increase P300 amplitude in schizophrenic patients
(Blackwood et al., 1987; Ford et al., 1994), there have been mixed results with the
atypical antipsychotic medications that target various subtypes of serotonin receptors
and D4, rather than the D2 dopamine receptors targeted by typical antipsychotic
medication. Clozapine has been reported to increase P300 amplitude (Umbricht et
al., 1998), while risperidone had no significant effect on P300 amplitude but
normalized the latency (Iwanami et al., 2001). Gonul et al. (2003) found that,
although olanzapine normalized P300 amplitude over the frontal area, the effect was
unrelated to changes in the patients' clinical symptoms, and P300 amplitude over the
parietal area remained below normal limits. The salient point here is that reduced
P300 amplitude in schizophrenia does not appear to be the consequence of
antipsychotic medication.

2.4.2 Effects of probability manipulations on P300 deficits in schizophrenia
Although there is a large body of work on the effects of probability and local
sequence effects on the P300 in the normal population, this area received little
attention in schizophrenia research. The bulk of studies on P300 in schizophrenia
have used low probability targets (Jeon & Polich, 2000). Duncan, Perlstein and
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Morihasa (1987) varied probability (0.10, 0.30 and 0.50) and found that patients with
schizophrenia had significantly reduced P300 only to low probability stimuli.
Mathalon and Ford (2002) varied probability between 0.2 and 0.8 and again found a
significant reduction in P300 amplitude only to the low probability stimuli in
schizophrenia. However the results in both these studies could be due to target to
target interval (TTI) (see Chapter 6 for review of TTI versus probability) rather than
probability. Sequence effects in schizophrenia have received even less attention, with
only one study on sequence effects on P300 and RT in schizophrenia (DuncanJohnson, Roth and Kopell, 1984). This Study used a choice reaction time task which
requires a response to all stimuli presented. No studies were found which
investigated sequence effects on ERPs elicited by the non-target stimulus, or to target
stimuli which occurred amongst stimuli which did not require a response. There is
thus a need for further investigation of the effects of stimulus sequence on ERPs
elicited by target and non-target stimuli in schizophrenia. The literature on sequence
effects on ERPs is discussed in more detail in Chapter 6 in which Study 3 examines
sequence effects on ERPs to target and non-target stimuli in FESz.

2.4.3 Interstimulus Interval (ISI) and P300 in schizophrenia
ISI is another variable demonstrated to influence the magnitude of P300
amplitude. Studies have shown that P300 amplitude is not reduced in schizophrenia
in comparison with normal controls in paradigms with long ISIs (Mathalon & Ford,
2002; Roth, Goodale & Pfefferbaum, 1991). Mathalon and Ford examined the
differences between short (1.5 secs) and long (8 sec) ISI and found that with the
increase in ISI controls showed a slight decrease in P300 amplitude to targets but a
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marked increase in P300 to standards. In contrast, patients with schizophrenia
showed no change in the P300 to targets and a relatively small increase in P300 to
standards with the ISI increase. Relative to the controls, P300 amplitude to targets
was reduced in the schizophrenic patients with the short but not the long ISI. Without
non-targets (standards) there is nothing with which to compare the target making
limited demands on comparative or working memory processes (Donchin and Coles,
1988). Ford (1999) suggests that whether P300 amplitude differs between
schizophrenia and normal controls, depends on either the absence of a comparator
process, i.e. where there is only the target and no non-target, or a very long ISI.

2.4.4 Skin conductance and P300 in schizophrenia
Some investigators have attempted to explore the relationship between skin
conductance and P300. The main difficulty in these attempts was that the P300 is
recorded in an attend paradigm usually with ISIs of a few seconds, while SCRs,
which have recoveries over tens of seconds, are usually acquired in an ignore
paradigm, with much longer ISIs. Roth, Goodale and Pfefferbaum (1991) attempted
to explore the interaction of P300 and skin conductance in a passive three stimulus
oddball and an active one stimulus reaction task with interstimulus intervals greater
than 12 seconds. Not surprisingly, and consistent with findings that the P300 is not
reduced in schizophrenia with experiments employing longer ISIs (Mathalon & Ford,
2002), they did not find a reduction in P300 in schizophrenia. The development of a
program to decompose the overlapped SCRs collected in a short ISI paradigm (Lim
et al., 1997) allowed the simultaneous collection of SCRs and ERPs in the traditional
short ISI P300 paradigm. Williams et al. (2003) subaveraged ERPs based on the
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presence or absence of an SCR defined orienting response (OR), and found that the
pattern of increased frontal P300 in the with OR' compared to the 'without OR'
condition present in the control group, was not found in the group with
schizophrenia. These results indicate that P300 may be modulated by arousal.

2.4.5

Single trial studies of P300 in schizophrenia

As P300 amplitude reduction in schizophrenia had been demonstrated in
ERPs averaged across the experiment, it was possible that the averaging process may
be obscuring variability within the ERPs elicited by individual targets. Ford, White,
Lim & Pfefferbaum (1994) applied a P300 screen to all single trial responses to
target stimuli and found that the schizophrenia group had fewer trials passing the
P300-screen, smaller P300s on each trial, and P300s that were more variable in
latency across trials than the normal control group.

Wagner, Roschke, Fell and Frank (1997) examined the P300 to all single trial
responses (target and non-target) in groups with depression, schizophrenia and
normal controls. Amplitude distributions of single trials' maximum positive
deflections (P300) for both target and non-target stimuli were determined, and served
as a basis for calculating the discrimination index d'. This index characterised
differences in the electrophysiological responses to target and non-target stimuli and
was significantly lower for patients with schizophrenia than for controls and
depressive subjects. Thus, calculating d' on the basis of single trial analysis
differentiated between schizophrenics and depressives, while there was no significant
difference between the two groups on the traditionally averaged P300 component
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elicited by target stimuli (Roschke & Fell, 1997; Wagner, Roschke, Fell, & Frank,
1997; Wagner, Roschke, Grozinger, & Mann, 2000). This suggests that it is not only
necessary to examine the ERPs to target and non-target stimuli, but it is also
necessary to investigate the relationship between target and non-target ERPs as this
may be important to the specificity of ERP findings in schizophrenia. Studies 2 and
4, in the current thesis have investigated the contrast between ERPs elicited by target
and non-target stimuli.

2.4.6 Theoretical interpretations of the P300 deficit in schizophrenia
P300 amplitude has been envisaged as a general index of cognitive
processing, however its specific meaning continues to be debated. The major
theoretical interpretation of P300 amplitude is that it is generated by "tasks that are
required in the maintenance of working memory" (Donchin, Karis, Bashore, Coles
and Gratton, 1986, p 256). P300 has been demonstrated to follow the decision "target
or non-target?" as subjects can accurately respond to target stimuli before the peak of
the P300 component (Ritter, Simson, & Vaughn, 1972; Picton, Hillyard &
Galambos, 1976). Verleger (1988) suggests that it represents perceptual closure, i.e.
the P300 is evoked by 'awaited' stimuli when participants deal with repetitive highly
structured tasks. On the other hand, Donchin and Coles (1988) suggest it may
represent context updating when stimulus events require that an individual's model
of the environment must be revised. This refers to the updating of memory after
incoming information has been evaluated. In addition to stimulus probability, the
extent to which this updating process is activated depends upon the value,
significance or relevance of the stimulus (Sutton & Ruchkin, 1984). These authors
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stress that this is a parietal P300 because of `awaitedness', not 'unexpectedness', i.e.
P300b reflects suspense and P300a a surprise. Both Verleger and Donchin agree that
P300 is concerned with expectancy: for Donchin P300 reflects 'expectancy violation'
whereas Verleger sees the P300 as the result of 'expectancy confirmation'.

However, there are criticisms of each of these hypotheses. A criticism of
Donchin's hypothesis of memory updating is that the P300 occurs in situations in
which one would not think that updating is necessary Picton (1992) suggests that in
the usual oddball task the brain should quickly develop a memory model that
incorporates the possibility of an occasional target stimulus. Updating this model
should not be necessary each time the target occurs. The relationship of P300 to
expectancy and probability has been challenged by the target to target interval (TTI)
hypothesis (Gonsalvez et al., 1999; Gonsalvez & Polich, 2002; Croft, Gonsalvez,
Gabriel & Barry, 2003). The TTI hypothesis proposes that increased P300 amplitude
could be better explained by target to target interval (TTI) than by expectancy. The
TTI hypothesis is reviewed in more detail in Chapter 6. Picton et al. (1992)
hypothesised that P300 reflects the transfer of information from automatic to
controlled processing or consciousness, yet P300 waves have been recorded in
patients who are not conscious of the stimuli (Shefrin, Goodin, & Aminoff, 1988).

Another approach to understanding the meaning of P300 amplitude has been
to correlate P300 amplitude with neuropsychological measurements. P300 amplitude
reduction has been correlated with poorer performance on tests of memory (Neiman
et al., 2002), including the verbal paired-association sub-test of the Weschler
Memory Scale (Nagasawa et al., 1999), and lower IQ (Shajahan, O'Carroll, Glabus,
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Ebmeier, & Blackwood, 1997). Prolonged P300 latency has been correlated with
verbal fluency scores (Souza et al., 1995). P300 amplitude reduction was also
correlated to measures of disability of daily life (Iwanama, Yamashina, Kazamatsuri,
& Kamijima, 1999).

Intracranial recordings describe both P3a and P3b generators for the P300
elicited to target stimuli (Halgren, Marinkovic & Chauval, 1997). The P3a, related to
the orientation of attention, is thought to occur in para-limbic and prefrontal
networks (Halgren et al., 1997; Yamaguchi & Knight, 1991; Yamaguchi & Knight,
1993). The P3b, associated more with contextural integration, is generated in the
temporo-frontal region (ventrally), association cortices (temporo-parietal region) and
the hippocampus (Frodl-Bauch, Bottlender, & Hergerl, 1999 for review; Halgren,
Squires, Wilson, Rohrbaugh, Babb & Crandall, 1980; Halgren, Marinkovic &
Chauvel, 1997; Okada, Kaufman, & Williamson, 1983). Functional neuroimaging
studies indicate that the P300 signal discrimination process engages preferential
anterior and posterior cingulate, supramarginal gyrus (SMG) and hippocampal
networks (Clark, Fannon, Lai & Benson, 2001; Kiehl, Laurens, Duty, Foster &
Liddle, 2001; McCarthy, Luby, Gore & Goldman-Rakic, 1997).

Research findings on whether: the P300 is a state or trait deficit; ERP
disturbances are present at onset of illness and/or different from chronic
schizophrenia; and also the differential effects of non-target sequence effects, age
and gender on ERPs in schizophrenia compared with normal controls; topography;

43

and symptom relationship to ERP deficits are discussed in Chapter 4, and provide the
rationale for Study 2.

2.5

BEFORE THE P300: TARGET AND NON-TARGET N100 P200

2.5.1 Rationale for investigating ERPs to non-target stimuli
In auditory oddball studies, ERPs elicited by non-target stimuli are
occasionally presented graphically, but are not usually the focus of investigation or
analysis. However, recent research suggests that there are both theoretical and
empirical indications for investigating possible ERP disturbances to non-target
stimuli in addition to target stimuli in people with schizophrenia. Houghton and
Tipper's (1996) model of "normal" selective attention proposes that, in addition to
the excitatory feed back loop elicited by target stimuli, selective attention involves an
inhibitory feedback loop elicited by non-target stimuli (see Figure 2.1). Thus ERP
responses to non-target stimuli, would reflect how the brain, when involved in an
oddball paradigm, processes information which is not task relevant.
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Figure 2.1 Model of the response system in selective attention (Houghton and
Tipper, 1996, p27).

Evidence of cognitive effects on ERPs to non-targets has come from
comparisons with ERPs elicited by 'neutral' stimuli, delivered while the subject is
not involved in any related cognitive task (Desmedt & Tomberg, 1991). GarciaLarrea, Lukaszewicz and Mauguiere (1992) compared ERPs to non-target stimuli in
an active oddball (count response required to target), a passive oddball (no
instructions given to subjects), and a neutral, ignore condition (only non-target
stimuli). ERPs elicited by non-target tones during either the passive or active
oddball, showed consistent differences when compared to ERPs to the neutral
condition, with N100 and P250 amplitudes enhanced in the two former conditions.
Notably, the P250 component was not even present in 8 of the10 subjects during the
neutral runs. There were early and late effects associated with N100 amplitude to
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non-target stimuli. The early effect found in all three conditions was maximal
centrally and disappeared with progression of the experiment. This effect was
interpreted to reflect changes in a vigilance-related component, the disappearance
seen as progressive optimisation of the alerting state. The later effect was not found
in the neutral condition and was more important in the active than passive oddball. It
was predominantly frontal, with higher amplitude over the right hemisphere and
persisted to the end of the recording session. This effect was thought to be processing
negativity evoked by active discrimination from relevant target tones. Similarly

Yordanova, Kolev and Polich (2001) found event-related desynchronisation in the
alpha band to stimuli when used as non-targets in the auditory oddball but no alpha
event related desynchronisation when the same stimuli were used for passive
listening.

2.5.2 Rationale for examining N100 and P200 components to target and non-target
stimuli and their differentiation
As participants can accurately respond to target stimuli before the peak of the
P300 component (Ritter, Simson, & Vaughn, 1972; Picton, 1992) the decision "target
or non-target?" may have preceded the process that generates the P300. Goodin,
Aminoff, and Mantle (1986) suggest that the decision also precedes the N200
component, based on changes in the EMG prior to the response. Models which
propose a deficit at the comparator stage (Gray, 1998; Hemsley, 1996) and stress a
failure in the inhibitory effect of context (Servan-Schreiber, et al., 1996) would thus
predict an earlier disturbance that perhaps might be reflected in deficits of N100 and
P200, elicited by both target and non-target stimuli in addition to the P300 deficit.
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Consistent with some current theories (e.g. Gray, 1998; Hemsley, 1996),
critical dysfunctions in schizophrenia could relate to mechanisms that are called into
play when switches from one stimulus to another occur. Such processes may be best
captured by differential response to target and non-target stimuli rather than by
studying only target related ERPs. In support of this, in a single trial study of P300
( Wagner et al., 1997) it was the discrimination index d' that was specific to
schizophrenia compared to depression (see 2.3.5). There is also evidence that N100
and P200 components elicited by target and non-target stimuli are sensitive to
schizophrenia. Boutros et al. (1997) suggest from their data that N100 and P200
elicited by target and non-target stimuli are helpful in diagnostic classification, and
Ford, Mathalon, Kalba, Marsh and Pfefferbaum (2001) demonstrated that N100
amplitude reduction to targets and non-targets is more specific to the "core
pathophysiology" of schizophrenia than P300 reduction and "deserves more study"
(p857). The current thesis provides a detailed examination of N100 amplitude to
target and non-target stimuli.

There are additional indications of disturbances in earlier components which
might have later 'flow on' effects on the P300 from studies which have found
reduced P50 suppression (Yee, Nuechterlein, Morris, & White, 1998) and mismatch
negativity (MN/IN) in schizophrenia (Javitt, Doneshka, Grochowski, & Ritter, 1995;
Mitchie et al., 2000; Shelley et al., 1991). MMN is a negative component of the ERP
elicited by a discriminable change in a repetitive background of auditory stimulation,
while the subjects attention is directed elsewhere, eg reading a book (Michie, 2001).
Unlike components elicited to the auditory oddball in this thesis, in which a response
is required to the deviant (target) stimuli, the MMN does not rely on attention to, or
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detection of the deviant stimuli. Javitt et al. (1993) suggests MMN reflects
widespread dysfunction of working memory. However, Michie (2001) suggests that
it represents an abnormality within the window of temporal integration,that is coincident with the early phase of auditory sensory memory. As this thesis focuses on
the oddball paradigm an in depth review of the MMN is beyond the scope of the
thesis (for a review of this literature see Michie, 2001).

2.5.3 N100 component
N100 is involved in stimulus classification: the decision to further process
information or ignore them (Fabiani, Gratton, & Coles, 2001; Kok, 1997) Several
studies have demonstrated correlations between N100 and specific aspects of
stimulus features (Naitanen & Picton, 1987; Pritchard, 1986), and between N100
and attention, with N100 amplitude larger with increases in attentional
requirements (Maclean, Ohman, & Lader, 1975; Pritchard, 1981) whether
automatic or directed (Ford, Roth, Menon, & Pfefferbaum, 1999). N100
amplitude is also related to arousal and is enhanced with caffeine (Bruce, Scott,
Shine, & Lader, 1992) and diminished with alcohol (Pfefferbaum, Roth,
Tinkleberg, Rosenbloom, & Kopell, 1979). Ford et al. (1994), found that during
antipsychotic treatment larger N100 amplitude to target and non-target stimuli
were associated with higher levels of methoxyhydroxyphenylglycol which they
interpreted to suggest an influence of arousal.
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N100 amplitude shows a systematic reduction in amplitude when the eliciting
stimulus is repeated (for both attend and ignore instructions) usually in habituation
paradigms. Whether this reflects a cognitively relevant process, or a more basic
neurophysiological process is not clear, i.e. can it be seen as habituation, as defined
by orienting response theory (Sokolov, 1963), or a process involving the recovery
cycle or refractory period of the neural generators underlying the N100 (Callaway,
1973; Naatanen and Picton, 1987). This attenuation has often been reported as
habituation. However, some studies (Barry, Cocker, Anderson, Gordon, & Rennie,
1992; Budd, Barry, Gordon, Rennie, & Mitchie, 1998) have challenged this, as there
is no evidence of dishabituation following the change stimulus. These studies suggest
support for the view that the N100 decrement is due to refractory periods or recovery
cycle processes of at least two generators contributing to activity in the N100 peak
latency range. Recovery cycle or refractory cycle effects reflect the dissipation of a
state of temporal excitability of the N1 generators following their activation by a
stimulus (Callaway, 1973; Wastell, 1980). It is generally maintained that closely
spaced presentations of auditory stimuli do not allow adequate recovery of these
mechanisms and produce a decline in Ni amplitude (Callaway, 1973; Naatanen and
Picton, 1987). However in direct contrast to this, N100 amplitudes to frequent tones
(non-targets) in the oddball paradigm have been found to change across the stimulus
sequence, with larger amplitudes associated with longer trains of frequent stimuli
(Hermanutz, Chen, & Sommer, 1981; Hirata & Lehman, 1990, Starr, Aguinado, Roe,
& Michalewski, 1997). This increase in N100 to non-target stimuli with stimulus
repetition challenges a recovery cycle explanation.
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Genetic analysis of ERPs suggests that several regions of the human genome
contain genetic loci related to the generation of N100, in particular the GABA (A)
receptor (Porjesz et al., 2002; Uraski, Ogura, Hirano, & Tomori, 1994). Additionally,
increased levels of GABA may affect N100 by reducing the signal that is recorded
over the prefrontal area of the brain (Winterer et al., 2000)
2.5.4 N100 in schizophrenia
Target stimuli
Reduced N100 amplitude to target stimuli has been found in both medicated
and unmedicated patients with schizophrenia (Blackwood et al., 1987; Ford et al.,
1994; Ford et al., 1999; Ogura et al., 1991; Pfefferbaum, Wenegrat, Ford, Roth,&
Kopell, 1984; Pfefferbaum, Ford, White, & Roth,1989; Pritchard, 1986; Roth,
Horvath, Pfefferbaum, & Kopell, 1980; Roth, Pfefferbaum, Kelly, Berger, & Kopell,
1981; Roth Goodale, & Pfefferbaum, 1991; Shagrass, Straumanis, Roemer, &
Armadeo, 1977; Shagrass, Roemer, Straumanis, & Armadeo,1978). It is thus
unlikely to be solely related to drug effects, despite reports that neuroleptic
medication reduces N100 amplitude (Baribeau-Braun, Picton, & Gosselin, 1983;
Pfefferbaum, Ford, White, & Roth, 1989). N100 latency to target stimuli has either
been found not to differ (Ford et al., 1994; Boutros et al., 1997 Laurent et al., 1998)
or to be earlier (Ford et al., 2001) for schizophrenia compared to controls.

Non-target stimuli
Reduced N100 amplitude to non—target stimuli has also been found in both
medicated (Pfefferbaum et al., 1984; Roth & Cannon, 1972) and unmedicated
(Laurent et al., 1999) patients with schizophrenia. Roth and Cannon (1972) further

50

clarified that N100 amplitude was larger for controls only for either target stimuli or
non-target stimuli that immediately precede a target, but not for the first or second
non-target that followed a target stimulus. However this study employed an ignore
condition, with no response required to target stimuli. Studies 2 and 4 (Chapters 5 &
7) in the current thesis examine these effects in the more commonly used attend
paradigm in which the subject is asked to respond to target stimuli.

Ford et al. (1994) found delayed N100 latency to non-targets. Other studies
have not found significant differences in N100 latency to non-target stimuli in
schizophrenia (Boutros et al., 1997, Laurent et al., 1999).

2.5.5 P200 component

The P200 component may represent inhibition of sensory input from further
processing (Hegerl & Juckel, 1993; Schupp, Lutzenberger, Rau, & Birbaumer, 1994)
and is normally associated with automatic stimulus identification and discrimination
(Lindholm & Koriath, 1985). Although the topography of N100 amplitude to target
and non-target stimuli is similar, there are differences in topography between target
and non-target P200 amplitude. This difference appears to result from the distortion
introduced by the concurrent negative shift of the N200 (Simson, Vaughan, & Ritter,
1977). Topographically, P200 to non-target stimuli is maximal centrally (Amenedo
& Diaz, 1998).
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2.5.6 P200 component in schizophrenia
The P200 has been reported to be earlier, or larger in people with
schizophrenia (Pfefferbaum, Horvath, Roth, Tinklenberg, & Kopell, 1980; Roth,
Horvath, Pfefferbaum, & Kopell, 1980), decreased in some studies (Faux et al.,
1987), but not different in other studies (Ford et al., 1994). No difference in P200
amplitude and latency to non-target stimuli was found in studies with unmedicated
patients (Ford et al., 1994; Laurent et al., 1999). However, Ogura et al. (1991) found
P200 amplitude increased in patients withdrawn from medication.

2.6

CONCLUSION

Most oddball research in schizophrenia has focused on the P300 component,
however both the theoretical and empirical evidence reviewed in this Chapter
indicate the need to investigate ERPs to non-targets in addition to targets in
schizophrenia. This evidence emphasizes the necessity for examination of the
differences between N100 and P200 components elicited by target and non-target
stimuli in schizophrenia as compared to normal controls.
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3 STUDY 1: ERP COMPONENTS ELICITED BY TARGET AND NONTARGET STIMULI IN SCHIZOPHRENIA AND NORMAL CONTROLS.

The main resultsof this study have been published (Brown et al., 2000, see Appendix
2 for a copy of the article). A more complete account of the Study and its results is
presented below.
3.1

INTRODUCTION

The review of the oddball ERP literature in schizophrenia in Chapter 2 indicated a
focus on the robust P300 defict. However the usefulness of this finding as a
biological marker for schizophrenia is limited by its lack of specificity. Theoretical
and empirical findings (see Chapter2, 2.5.1 and 2.5.2) provide some support for the
notion that a comparator disturbance in schizophrenia, leading to a failure to make
use of context in information processing, might occur 100-200ms post-stimulus and
consequently would be better captured in the differentiation between target and nontarget ERP components, particularly the earlier N100 and P200 components. ERP
studies in schizophrenia have focused mainly on the P300 component elicited by
target stimuli, many restricting their analysis solely to P300. Less attention has been
given to earlier N100, P200 components to target stimuli and even less to non-target
stimuli (see Chapter 2, 2.5.4 and 2.5.6). This study investigated deficits in earlier
components, N100 and P200, to both target and non-target stimuli in schizophrenia,
in addition to the later components N200 and P300.

3.2

HYPOTHESES

a) Between groups, Non-targets
1. The N100 to non-target stimuli will be reduced and occur later in the
schizophrenia group.
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2. P200 amplitude will be reduced or not differ and P200 latency will be earlier,
to non-target stimuli in the schizophrenia group.

b) Between Groups, Targets
1. N100 will be reduced and earlier to target stimuli in the schizophrenia group.
2. P200 will be increased and delayed to target stimuli in the schizophrenia
group.
3. N200 will be reduced and delayed to target stimuli in the schizophrenia
group.
4. P300 will be decreased and delayed to target stimuli in the schizophrenia
group.

c) Group by Stimulus Contrasts
1. N100 will be increased and delayed to target compared with non-target
stimulus in the control but not the schizophrenia group.

2. P200 amplitude will be increased and prolonged to non-target compared with
target stimulus in the control but not the schizophrenia group.

3.3

MET HOD

3.3.1 Participants
Forty participants with Schizophrenia (11 females and 29 males; mean age
35.45 years, range 20 to 53 years) were recruited from hospitals and community
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centres in Sydney. Each participant was interviewed with Sections G (Schizophrenia
and other psychotic disorders), M (Organic mental disorders), and P (interviewer
observations) from the Composite International Diagnostic Interview (CIDI) (World
Health Organisation, 1992a), resulting in a DSM-IV (American Psychiatric
Association, 1994) and ICD10 (World Health Organisation, 1992b) diagnosis of
schizophrenia. Exclusion criteria for both this group and for the normal control group
were a recent history of substance abuse, epilepsy or other neurological disorders,
and mental retardation or head injury, assessed using section M from the Composite
International Diagnostic Interview (World Health Organisation, 1992a) and the
Westmead Hospital Clinical Information Base questionnaire. After interview,
schizophrenic symptoms were rated by the participating psychiatrist, using the
Positive and Negative Syndrome Scale (PANNS) (Kay and Opler, 1987). The mean
chlorpromazine equivalent for medication in the participants with schizophrenia was
660.5 ± 636.6 mg.
Forty control participants (mean age 36.7 years, range 20 to 54 years) were
drawn from the general population and were age and gender matched to within 5
years with the schizophrenia group. Control participants were screened for history of
psychiatric illness (themselves or first degree relative). The Westmead Hospital
Clinical Information Base questionnaire was also used to obtain demographic
information for both groups.

3.3.2 Data Acquisition Procedure

All participants were asked to refrain from drinking caffeine or smoking for
at least three hours prior to their recording. Participants were seated in a reclining
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chair in a quiet, dimly lit laboratory; facing a video screen and wearing a pair of
headphones (see Figure 3.1). To reduce eye blinks, participants were instructed to
look at a small dot on a computer screen placed 60 cm in front of them during the
task. The Study was approved by Western Area Health Service and University of
Wollongong ethics' committees.

A conventional auditory oddball paradigm was employed, consisting of 40
target tones (1500 Hz with 15% probability and 247 non-target (1000 Hz) tones both
lasting 50ms (with 10ms rise and fall). The tone intensity was 60 dB SPL and the
interstimulus interval (IR) was 1.3 s. Participants were asked to ignore the low
pitched (non-target) tones and press two reaction time buttons (with the index finger
of each hand, to control for possible lateralised effects of motor responding) when
they identified a high pitched (target) tone. Speed and accuracy of response were
emphasised equally. EEGs were recorded on a DC based system (Synamps equipped
with a 16-bit AID converter) from 19 scalp sites (Fp 1, Fp2, Fz, F3, F4, F7, F8,C3,
C4, Cz, T3, T4, T5, T6, P3, P4, Pz, 01, 02) according to the 10-20 International
system (Bloom, 1982) in reference to linked-ear electrodes. In this Study analysis
was restricted to midline sites, while full topography is analysed in Study 2. The
sampling rate was 250 Hz. A low pass filter was applied to the signals prior to
digitization. The cut-off of this filter was 50 Hz, with attenuation being 40dB/decade
above 50 Hz. In addition, a 50Hz notch filter was applied to eliminate 50Hz AC
mains power supply interference. Horizontal eye movement potentials were recorded
using two electrodes, placed 1 cm lateral to the outer canthus of each eye. Vertical
eye movement potentials were recorded using two electrodes, placed on the middle
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of the supraorbital and infraorbital regions of the left eye. Impedance for all
electrodes was less than 5 kOhms.

EOG correction was carried out off line using a standard procedure (Gratton,
Coles, & Donchin, 1983). Only correctly identified target epochs for which a button
press response was obtained within one second of the target tone were analysed.
Averaged ERPs to target stimuli were computed and N100, P200, N200 and P300
peaks were measured relative to a prestimulus (200ms) baseline by an automated
system based on the detection of a consistent change in the sign of the gradient of the
wave form. Thus a change from a consistently positive to a consistently negative
gradient was identified as a positive peak, and vice versa for a negative peak (Haig,
Gordon, Rogers, & Anderson, 1995) with the criteria that N100 occurred between 80
-140ms, P200 between 150-240ms, N200 between 200-280ms and P300 between
250-500 ms. Peaks thus identified were then verified through visual inspection. N100
and P200 peaks in averaged ERPs to non-targets before and after were ascertained
according to the same method.
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Figure 3.1 Picture of a participant, fitted with the electrocap, in the laboratory.

3.3.3 Analysis
N100 and P200 amplitudes and latencies were submitted separately to a 3
way ANOVA repeated measures design, incorporating group (schizophrenia vs.
controls) by stimuli (target vs. non-target) by electrode site (Fz, Cz, Pz), with
repeated measures for stimulus and site factors. For the site factor, linear and
quadratic contrasts were examined, the linear contrast purporting to examine reduced
amplitudes at parietal sites (Fz vs. Pz) and the quadratic contrast purporting to test
the frequently observed maximal amplitudes at central sites (Cz vs. Fz + Pz). N200
and P300 components were reliably observed only to the target stimulus and were,
therefore, subjected to a two way ANOVA, incorporating group (schizophrenia vs.
controls) and electrode site (Fz, Cz, Pz) with repeated measures for the site factor.
Similar linear and quadratic contrasts as above were carried out for the site factor.
Only results form midline sites are included in this Study, full topography is
examined in the second Study (Chapter 5).

3.4

RESULTS

Average ERPs for midline sites are presented in Figure 3.2 (between-groups)
and Figure 3.3 (within group). Means and standard deviations for each component
amplitude and latency appear in Table 3.1. A small percentage (between 1% and
2.5% in each group) of ERP measures were identified as outliers (greater or less than
one and a half the interquartile range from the upper and lower quartile). Because
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results remained unchanged following removal of outliers only results based on
entire dataset (with outliers) is presented here.
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Figure 3.2 Between-Group ERP differences for target and non-target stimuli.
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Figure 3.3 Within-group ERP differences for target and non-target stimuli.
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Table 3.1 Component means and standard deviations (SD) for control and
schizophrenia groups to target and non-target stimuli.

Target
Control
Mean
N100
amplitude

N100
latency

SD

Non-target
Schizophrenia
Mean

SD

Control
Mean

SD

Schizophrenia
Mean

Fz

-10.01

3.06

-7.11

3.10

-7.99

2.80

-5.35

SD
2.65

Cz

-11.57

3.68

-7.34

3.36

-9.42

3.41

-5.88

2.61

Pz

-6.48

2.73

-3.74

2.44

-5.41

2.45

-3.33

1.45

Fz

108.60

13.61

102.70

17.60

100.60

13.24

103.28

13.73

Cz

105.80

10.55

98.78

11.28

99.00

9.26

99.25

8.03

Pz

103.30

10.57

94.55

13.36

99.40

8.09

99.00

13.01

P200

Fz

1.17

4.27

2.86

4.61

3.97

3.00

3.33

2.73

amplitude

Cz

0.10

4.28

5.41

5.35

6.45

3.70

5.59

2.74

Pz

1.93

3.79

4.61

4.03

3.70

3.09

3.40

2.10

P200

Fz

171.14

16.19

173.35

19.05

204.50

31.02

184.20

24.13

latency

Cz

164.42

15.11

173.88

21.64

209.03

31.27

182.65

21.56

Pz

161.26

20.38

169.22

33.29

198.63

39.72

179.00

27.82

N200

Fz

-5.28

3.72

-5.08

4.94

amplitude

Cz

-7.62

6.52

-2.40

6.46

Pz

-2.62

5.24

0.20

5.76

N200

Fz

215.85

19.12

227.93

35.50

latency

Cz

210.15

19.29

226.15

40.55

Pz

202.57

22.50

223.39

40.47

P300

Fz

9.92

6.45

5.00

5.79

amplitude

Cz

11.18

8.15

10.35

7.13

Pz

17.38

7.59

15.01

7.14

P300

Fz

323.33

25.20

327.28

34.23

latency

Cz

322.69

29.21

327.98

49.64

Pz

334.83

37.50

350.38

48.03
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3.4.1 N100
Amplitude
Main effects were significant for group, F(1,78) = 30.8, p<.001, with the
schizophrenia group showing reduced N100 amplitude compared with controls, and
for stimulus, F(1,78) = 58, p<.001, with N100 amplitude for non-target stimuli
reduced compared to target stimuli. Significant linear, F(1,78) = 130.56, p< .001 and
quadratic, F(1,78) = 259.51, p<.001 contrasts for the site factor indicated N100
amplitude was maximal fronto-centrally. The main effect for group was qualified by
a significant quadratic contrast for Group X Site, F(1,78) = 5.97, p<.01, as the
between-group difference was maximal at the vertex compared with frontal and
parietal sites. Significant linear F(1,78) = 21.45, p<.001 and quadratic F(1,78) =
25.02, p<.001 contrasts, for Stimulus X Site arose as the reduction to non-target
compared with target N100 amplitude was maximal at fronto-central sites.

-12 -

—12 —

Amplitude !IV

—10 —

a)
-cs

—8 —
—6 —

Ra
—4 —
—2 —

Fz Cz

Pz

Site
Control—N— Schizophrenia

0

Fz

Cz

Pz

Site

Target

Non-target

Figure 3.4 N100 amplitude for control and schizophrenia groups, across stimuli, at
midline sites (left). N100 amplitude to target and non-target stimuli, across group, at
midline sites
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Latency
The main effect for group was not significant, F (1,78) = 2.9, p = .09,
however there was a Stimuli X Group interaction, F(1,78) = 9.8, p<.01, as N100
latency was significantly delayed for target compared to non-target stimuli for the
control but not the schizophrenia group (see Figure 3.4). There was a significant
linear contrast for site, F(1,78) = 16.20, p<.001, with N100 latency prolonged at Fz.
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Figure 3.5 N100 latency to target and non-target stimuli, across sites.

3.4.2 P200
Amplitude
Main effects were significant for group, F(1,78) = 5.3, p < .05, with the
schizophrenia group showing increased P200 amplitude overall, and for stimulus,
F(1,78) = 16.3, p <.001, with P200 reduced to target compared with non-target
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stimuli. There was a quadratic contrast for site, with P200 maximal at Cz compared
with Fz and Pz. These main effects were further qualified by a significant Group X
Stimulus, F(1,78) = 19.8, p < .001, Group X Site (quadratic contrast), F(1,78) = 10.0,
p<.01 and Group X Stimulus X Site (quadratic contrast), F(1,78) = 22.69, p<.001,
interactions. Whereas the schizophrenia group responded similarly to target and nontarget stimuli, normal controls responded differentially with decreased P200 to target
compared with non-target stimuli, with this difference most marked at Cz (see Figure
3.6).
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Figure 3.6 P200 amplitude to target and non-target stimuli.
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Latency
Main effects were significant for group, F(1,78) = 5.2, p<.05 with the
schizophrenia group demonstrating earlier P200 latency overall; for stimulus, F(1,78)
= 53.2, p<.001, with a delay to non-target stimuli compared with target stimuli; and
for site with a significant linear contrast, F(1,78) = 6.34, p<.05, which was maximal
fronto-centrally. The Group X Stimuli interaction, F(1,78) = 18.77, p<.001, for P200
latency, arose because there was a pattern of prolonged P200 latency for non-target
compared with target stimuli for the control but not the schizophrenia group, which
resulted in an earlier P200 latency to the non-target stimulus for the schizophrenia
compared with controls (see Figure 3.7).
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Figure 3.7 P200 latency to target and non-target stimuli.
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3.4.3 N200
Amplitude
The main effect for group was significant, F(1,78) = 6.9, p = .01, with N200
amplitude reduced for the schizophrenia group. Significant linear, F(1,78) = 39.5, p
< .001, and quadratic, F(1,78) = 18.12, p < .001, contrasts for site, indicated a frontocentral maximum for N200 amplitude. These main effects were further qualified by
significant Group X Site linear, F(1,78) = 4.29, p<.05, and quadratic F(1,78) = 18.97,
p<.001, contrasts. In sum, as compared with the normal controls, the schizophrenia
group produced reduced N200 amplitudes, with this reduction being specific to
central and parietal sites.

Latency
The main effect for group was significant, F(1,78) = 7.2, p<.01, for N200
latency, with the schizophrenia group delayed overall. A significant linear contrast
for site, F(1,78) = 7.55, p<.01, indicated that N200 latency was prolonged at Fz
compared with Pz for all subjects.

3.4.4 P300
Amplitude
The main effect for group was significant, F(1,77) = 4.4, p<.05, with P300
amplitude reduced overall in the schizophrenia group. There were also significant
linear, F(1,77) = 119.4, p<.001, and quadratic, F(1,77) = 7.87, p<.01, contrasts for
site, with P300 amplitude maximal at centro-parietal sites for all subjects. These
main effects were further qualified by a Group X Site quadratic contrast, F(1,77) =
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13.03, p‹.001, as the reduction in P300 amplitude for the schizophrenia group was
maximal frontally and parietally compared with the vertex (See Figure 3.8).
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Figure 3.8 P300 amplitude for schizophrenia and control groups at midline sites.

Latency
Effects were not significant for group. For site, there were significant linear,
F(1,77) = 11.68, p<.001, and quadratic, F(1,77) = 5.68, p‹.05, contrasts
demonstrating prolonged latencies at parietal compared with fronto-central sites for
both groups.
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3.4.5 Response Time
The schizophrenia group had a mean RT of 384ms (SD = 90ms) which was
significantly slower, t (1,76) = -4.43, p <.001, than the control group, with a mean
RT of 309ms (SD = 50ms).

3.5

DISCUSSION

Few studies have examined ERPs to non-target stimuli or systematically
focused on components prior to the P300 complex. This Study was primarily
designed to examine differences in ERP components to target and non-target stimuli
in patients with schizophrenia and age and sex matched controls. The results indicate
significant group differences in early components to target and non-target stimuli
validating this approach. Earlier components may not be as conspicuous as the larger
P300, nevertheless reliable differences between groups emerged. The Study of ERPs
elicited by target and non-target stimuli together has an additional advantage, as
relational and interactive mechanisms between the two categories of stimulus can be
examined. As hypothesised, the schizophrenia group responded similarly to the two
stimuli, in comparison to the normal controls, who differentiated between the two
stimuli on the N100 and P200 components.

The N100 amplitude deficit to non-target stimuli, across midline sites, in the
schizophrenia compared to the control group, is consistent with previous studies with
attend (Pfefferbaum, 1984; Laurant et al., 1999) and ignore (Roth & Cannon, 1972)
instructions. The schizophrenia group also demonstrated earlier P200 latency to nontarget stimuli, across midline sites, compared to controls as hypothesised. The
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hypothesised decrease in P200 amplitude to non-target stimuli in the schizophrenia
compared with control group was not found.

Consistent with previous literature (see Chapter 2), that focused on processing
task relevant target stimuli, the patient group showed a decreased and earlier N100
amplitude (associated with attention) to target stimuli across midline sites, increased
P200 amplitude to target stimuli maximal at the vertex, (associated with decision
making), reduced and delayed N200 latency centro-parietally (associated with
response selection) and diminished P300 amplitude frontally and
parietally(associated with the context of information processing) which was also
delayed parietally. The relational and interactive mechanisms between target and
non-target stimuli are best reflected in the group by stimulus analyses. With the
exception of N100 amplitude, the schizophrenia group did not differ in the way they
responded to target and non-target stimuli. The normal controls, however, did
differentiate, with delayed N100 latency and an earlier and reduced P200 to target
compared to non-target stimuli. In the schizophrenia group N100 latency and P200
amplitude and latency to both target and non-target stimuli resembled the control
group's response to non-target stimuli. The hypothesised group difference for within
group N100 amplitude effects was not found as both groups showed reduced N100
amplitude to non-target compared to target stimuli.

The pattern of ERP response in the patient group therefore, was firstly
diminished N100 to both non-target and target stimuli, reflecting globally diminished
aspects of attention. Secondly, the earlier P200 response to non-target stimuli in
patients, was enhanced in amplitude and delayed when processing target stimuli.
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This may suggest that for nontarget stimuli there was a premature closure of decision
making (reflected in earlier P200 latency), whereas for target stimuli there was an
increased network activation (reflected in increased amplitude) and a consequent
delayed speed of processing (reflected in P200 latency) in the patient group.
However, it is difficult to disentangle target P200 amplitude and latency differences
from the influence of the overlapping N200 component, and it is possible that these
between-group P200 changes are influenced by differential N200 responses to the
target stimuli.

This disturbance in the processing of target and non-target information is
consistent with single trial P300 findings (Ford et al. 1994; Roschke et al., 1996),
and with the Gray-Hemsley model, in which misattributions in the
"match:mismatching" are proposed to underlie the positive symptoms in
schizophrenia. Precisely how this misattribution effects subsequent information
processing is not known. However, it may modulate the delay in N200 latency, and
the decrease in processing the context of target information (as reflected in this Study
and numerous other studies by decreased P300 amplitude). This would be consistent
with Broadbent's (1958) suggestion that early stages of processing may lead to later
dysfunctions.

This potential disturbance in selective processing of relatively relevant and
irrelevant information is also consistent with an entirely different body of research.
Positron emission tomography (PET) studies suggest that the anatomical circuitry
involved in extracting relevant and filtering irrelevant information, particularly
involves the pulvinar nucleus of the thalamus (Posner and Dehaene, 1994), and there
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is some evidence that these circuits may be impaired in schizophrenia (Andreasen et
al., 1994). These networks overlap with those suggested by Gray (1998), where
familiar non-targets (match) and novel targets (mismatch) engage the reticular
nucleus of the thalamus, but, thereafter, familiar stimuli activate ongoing processes
in the basal ganglia, whereas novel stimuli activate the cingulate and exploratory
processing networks.

These psychophysiological findings may also be linked to disturbances in
neurochemistry. For example, there is a body of evidence linking dopamine
hyperactivity to schizophrenia (Gray, 1991). Dopamine is thought to suppress
spontaneous neural firing while enhancing the capacity of neural systems to increase
activity in response to a specific stimulus or task (Foote and Morrison, 1986; Cohen
and Servan-Schreiber, 1993). In addition, dextroamphetamine (indirect monoamine
agonist) has been found to 'focus' neural activity that is specific for a particular task
(Mattay et al. 1996).

However, these results are preliminary and raise several issues which need to
be clarified. Firstly, this Study averaged all non-target stimuli together, however,
there is evidence that non-target stimuli immediately before the target stimuli (T-1),
and non-target stimuli immediately following the target stimuli (T+1), are processed
differently (Hirata & Lehman, 1990) and that this process may be disturbed in
schizophrenia (Roth and Cannon, 1972). It would be important to investigate these
results with non-target stimuli subaveraged for T-1 and T+1 stimulus, as differences
between N100 amplitude to target and non-target stimuli may have been obscured by
averaging in this Study. Computing averaged ERPs to non-target and target stimuli
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regardless of their sequential position (e.g. number of preceding target or non-target
stimuli) obscures systematic ERP effects that may be observed when sequences are
sorted and averaged separately (e.g., non-target following a target stimuli versus nontarget preceding a target stimuli) according to their sequential position Secondly, the
duration of illness ranging from 1 to 33 years, for patients in this Study, may have
obscured changes in deficits with age and chronicity. It would be important to
establish that these deficits are present at onset of illness, and are not a product of
chronicity. Several other factors which could interact with these results and would
also be important to investigate are the interaction of ERP results with symptom
factors, the differential effects of aging and gender on ERPs in schizophrenia and
normal controls, and an extension of analysis from midline sites to full topography.
The sensitivity and specificity to schizophrenia of N100 and P200 to target and nontarget stimuli in comparison with P300 amplitude also need to be demonstrated.
These issues are explored in the following Chapters. Chapter 4 evaluates the existing
literature and Study 2 (Chapter 5) is an empirical investigation (with the exception of
specificity which is explored in Study 4 [Chapter 7]) of these issues.
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4 BACKGROUND AND RATIONALE TO STUDY 2

4.1

ERPs AT FIRST ONSET OF ILLNESS VERSUS CHRONIC SCHIZOPHRENIA

Although numerous studies have found deficits in the ERPs of patients with
schizophrenia to target stimuli, and in a smaller number of studies to non-target
stimuli (reviewed in Chapter 2), most of these studies investigated ERPs in chronic
patients. An important emerging issue is whether these deficits are trait-like, and
therefore present at the onset and throughout the developmental course of illness, or
whether they are markers of chronicity (Salisbury et al., 1998; Ford, 1999; FrodlBauch, Meisenzahl, Galinat, Hegerl, & Moller, 1998; Mathalon, Ford, &
Pfefferbaum, 2000; Blackwood, 2000), This is significant because ERP deficits
observed in patients with chronic schizophrenia may be secondary to chronic
morbidity, neuroleptic medication, or other effects associated with chronic mental
illness such as hospitalisation. If established as a trait, ERP deficits would be most
useful in identifying "at risk" individuals, in addition to providing potential for the
implementation of preventative strategies, and provide a useful endophenotype for
genetic investigation.

There is some evidence suggesting that reduced P300 amplitude is a stable trait
marker in schizophrenia (Mathalon et al., 2000; Blackwood, 2000), with findings of
genetic association (Blackwood et al., 2001; Weisbrod, Hill, Niethammer, & Sauer,
1999). However, other results have not been consistent with these findings. For
example, in one study, P300 amplitude reduction wasn't found in undiagnosed
family members of people diagnosed with schizophrenia (Friedman, Cornblatt,
Vaughan, & Erlenmeyer-Kimmling, 1988) nor was it found to be predictive of

73

subsequent schizophrenic breakdowns (Squires-Wheeler, Friedman, Skodol, &
Erlenmeyer-Kimmling, 1993). Because of the relatively low incidence of
schizophrenia, even among relatives of those diagnosed with schizophrenia, in the
Squires-Wheeler et al. study, as might be expected, there were no more than 6
participants classified as having a schizophrenia-like breakdown and only one met all
criteria for schizophrenia (this participant's P300 amplitude was reduced one and a
half standard deviations below the mean for the normal group). These findings
highlight the need for further confirmation, and for alternative methods to determine
whether ERP deficits observed among chronic schizophrenics are trait-like. One such
method, included in Study 2 (Chapter 5) comprises a cross-sectional comparison of
ERP deficits early (at first presentation) and late (chronic schizophrenia) in the
developmental course of schizophrenia.

There have been few studies investigating auditory oddball ERP deficits in
people with FESz. Two studies specifically investigated patients at first admission
(Demiralp et al., 2002; Salisbury et al., 1998) and a further study (Hirayasu et al.,
1998) also included patients whose schizophrenia illness had occurred within one
year. All three studies found reduced P300 amplitude, however there were
topographical differences between their results. Salisbury et al. found reduced left
temporal P300, while Hirayasu et al. and Demiralp et al. found a marked frontal and
modest parietal P300 reduction. Of these studies, two (Demrilap et al. & Hirayasu et
al.) also examined the N200 component and found both N200 and P300 latencies
prolonged in the FESz participants compared to normal controls. Medication status
and electrode sites are two factors which may have influenced the different
topographical findings. Participants in the Salisbury et al., study were medicated
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while participants in the other two studies were unmedicated. The Hirayasu et al.
study used T5/T6 electrode sites for their lateral comparison instead of the T3/T4 or
TCP1/TCP2 at which left lateralised deficits are usually found (see 4.4). Although
the nature of the response required to the target is often considered to affect
topography, with the left lateralised deficit more commonly found in the count, than
button press response (see 4.4), it is unlikely that response was a confounding factor
in this case as all three studies used count rather than button press responses to the
target. Other task parameters such as ISI and probability were also consistent across
studies and therefore unlikely to affect responses.

Two of these studies did not have large samples, Salisbury et al. with 14
medicated and Demrilap et al., with 12 unmedicated FESz participants, and all three
restricted analysis, either to P300 alone (Salisbury et al.) or to N200 and P300
(Demrilap et al. & Hirayasu et al.).

The limitation of these studies to N200 and P300 components, combined with
the N100 and P200 component deficits to target and non-target stimuli, found in
Study 1 (Chapter3) highlight the need for further investigation of ERPs in FESz.
Notably, no studies have examined ERPs to non-target stimuli in FESz. A direct
comparison of ERPs in first episode and chronic schizophrenia in a substantial
sample, as in Study 2, provides an opportunity to investigate the differences between
ERPs at different time points during the course of schizophrenia, i.e. at onset and
when illness has become chronic.
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The conceptualisation of schizophrenia as a neurodevelopmental disorder and
the notion that ERPs might be a biological marker for the condition, suggests that the
normal ontogeny of the ERP will be distorted in subjects with schizophrenia. In
Study 2, this question of predominantly neurodevelopmental, as against later
neurodegenerative change in the cortex, is examined by two methods. The first
method is to compare ERP components between both a FESz group and their age and
sex matched controls and a chronic schizophrenia group with their controls, to
determine if the pattern of deficits found in chronic schizophrenia is present at first
onset. The second combines the first episode and chronic groups into one
schizophrenia group spanning adolescence to late middle age and similarly combines
the younger and older control groups. ERP components from each group are
correlated with age, to see if the patterns of age effects differ in the schizophrenia
group compared to the control group. This will point to whether changes in ERPs are
completed at the time of first presentation, thereby providing some support for the
neurodevelopmental hypothesis, or continue to change over time, providing support
for a neurodegenerative hypothesis.

4.1.1 Age effects on target and non-traget ERP components
The effects of age on the auditory oddball ERP in the normal population have
been explored in a number of studies discussed below.
N100 component
Amplitude
Reports of the effect of age on N100 amplitude have been inconsistent. The
relationship between N100 and age appears to vary depending upon the stimulus,
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with age effects maximal for non-target compared to target stimulus. In a number of
studies no relationship between age and N100 amplitude to target stimulus has been
found in younger people aged 7-20 years (Johnson,1989), 4-21 years (Fuchigami et
al., 1993) and 11-18 years (Friedman, Brown, Vaughan, & Erlenmeyer-Kimling,
1984). However, in another study, N100 amplitude to targets was found to increase
with age in a group 5-19 years (Ladish & Polich, 1989). In adult populations, N100
amplitude to target stimuli has also generally been unchanged in groups aged 18-70
(Bahramali et al., 1998) and 20-79 (Picton, Stuss, Champagne, & Nelson, 1984).
Decreased N100 amplitude with age was found in a group aged 18-85 years
(Syndulko et al., 1982).

In contrast to target stimuli, N100 amplitude to non-target stimuli has
generally been found to increase with age (Anderer, Semlitsh, & Saletu, 1996; Ford
& Pfefferbaum, 1991 Pfefferbaum, Ford, Wenegrat, Roth, & Koppell, 1984),
although one study reported no effect of age a group 18-82 years (Iragui et al., 1993).

Several studies (Anderer, Semlitsh, & Saletu, 1996; Ford & Pfefferbaum,
1991 Pfefferbaum, Ford, Wenegrat, Roth, & Koppell, 1984; Iragui et al., 1993;
Picton et al., 1984) have examined the effects of age on N100 amplitude topography.
These studies have indicated that topography remained stable over age.

Latency
N100 latency appears to become earlier with increasing age in the child and
adolescent age range, but not in the adult age range. N100 latency to target stimuli
has been reported to be earlier with age in groups 4-21 years (Fuchigami et al.,
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1993), 8-16 years (Tonnquist-Uhlen, Borg, & Spens, 1995) and 5-19 years (Ladish &
Polich, 1989). In adults, N100 latency to target stimulus does not show any
significant age effects for 17-80 years (Coyle, Gordon, Howson, & Meares, 1991)
15-80 years (Brown, Marsh, & La Rue, 1983) and 18-70 years (Bahramali et al.,
1999).

Despite one study to the contrary (Amenado and Diaz, 1998), N100 latency
to non-target stimuli, on the other hand, has generally been reported to increase with
age in a group aged 18-82 (Iragui et al., 1993) or to show increase at temporal, but
not central sites in a group aged 20-88 years (Anderer et al., 1996).

P200 component
Amplitude
Age changes in P200 amplitude to target stimuli have generally not been
found in child or adult groups. P200 amplitude showed no significant change with
age for subjects aged 7-20 years (Johnson, 1989), 11-18 years (Freidman et al.,
1984), 18-70 years (Baharamali et al., 1999) and 20-79 years (Picton et al., 1984).
However, a reduction in amplitude has been reported for ages 18-80 (Smith,
Michalewski, Brent, & Thompson, 1980) and for ages18-85 (Syndulko et al.1982).

In contrast to target stimuli, P200 amplitude to non-target stimuli has been
found to increase with age in ages 20-80 (Anderer, Semlitsh, & Saletu, 1996) and 2086 (Amenedo and Diaz, 1998). Topographic distribution changes evident include
higher amplitudes in parietal compared to frontal regions in young subjects, whereas
in the elderly the reverse was evident (Anderer et al.). Both these studies had large
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sample sizes, with 172 subjects (Anderer et al.) and 73 (Amendeo & Diaz). However
no effect of age was reported from 18-82 years in both target and non-target stimuli
by Iragui et al. (1993) with a sample size of 71.
Latency
P200 latency to target stimuli has been found to decrease with increasing age
in young people aged 5-19 years (Ladish & Polich, 1989), but to either increase with
age to non-target stimuli in adult groups (Goodin, Squires, Henderson, & Starr, 1978;
Polich et al., 1995) or show no difference (Brown et al., 1983) with age. Anderer et
al. (1996) have suggested that the delay may depend on the site, occurring at anterior
but not posterior sites because in his study found that P200 was earliest at Fz in the
elderly but was delayed at Fz in the young group.

N200 component
Amplitude
N200 amplitude to target stimuli has been found to decrease with increasing
age in young groups 5-19 years (Ladish & Polich, 1989) and 4-16 years (Enoki et al.,
1993). However, Fuchigami et al. (1993) failed to find a decrease in a group 4-21
years. The amplitude of N200 has also been reported to be decreased in adults aged
18-82 years (Iragui et al., 1993), and 20-88 years (Anderer et al., 1996) or unchanged
( Amenedo et al., 1998; Brown et al., 1993; Picton et al., 1984) with age.

Latency
N200 latency has been reported to decrease with age in groups 4-21 years
(Fuchigami et al. 1993) and 5-19 years (Ladish & Polich, 1989). Enoki et al., (1993)
reported a significant decrease in children and adolescents (9.03 msec/year) reaching
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its minimum latency at age 16, and then changing to a slight but significant increase
in latency with age (0.97ms/year) through to 77 years. In adult groups N200 latency
has been found to be prolonged with age in many studies; with an increase in latency
of .065msec/year from 20-79 years (Picton et al., 1984); 0.8msecs/year from 16-76
years (Goodin et al., 1978), 0.58 msec/year (Iragui et al.), 0.25msec/year from20-88
(Anderer et al., 1996).

P300 component
Amplitude
The relationship between age and P300 amplitude has been inconsistent in
studies with young people, which may reflect the possibility that changes in
probability and other task demands may interact with age to affect results. For
example, a decrease in P300 amplitude at Pz from 7-20 years (1.11 µv/year) has been
found in a reaction-time version of the oddball task, but not in the count version of
the oddball task (Johnson, 1989). P300 amplitude increased from 4-20 years at Fz
(4.6 µv/year, Cz (2.6 µv/year) and Pz (4.1 µv/year) in a low probability condition
(10% target) and at Pz only (8.4 liv/year) in a high probability condition (30% target)
in a study using finger movement to respond to the target stimulus (Polich, Ladish, &
Bums, 1990). No age effects on P300 amplitude were found in a group aged from 421 years using a button press response (Fuchigami et al., 1993)

In studies with adults, decreases in P300 amplitude with increasing age have
been found in a number of studies. For example, a decrease of 0.18 µv/year from 2079 years (Picton et al., 1984); 0.15 jay/year from 15-80 years (Brown et al., 1983);
0.1 jay/year from 18-82 years, (Iragui et al., 1993); and 0.47 V from 20-88 years
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(Anderer et al., 1996). This relationship may also interact with gender as Amendio
and Diaz (1998) found that age affected P300 amplitude in men, but not in women.
P300 amplitude has also been found to be more frontally oriented with age in some
studies (Anderer et al., 1996; Ford & Pfefferbaum, 1991; Picton et al., 1984).

Latency
P300 latency has been consistently found to increase with age. This effect has
been found amongst studies that included young (6-15 years, Goodin et al., 1978; 623 years, Martin, Barajas, & Fernandez, 1988), or adult (Iragui et al., 1983; Picton et
al., 1984) subjects only, and in studies including both young and adult populations
(5-86 years Polich, Howard, & Starr, 1985). With regard to this slowing of P300
among adults, delays from 0.53 to 2.45 msec/year have been found as follows: for
example, an increase of 1.36 msec/year from 20-79 years (Picton et al., 1984), 1.8
msec/year from 16-76 (Goodin et al., 1978), 2.45 msec/year from 18-90 years
(Pfefferbaum et al., 1984), 0.53 msec/year for subjects over 45 years (Brown et al.,
1983), 0.80 msec/year from 18-82 years (Iragui et al., 1993), 0.92 msec/year from 20
-88 years (Anderer et al.,1996) and 0.82 msec/year from 20-86 (Amenedo & Diaz,
1998) . Accelerated rates of slowing have also been reported in elderly subjects aged
from 70-88 years and also in subjects 63 years of age and over (Gordon, Kraiuhin,
Stanfield, Meares et al., 1986).

Summary of age effects on ERPs
To summarise, the effects of increasing age on ERPs to non-target stimuli are:
an increase and delay in N100 amplitude and an increase in P200 amplitude. The
effects of increasing age on ERPs to target stimuli are: earlier P200 latency to target
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stimuli, an initial decrease in childhood, till around 16 years, and then decrease in
adulthood of N200 amplitude; a prolongation of N200 latency; and a decrease and
delay in P300.

4.1.2 Gender effects on ERPs to target and non-target stimuli
Attempts to explain and integrate the heterogeneity of research findings in
schizophrenia have mostly focussed on symptom factors (see Chapter 4.2). An
additional approach is the examination of gender differences (See Chapter 1.2.1)
suggesting that men and women are prone to different subtypes (Castle & Murray,
1993; Goldstein, Santangelo, Simpson, & Tsuang, 1990; Murray, O'Callahan, Castle,
& Lewis, 1992).

Few studies have examined gender effects on ERPs in schizophrenia. ERP
studies (Hirayasu et al., 1998; Josiassen, Roemer, Johnson, & Shagrass, 1990;
Turetsky, Colbath and Gur, 1998) which have found gender differences, suggest that
it may not be sufficient to control for gender by matching control and patient
participants, as the effects of gender may be different in schizophrenia. For this
reason, Study two has examined the gender differences found in control and
schizophrenia groups to see if there is a different pattern in the schizophrenia group
compared to the control group. Turestsky et al., for example, found differences in the
profile and severity of P300 deficits for men and women with schizophrenia, with
women showing greater left temporal and frontal P300 deficits while men had
greater right parietal P3 deficits. This pattern of gender differences was not found in
the control group. Hirayasu et al. included gender as a factor in the analysis of N200,
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P300 components, and found earlier N200 latency in females compared to males in
the control and medicated schizophrenia group, but not in a neuroleptic naïve group.
In addition, increased P300 amplitude in females compared to males in both clinical
and control groups was evident. Even in normal groups, ERP gender differences
have not been clearly explicated. Again the focus has been on gender effects on the
P300 component, with males having a reduced (Deldin, Duncan, & Miller, 1994;
Hoffman & Polich, 1999; Polich & Geissler, 1991 although see Shelton, Hartmen, &
Allen, 2002) and prolonged (Deldin et al., Golgeli et al., 1999; Polich, Burns, &
Bloom, 1988; Shelton et al., 2002) P300 component compared to females. These
findings highlight the need to explore the modulatory effects that gender may have
on ERPs in first episode and chronic schizophrenia

4.2

EFFECTS OF SEQUENTIAL POSITION OF NON-TARGETS ON ERPs.

ERPs are averaged to increase the signal to noise ratio of small stimulus
related responses from the background EEG activity. The underlying assumption is
that the response elicited by all occurrences of an event (e.g., either target or nontarget stimuli) are identical or of little consequence. However, this assumption has
been challenged by findings of systematic trial to trial variations in response to both
target and non-target stimuli (Squires, Wickens, Squires, & Donchin, 1976;
Hermanutz, et al., 1981). Typical analyses of ERPs elicited by target and non-target
stimuli averages obscure these variations. Study 2 will examine the relationship
between certain specific sequence effects and non-target stimuli and Study 3
(Chapter 6) will examine the sequence effect of preceding stimuli on ERPs elicited
by targets.
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In non-target sequence studies the non-target immediately before and after
the target stimuli are referred to with various nomenclatures. For simplicity of
expression the terminology used by Starr, Sandroni and Michalewski, (1995) will be
followed in this thesis, with the non-target immediately preceding the target referred
to as T-I and the non-target immediately following the target referred to as T+I.
ERPs may be influenced by the momentary brain state at stimulus presentation
(Ban-y, de Pascalis, Hodder, Clarke, & Johnstone, 2003; Basar, Basar-Eroglu, Rosen,
& Schutt, 1984), which in turn may be affected by the category of the previous
stimuli (target or non-target, match or mismatch). For example, the processing of a
target stimulus may activate additional, transient neural processes that operate on
T+1 stimuli (Hirata & Lehman, 1990). There is also the possibility of a difference in

preparedness associated with the predictability of the T+1 stimulus, in those oddball
designs in which a target stimulus is always followed by a non-target stimulus, either
by constraint or by nature of the low probability of target stimuli. In this case
efficient information processing would involve reduced allocation of attention to a
stimulus known to occur at a particular position, T+1, while there would be more
active processing of the more salient T-1 stimulus which could be either a target or
non-target stimulus.

Non-target sequence effects have also been investigated according to the
number of preceding non-target stimuli (Hermaneutz et al., 1981) with results
showing that N100 amplitude increases with an increasing number of preceding nontargets. This is an intriguing finding when contrasted with habituation findings in
N100 amplitude (Budd, Barry, Gordon, Rennie, & Mitchie, 1998; Fruhstorfer, 1971;
Ritter, Vaughan, & Costa, 1968). However, whereas habituation studies generally

84

have task instructions to ignore the stimuli, the non-target sequence results have been
found with paradigms in which a response to target stimuli is required. The
increasing N100 amplitude with the number of preceding non-targets could thus
reflect progressively increasing vigilance for the target stimulus.

In Study 2, ERPs to both T-1 and T+1 stimuli are averaged seperately. The
Gray-Hemsley model and other conceptualisations of schizophrenia as a failure to
make use of context in information processing (Chapter 1) would suggest that the
preparedness for the T+1 stimulus would be impaired in participants with
schizophrenia, as they would fail to make use of previous regularities, i.e. that a
target is always be followed by a non-target to make redundancies in information
processing.

Empirically, in the few studies in which ERPs to non-target stimuli have been
sub-averaged according to their temporal position to the target stimuli (immediately
preceding or immediately following) significant differences have been found in
normal samples (Hirata & Lehman, 1989; Roth & Cannon,1972; Starr, Sandroni, &
Michalewski, 1995; Starr, Aquinaldo, Roe and Michalewski,1997). In each of these
studies the target stimulus was always followed by a non-target stimulus. These
studies found N100 amplitude (or its equivalent maximal potential range in the
Hirata and Lehman study) reduced to T+1 compared to T-1 stimuli in normal
subjects. However the Starr, Aguinaldo et al. study only found N100 reduced to T+1
in button press, but not count response condition; while Hirata & Lehman found a
reduction with mental count. However, this reduction was not present in a
schizophrenia group (Roth & Cannon) or in a group with Alzheimer's disease or
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their elderly controls (mean age 66.3

1.6; Golob & Starr, 2000). The N100

component to T+1 was also delayed in latency, and decreased in global field power
and current source density compared with the T-1 N100 (Hirata & Lehman).

Compared to the T+1 stimulus, the T-1 P200 component was reduced in
amplitude (Starr, Aguinaldo et al., 1997) and occurred earlier. Starr, Sandroni et al.
(1995) found a pre-stimulus negative shift (RP) and P300 component to T-1 stimuli,
which were both absent to T+1 stimuli and

T-1 P50 amplitude was reduced

compared to T+1 stimuli. Hirata and Lehman (1990) concluded that an average of all
non-target stimuli should be avoided as they involved distinctly different ERP
characteristics, which the authors interpreted as manifestations of different brain
states.

The reduction in N100 amplitude to T+1 compared with T-1 stimulus in
normal subjects was consistent across studies, despite differences in task instructions
and analyses. For example, in the Roth & Cannon study the instructions were to
ignore the stimuli as much as possible while the remaining studies all required a
response to the target stimuli, Starr et al. (1995,97) compared two response
conditions (button press and count) and the Hirata & Lehman (1990) study used a
mental count response.

4.3

SENSITIVITY OF ERP DEFICITS FOR SCHIZOPHRENIA

Research has demonstrated a widely reproducible, reduced P300 amplitude in
schizophrenia (Ford, 1999; Jeon & Polich, 2000; Pritchard, 1986). Previous
literature has focused on the sensitivity of the P300 component in schizophrenia, the
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classification of patients with schizophrenia from normal controls. For example,
Ford, Pfefferbaum & Roth (1992) established criterion P300 amplitude, above which
a diagnosis of schizophrenia may be excluded. Most have focused on P300 amplitude
to the target stimulus. Boutros et al. (1997) however, found that non-target N100 and
P200 components were also sensitive measures and recently Ford (2001) proposed
that N100 amplitude reduction to target and non-target stimuli may not only be
sensitive for schizophrenia, but may also have greater specificity (i.e. the extent to
which this deficit is not present in persons without schizophrenia, in including those
with non-schizophrenic psychiatric disorders) for schizophrenia than P300 reduction.
In that study, while P300 amplitude was sensitive to schizophrenia-like symptoms
found both in schizophrenic and in epileptic patients with interictal chronic
schizophrenia-like features, only N100 amplitude reduction was specific to those
symptoms in schizophrenia.

Study 2 investigates the sensitivity of the N100 and P200 components elicited
by non-targets and targets and compares this to the P300 component to targets in
discriminating chronic schizophrenia and FESz groups from their respective normal
control groups. It can be seen that the rationale for examining whether discriminant
function analysis of N100 and P200 components to target stimuli and non-target
stimuli, separately to T-1 and T+1 stimuli shows greater sensitivity for schizophrenia
than P300 amplitude includes both theoretical and empirical reasons. The results of
Studyl (see Chapter 3) indicate that there is a reduced difference between target and
non-target N100 and P200 scores in a schizophrenia group. The results of Roth and
Cannon's early study demonstrated reductions in N100 amplitude to T+1 compared
with T-1 stimuli in normal control subjects but not in schizophrenia. There is also a
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theoretically based prediction that there would be reduced processing of T+1
compared withT-1 stimuli in normal controls but not in schizophrenia.
4.4

ERP TOPOGRAPHY IN SCHIZOPHRNEIA

Topographical variations in ERP component measures in schizophrenia may
have diagnostic (Gruzelier et al., 1999; Maurer, Riederer, Heinsen, & Beckmann,
1989; Salisbury, Shenton & McCarley, 1999; Weir, Fiaschi & Machin, 1998) and
pathophysiologic (McCarley et al., 1989, 1993,; O'Donnell et al., 1995, 1999)
significance. Most studies of ERP topography in schizophrenia have restricted their
investigation to the topography of the P300 component with several studies showing
a left lateralised amplitude reduction in schizophrenia compared to normal controls
(e.g., Faux et al., 1990, 1993; Faux, Torello, McCarley, Shenton, & Duffy, 1988;
Morstyn, Duffy, & McCarley, 1983; Potts, Hirayasu, O'Donnell, Shenton &
McCarley, 1998; Salisbury, Shenton, & McCarley, 1999). This has also been found
to be present at first onset by some studies (Demiralp et al., 2002; Salisbury et al.,
1998). However, the robustness of these findings is challenged by other studies
which have not found this difference (Ford et al., 1994; 2000; Hirayasu et al., 1998;
Iwanama et al., 2002; Pfefferbaum, Ford, White, & Roth, 1989).

There are several possible explanations for the variable findings. A metaanalysis of 11 topographic studies of P300 amplitude elicited by the auditory oddball,
in schizophrenia, indicated the importance of electrode site placement with greater
effect sizes found using TCP1/TCP2 sites than T3/T4 (Jeon &Polich, 2001). Task
requirements have also been found to influence results with inter-hemispheric
differences more prevalent in tasks requiring silent counting of targets compared to
button press. However, investigations comparing button press and count in the same
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schizophrenia and normal control groups have been conflicting. For example, Ford,
Mathalon, White and Pfefferbaum (2000) did not find smaller P300s over the left
(T3) than over the right (T4) lateral scalp in the schizophrenia group, in both button
press and silent count, while Salisbury, Rutherford, Shenton , McCarley (2001)
found left lateralised deficit in the silent count condition, but not in the button press
condition in another schizophrenia group. Turetsky et al. (1998) demonstrated a left
temporal deficit in schizophrenia, using the button press. Stimulus discriminability
has also been found to influence topographical results, with asymmetrical findings in
schizophrenia associated with easier discrimination of pitch tone (Salisbury et al.,
1994; Weisbrod et al., 1997). It is also possible that patient differences, for example,
variable structural deficits, may have contributed to the conflicting results.

Potts et al. (1998) also investigated the topography of N100 amplitude and
found no topographic difference between the schizophrenia and control groups.
Study 2 investigates laterality and anterior/posterior differences in topography of all
target and non-target ERP components in first episode and chronic schizophrenia
groups compared to normal controls.

4.5

SYMPTOM INTERACTIONS WITH ERPs

Consideration of symptom factors can reveal significant associations with
brain function that can be obscured through averaging across subgroups of the
disorder (Harris et al., 2001; Liddle, 1987, 1992; Liddle et al., 1992; Williams,
Gordon, Wright, & Bahramali, 2000; Williams et al., 2003). Chapter one reviewed
the heterogeneity of schizophrenia symptoms and their organisation into factors.
Three syndromes or factors (Liddle, Barnes, Morris, & Hague, 1989): reality
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distortion, psychomotor retardation and disorganisation, (also called positive,
negative and disorganisation factors in some studies, with minimal item differences),
have been replicated extensively in factor analytic studies, even when additional
factors have also been found (Andreasen, Arndt, Alliger, Miller, & Flaum, 1995; Bell
et al., 1994; Hori et al., 1999; Johnstone & Frith, 1996; Lenzenweger & Dworkin,
1996; Malla, Norman Williamson, Cortez, & Diaz, 1993; Maziade et al., 1995;
Minas, Klimidis, Stuart, Copolov, & Singh, 1994; Murphy, Burke, Bray, Walsh, &
Kendler,1994; Peralta, Cuesta, & Fan-e, 1997; Ratakonda, Gorman, Yale, &
Amador,1998; Thomson & Meltzer, 1993) including recent onset psychosis studies
(Gureje, Deribigbe, & Obikoya, 1995; Van de Does, Dingemans, Linszen, Nugter, &
Scholte,1996; Vazquez- Barquero et al., 1996 - with 2 positive; but see McGorry ,
Bell , Dudgeon, & Jackson, 1998 & Van Os et al., 1996 who found different factor
structures in FESz).

Most studies which relate psychophysiological, neurocognitive and
neuroanatomical structural and functional findings to symptom factors (Baxter &
Liddle, 1998; Brown & White, 1992; Chua et al., 1997; Harris et al., 2001;
Higashima et al., 1998; Liddle, 1987, Liddle & Morris, 1991; Liddle et al., 1992
Norman et al.,1997a, 1997b; Schroder et al., 1992, 1995) limit these factors to these
three core symptom factors. Although five or more factors can be obtained with the
addition of the general psychopathology scale of the PANNS, the three factors have
been shown to adequately account for the heterogeneity of the core schizophrenic
symptoms. Other studies have only used two subgroups, for example, active and
withdrawn (Gruzellier et al., 1999), positive and negative (Laurent et al., 1999).
There are 14 items each in the Positive and Negative subscales of the PANSS, the

90

inclusion of the general psychopathology scale, which adds an additional 14 items
would require a sample size of more than 120 patients with schizophrenia to meet the
minimum subject to variable ratio requirements, while the sample size of most EEG,
sMRI, fMRI and SPECT studies would preclude the use of principal component
factor analysis with this number of items.

Because of the relative reliability of the three factor solution derived by Liddle
(1987) and to allow direct comparison with other psychophysiological studies (e.g.
Norman et al., 1997; Harris et al., 2001; Higashima et al., 1998; Kawasaki et al.,
1997) correlations in Study 2 are based on Liddle's three factor solution:
disorganisation, psychomotor poverty and reality distortion. This allows a
comparison between the first episode and chronic groups in Study 2. The scores for
the three factors were obtained by summing up PANS S scores according to the item
structure of Liddle's factor analysis (Cuesta & Peralta, 1995; Liddle, 1992, Shean,
1999; See Chapter 5, Table 5.3 for item structure).

Disorganisation
The disorganisation factor, reflecting thought disorder or cognitive
impairment, has been assumed to represent the core feature of schizophrenia
(Higashima et al., 1998). It has been found to be correlated with patients with a
familial history of schizophrenia (Cardno, Rijsdijk, Sham, Murray, & McGuffin
1997; Loffler and Hafner, 1999; Loftus, Delisi, & Crow, 1998), the highest
neurological soft-signs scores (Arango, Kirkpatrick and Buchanan, 2000; Schroder et
al., 1992) and putative psychophysiological markers such as smooth pursuit eye
movement (SPEM) dysfunction (Lee and Williams, 2000; Lee, Williams, Loughland,
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Davidson, & Gordon, 2001). High scores on this factor have been associated with
poor performance in tasks which involve using context in information processing or
the ability to inhibit irrelevant mental activity, as when the subject is required to:
inhibit an established but inappropriate response (Liddle and Morris, 1991), suppress
irrelevant verbal responses (Baxter and Liddle, 1998), use inhibition in a verbal
fluency task (Cohen, Barch, Carter and Servan-Schreiber, 1999), inhibit proactive
interference (Guillem, Bicu, Bloom, Wolf, Desautels et al., 2001), combine context
related stimuli (Silverstein, Kovacs, Corry, and Valone, 2000), and by showing
reversed negative priming (Williams, 1996) and perseveration on a test of set shifting
ability (Cohen et al., 1999).
Structural studies (MRI and CT) have either not found a relation between
disorganisation and structural deficits (Flaum et al., 1995; Malla, Takhar, Norman, &
Assis, 1999; Mozley et al., 1994) or have found a relationship with increased third
and lateral ventricles and ventricle:brain ratio (Schroder, Buchsbaum, Siegel, Geider,
& Niethammer, 1995) or increased bilateral parahippocampal grey cortex volume
(Chua et al., 1997). Disorganisation has been more robustly associated with
functional compared with structural changes, a pattern of results that suggests a
widespread abnormality of function consistent with disconnectivity models (see
Chapter 1). In functional imaging studies (PET and SPECT) disorganisation has been
associated with increased anterior cingulate activity (Liddle et al., 1992; Schroeder et
al., 1996; Yuasa et al., 1995) and decreased activity in the right ventrolateral
prefrontal cortex and right and left angular gyms (Liddle, Friston, Frith, Hirsch,
Jones and Frackowiak, 1992).
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4.5.1 Psychomotor Poverty
Psychomotor poverty has been associated with: slowing of mental activity
(Baxter & Liddle, 1998; Bilder, Mukherjee, Rieder, & Pandurangi 1985; Johnson &
Frith, 1996; Liddle & Morris, 1991; Sauer et al.,1999; Van der Does, Dingemans,
Linszen, & Nugter, 1996), tasks that require planning abilities (Brown & White,
1992; Himelhoch, Taylor, Goldman, & Tandon, 1996), memory - both long term
and procedural (Norman et al., 1997; Schroeder, Tittel, Stockert, & Karr, 1996), and
poor conceptual thinking (Bilder et al., 1985; Liddle, 1987). Differing patterns of
structural and functional abnormalities have been associated with psychomotor
poverty, the most consistent a relationship with frontal lobe structural abnormalities
(Chua et al., 1997; Schroder et al., 1992, 1996; Liddle et al., 1992; Schroder et al.,
1996; Woodruff et al., 1997). The psychomotor poverty or negative dimension is
thus associated with a loss of function and is correlated both with the existence of
pre-morbid abilities (Sauer et al., 1999) and with eventual outcome (Carpiniello &
Carta., 2002; Weiselgren, Lindstrom, & Lindstrom, 1996).

4.5.2 Reality Distortion
Reality distortion (or the positive/psychotic factor) has not been reliably
correlated with neurocognitive measures, with a large number of studies failing to
demonstrate a significant association (Brown & White, 1992; Frith, Leary, Cahill, &
Johnstone, 1991; Gureje et al., 1995; Liddle & Morris, 1991; Sauer et al., 1999; Van
der Does et al., 1993). However, a few studies have indicated an association between
reality distortion and performance on tests of recognition and logical memory
(Johnstone & Frith, 1996; Norman et al., 1997; Schroeder et al., 1996). Reality
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distortion has also been associated structurally (NIRI & CT) with increased
interhemipheric fissure (Schroder et al., 1995).
4.5.3

Pychophysiology and symptom factor
In resting EEG, reality distortion has been associated with reduced frontal-

temporal EEG coherence (Norman et al., 1997) and psychomotor poverty has been
associated with increased levels of frontal slow wave activity (Gerez & Tello, 1995;
Gattaz et al., 1992; Harris, Williams, Gordon, Bahramali, & Slewa-Younan, 1999).
Correlations with P300 have not been consistent. Some studies have found no
significant correlations between P300 and clinical symptoms (Pritchard, 1986) while
others have found relations between P300 amplitude and both negative (Blackwood
et al., 1987; Eikmeier, Lodemann, Zerbin, & Gastpar,1992; Pfefferbaum, Ford,
White & Roth, 1989; Strik, Dierks, & Maurer, 1993) and positive symptoms (Egan
et al., 1994; McCarley et al., 1989; Shenton et al., 1989). Disorganisation has been
associated with reduced P200 amplitude and delayed N100 latency to non-target
stimuli (Williams, Gordon, Wright, & Bahramali, 2000).

4.6

OBJECTIVES FOR STUDY 2

1. To clarify whether target and non-target ERP deficits are present among
participants with FESz and chronic schizophrenia.
2. To determine if a combination of target and non-target (T- I & T+1) ERP
deficits can enhance prediction of diagnostic status derived solely from the
P300 deficit to targets.
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3.

To determine if non-target sequence effects (T-1 & T+1) found in normal
groups are present in first episode and chronic schizophrenia.

4. To explore the relationship between ERP findings and clinical variables,
especially clinical symptoms.
5. To examine maturational effects on ERPs to target and non-target ERPs in
schizophrenia and normal controls.
6. To examine gender effects on ERPs to target and non-target ERPs in
schizophrenia and normal controls.
7. To examine topographical differences between the groups with schizophrenia
and their control groups.
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5 STUDY 2 - ERPs TO TARGET AND NON-TARGET (BEFORE & AFTER
TARGET) STIMULI: FIRST EPISODE VS. CHRONIC SCHIZOPHRENIA

The purpose of this Study was to examine target and non-target (T-1 & T+1)
ERP disturbances in first episode and chronic schizophrenia. The main results have
been published (Brown, Gonsalvez, Harris, Williams, & Gordon, 2002, see
Appendix 2 for a copy of this article). A more complete account of the Study and its
results is presented below.

5.1

HYPOTHESES

Compared to age and sex matched controls, chronic and FESz groups will
show similar patterns of target and non-target ERP disturbances. Specifically:

a) Non-targets (T- I & T+ I)
1. N100 will be reduced to T- I and T+1 stimuli in the schizophrenia groups.
2. P200 will be reduced and early to both T-1 and to T+1 stimuli in the
schizophrenia groups.

b) Targets
1. N100 will be reduced and earlier to target stimuli in the schizophrenia
groups.
2. P200 will be increased and delayed to target stimuli in the schizophrenia
groups.
3. N200 and P300 will be reduced and delayed to target stimuli in the
schizophrenia groups.
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c) Between-stimuli
1. N100 will be increased to target compared with non-target stimulus in the
control but not the schizophrenia groups.
2. N100 will be increased to T-I compared with T+1 stimuli in the control
but not the schizophrenia groups.
3. P200 amplitude will be increased and prolonged to non-target compared
with target stimuli in the control but not the schizophrenia groups.
4. P200 amplitude will be increased and prolonged to T-1 compared with
T+1 stimuli in the control but not the schizophrenia groups.

d) Gender effects on ERPs
There will be an interaction between gender and groups. Specifically it is
hypothesised that males will show greater deficts than females in the schizophrenia
group.

e) Age effects on ERPs
In comparison to the control group, age effects on ERP components will be
diminished (support for neurodevelopmental hypothesis) rather than enhanced
(support for neurodegenerative) hypothesis in the schizophrenia group. Specifically:
1. N100 amplitude to non-target stimuli will increase with age in the control,
but not the schizophrenia groups.
2. P300 will be reduced and delayed with age in the control, but not the
schizophrenia groups.

f) Symptom effects on ERPs
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ERP deficits in schizophrenia will be related to clinical symptoms, particularly
severity of thought disorganisation.
g) Sensitivity for schizophrenia
Inclusion of variables derived from non-target ERPs such as N100 and P200
components will improve classification rates for both first episode and chronic
schizophrenia than classification using only target parameters (N200/P300).

5.2

METHOD

5.2.1 Participants
5.2.1.1 Participants with chronic schizophrenia
Forty l participants with chronic schizophrenia, aged between 23 and 51 years of age,
with a mean age of 36.0 years (SD = 7.1 years) were recruited from inpatient (both
acute and long stay) and community settings in the western suburbs of Sydney (see
Table 5.1 for demographic and clinical information). Diagnosis was confirmed using
Section G (schizophrenia and psychotic disorders) of the Composite International
Diagnostic Interview (World Health Organisation, 1992a) or by two psychiatrists
according to the Diagnostic and Statistical Manual of Mental Disorders 4th edition
(DSM — IV: American Psychiatric Association, 1994). Although chronic
schizophrenia is defined as a period of symptomatic illness lasting for greater than
two years, all participants had been diagnosed with schizophrenia for a minimum

Twenty five of these were subjects included in Study 1. An additional 15 subjects were acquired to
meet chronicity requirements.
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period of at least four years (range 4 -34 years) with a mean duration of illness of
14.3 yrs (SD = 7.0 yrs). All patients were medicated and details about medication are

Table 5.1 Demographic and clinical variables of chronic schizophrenia and FESz
participants.
Chronic
schizophrenia
Age (yrs)
Illness duration (yrs)
Chlorpromazine equi
Years of education
PANSS scores
Positive symptoms
Negative symptoms
General symptoms
Total

Male (n=26)

Female (n=14)

Total (n=40)

Mean
36.4
15.1
568
11.72

sd
6.3
7.2
471
2.2

Mean
35.4
12.7
431
11.27

sd
8.7
6.8
312
2.5

Mean
36.0
14.3
520
11.57

sd
7.1
7.0
423
2.3

20.5
21.0
37.2
78.7

7.0
6.5
8.4
19.5

19.9
19.9
38.3
78.1

5.5
6.6
8.4
17.9

20.3
20.6
37.6
78.5

6.5
6.5
8.3
18.7

First
episode Male (n=28)
schizophrenia
Mean sd
Age (yrs)
19.7
2.7
Chlorpromazine equi 262
215
Years of education
11.5
1.8
PANSS scores
Positive symptoms
17.8
5.9
Negative symptoms
21.0
6.2
General symptoms
39.3
6.9
Total
78.1 14.6
Table 5.2 Medication

Female (n=12)

Total (n=40)

Mean
19.5
222
11.2

sd
4.4
173
2.1

Mean
19.6
250
11.3

sd
3.2
202
1.9

15.3
15.9
37.3
68.5

4.6
4.6
6.8
14.8

17.2
19.5
38.7
75.2

5.7
6.2
6.9
15.1
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Chronic schizophrenia

FESz

Nil Medication

Males
Females
(n=26)
(n=14)
n
%n
%
0
0 0
0

Total
(n=40)
n
%
0
0

Males
(n=28)
n
%
4
14

Females
(n=12)
n %
0
0

Total
(n=40)
n
%
4
14

Antipsychotics
-typical
-atypical
-clozapine

15
5
7

58
19
27

5
3
6

36
21
43

20
8
13

50
20
33

0
23
1

0
82
27

0
12
0

0
100
0

0
36
1

0
86
3

15

58

8

57

23

58

19

68

9

75

28

70

1
8
3

4
31
12

4
2
0

29
14
0

5
10
3

13
25
8

3
3
0

11
11
0

1
1
0

8
8
0

4
4
0

10
10
0

Antipsychotics
alone
Antidepress ants
Anticholinergics
Anticonvulsants

included in Table 5.2 Exclusion criteria were a recent history of substance abuse,
past history of substance dependence, mental retardation, and other neurological
disorders including epilepsy and head injury (defined as an injury requiring hospital
observation for at least 4 hours or unconsciousness for greater than one hour).

5.2.1.2 Participants with FESz
Forty people with FESz aged between 14 yrs and 26 yrs (mean = 19.6 yrs; SD
= 3.2 yrs), were recruited from community and hospital settings through the Western
Sydney First Episode Psychosis Project (see Table 5.1 for clinical and demographic
variables). Young people, presenting for the first time to health services, with
psychotic symptoms that warranted a diagnosis of either schizophrenia or
schizophreniform disorder were included. Diagnosis was made by means of a
consensus conference (of at least three fully qualified psychiatrists) that drew upon
information from a clinical interview by the participating psychiatrist, information
from family and case manager and the case notes. Diagnoses were made according

100

to the Diagnostic and Statistical Manual of Mental Disorders (4th edition) (DSM IV) (American Psychiatric Association, 1994). Exclusion criteria were the same as
that for the chronic group. The majority of participants were medicated with atypical
antipsychotics alone (M=250 chlorpromazine equivalents: SD = 202), though a small
number were also receiving antidepressant or anticholinergic medications (see Table
5.2 for details of medication). Four participants were not on medication.

5.2.1.3 Positive and Negative Symptom Scale (PANS S)
Schizophrenic symptoms for both chronic and FESz groups were rated, using
the Positive and Negative Syndrome Scale (PANSS., Kay and Opler, 1987) by the
interviewing psychiatrist on the same day as the data acquisition (see Table 5.1).

5.2.1.4 Normal control participants
Normal control participants for the two groups were recruited from the
community and were age and gender-matched to within 2 years of the ages of their
clinical counterparts under the age of 25 years, and to within 5 years for those over
the age of 25 years. The rationale for closer age-matching of the younger
participants derived from research indicating maturational changes in the EEG/ERP,
occurring up to early adulthood (Niedermeyer, 1999; also see Chapter 4.1.1). The
older control group, with a mean age of 36.7 yrs (SD = 7.6), was compared with the
chronic schizophrenia group, and the younger control group, with a mean age of
19.65 yrs (SD = 3.86), was compared with the FESz group. Persons with a recent or
past history of mental illness, epilepsy, other neurological disorders, mental
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retardation or head injury were excluded from the sample as were persons with a
recent history of substance abuse, or past history of substance dependence.

5.3

PROCEDURE AND DATA ACQUISITION

After first obtaining voluntary consent, participants were interviewed using a
semi-structured interview schedule and were questioned about their previous
psychiatric history, family psychiatric history, medical history and level of
educational attainment. The PANSS was also administered at this time. All
participants were asked to refrain from smoking or drinking caffeine for three hours
prior to testing. The Study was approved by Western Area Health Service and
University of Wollongong ethics' committees. The task used and procedures for data
acquisition were the same as Study 1 (see Chapter 3.2.2 p 53). Additionally, (T-I)
non-targets which occurred immediately before the target were averaged separately
from (T+1) non-targets which immediately followed the target tone. For targets
N100, P200, N200 and P300 peaks were measured relative to a prestimulus (200ms)
baseline by an automated system based on the detection of a consistent change in the
direction of the gradient of the waveform (Haig et al., 1995). Thus a change from a
consistently positive to a consistently negative gradient was identified as a positive
peak, and vice versa for a negative peak. Although a 100 ms epoch is used for
analysis graphs shown in this thesis are contracted to show 100ms before and 700 ms
post stimulus, as all ERP components occur within this window and it allows the
most efficient use of space in the figures. The time window for N100 was set at 80 140ms, for P200 between 150-240ms, for N200 between 200-280ms and for P300
between 250-500 ms. Components were scored at all 19 sites (Fpl, Fp2, Fz, F3, F4,
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F7, F8,C3, C4, Cz, T3, T4, T5, T6, P3, P4, Pz, 01, 02) according to the 10-20
International system (Bloom, 1982) in reference to linked-ear electrodes.

5.4

ANALYSIS

Analysis is considered under three main sections, midline ERPs, topography and
response time. The Statistical Package for Social Sciences 10.0 program (SPSS Inc.,
1999) was used in all analyses.

5.4.1 Midline ERPs
5.4.2

Clinical vs. control groups
N100 and P200 amplitudes and latencies were submitted separately to a 4-

way ANOVA repeated measures design, incorporating group (schizophrenia vs.
controls) by gender (male vs. female) by stimuli (T-1, target and T+1) by electrode
site (Fz, Cz, Pz) with repeated measures for electrode site and stimulus factors. For
the stimulus factor, two specific planned contrasts were carried out: (i) target vs. nontargets (T vs. T-1/T+1), to examine whether the target status influenced ERP
components, and (ii) between non-targets (T-1 vs. T+1), to examine whether the
sequential position of the non-target affected ERP components. For the site factor,
linear and quadratic contrasts were examined, the linear contrast purporting to
examine reduced amplitudes at parietal sites (Fz vs. Pz) and the quadratic contrast
purporting to test the frequently observed maximal amplitudes at central sites (Cz vs.
Fz + Pz).
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N200 and P300 components were reliably observed only to the target
stimulus and were therefore subjected to a 3-way ANOVA incorporating group
(schizophrenia vs. controls) by gender (male vs. female) by site (Fz, Cz, Pz), with
repeated measures for the site factor. Similar linear and quadratic contrasts as
described above were conducted for the site factor. These analyses were done
separately for the chronic schizophrenia group vs. older controls and the FESz group
vs. younger controls.
5.4.2.1 Effects of age on ERPs
Pearson's two-tailed correlations between age and all component amplitudes
and latencies at the site at which the component was maximal (N100 and P200 at Cz,
N200 at Fz and P300 at Pz) were performed separately for the combined control
group and the combined schizophrenia group.

5.4.2.2 Effects of clinical symptom on ERPs
This analysis was based on the three factor structure (see Table 5.3) identified
by Liddle (Cuestra & Peralta, 1995; Liddle, 1982, Shean, 1999).
Table 5.3 PANS S items included in each factor

Reality Distortion
P1 Delusions
P6 Suspiciousness
P3 Hallucinatory
behaviour

Psychomotor poverty
N2 Emotional
withdrawal
N4 Passive/apathetic
social withdrawal
N6 lack of spontaneity
G7 Motor retardation

Disorganisation
P2 Conceptual
disorganisation
N7 Stereotyped
thinking
N5 Disorientation
and difficulty in
abstract thinking
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Pearson's two-tailed correlations between symptom factors and component
amplitudes and latencies at the site at which the component was maximal (N100 and
P200 at Cz, N200 at Fz and P300 at Pz) were performed separately for chronic and
FESz groups.

5.4.2.3 Classification of subjects into diagnostic groups
The accuracy with which ERP components could be used to classify subjects
into their respective diagnostic groups was examined by discriminant function
analysis (DfA). Two separate stepwise DfA were performed: the first to determine
the classification rate derived from the early components (N100 and P200) elicited
by target and non-target stimuli; and the second, to determine whether classification
rates improved with the inclusion of N200 and P300 amplitudes and latencies to
target stimuli. In order to satisfy the subject-to-variable ratio of DfA, only variables
that produced significant results in the ANOVAs previously conducted were entered
in the analysis. Independent DfAs were conducted for the chronic schizophrenia
group versus their controls, and for the FESz group versus their controls. The
variables included in the first DfA are listed in Table 5.4
Table 5.4 Variables entered for N100, P200 DfA.
Chronic Sz
T-1 N100 amplitude (Fz)
T-1 P200 amplitude(Cz)
T-1 P200 latency (Cz)
target N100 amplitude (Fz)
target P200 latency (Cz)
T+1 N100 amplitude (Fz)
T+1 P200 amplitude (Cz)
T+1 P200 latency (Cz)

FESz
T-1 N100 amplitude (Fz)
T-1 P200 amplitude(Cz)
T-1 P200 latency (Cz)
target N100 amplitude (Fz)
target P200 latency (Cz)
T+1 N100 amplitude (Fz)
T+1 P200 amplitude (Cz)
T+1 P200 latency (Cz)
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Variables entered in the second DfA included target P300 amplitude and latency at
Pz and N200 amplitude and latency at Fz (four variables).

5.4.3

Topography effects

For topographical analysis, all left handers (chronic schizophrenia = 3 and
FESz = 6) were removed from the data set. T- land T+1 ERP components, (N100 and
P200) and target ERP measures (N100, P200, N200, P300 amplitude & latency) were
submitted separately to a 4-way ANOVA (3-way for N200 and P300 as there was
only the target condition) with the between-group factor of diagnosis (schizophrenic
vs. controls) and the within-group factors of stimulus (T-I, target, T+1 ), hemisphere
(left/right) and site (left = F3, F7, C3, T3, T5, P3; right = F4, F8, C4, T4, T6, P4). To
examine anterior/posterior differences in topography a similar 2 Group X 3 Stimulus
X 2 region (anterior/posterior) X 7 sites (anterior = Fp 1, Fp2, Fz, F3, F4, F7, F8;
posterior = 15, T6, Pz, P3, P4, 01, 02 ), was conducted. Because the primary focus
was on lateralisation and regional effects and their interaction with stimulus and
group, only these results are reported. Differences among the site factor are partially
described earlier and are not further elaborated here. The use of vector scaling of
ERP data when performing topographical analysis recommended by Picton et al.
(2000) was not employed because in this case it was not necessarily appropriate, as
suggested by other researchers (Haig, Gordon, & Hook, 1997; Urbach & Kutas,
2002).
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5.4.4 Response time
Response times were determined for each participant to target tones. Only
correct responses, defined as correctly identified targets for which a button press
response was obtained within one second of the target tone, were analysed. The
between-group (chronic schizophrenia vs. control, FESz vs control) differences were
analysed by t-tests.

5.5

RESULTS

5.5.1 Midline sites
The ERP waveforms are presented in Figures 5.1 and 5.2, the former to
accentuate between-group differences at midline sites, and the latter to accentuate
within group differences at the central site. Mean and standard deviation amplitude
and latency scores appear in Table 5.5 and 5.6. A small percentage (between 1% and
2.5% in each group) of ERP measures were identified as outliers (greater or less than
one and a half the interquartile range from the upper and lower quartile). All results
below are based on data with outliers; however, results remained significant
following removal of outliers and covarying for medication (CPZ equivalents). Nonsignificant results and values appear in Appendix 3 (the inclusion of these would
make the results section unwieldy).
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Figure 5.1 Average ERPs to target and non-target (T-1& T+1) stimuli, at midline
sites, superimposed to show between-group differences.
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Figure 5.2 Average ERPs to target and non-target (T-1 &T+1) stimuli, superimposed
to show within subject differences at Cz.
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Table 5.5 N100 and P200 mean and SD values to target stimuli for clinical and
control groups.

N100 amp

Older NC
Chronic Sz
Yc
r NC FESz
Mean SD Mean SD
Mean SD
Mean SD
111-"r7
1
1=1-5.6 4.2 -7.5
Fz
-9.1
2.6
4
-6.3
2.8
Cz
-10.2
3.4
-5.9
3.5
-7.7
3.9
-5.5
2.8
Pz
-6.2
2.7
-3.5
2.1
-5.2
2.7
-4
2.5

N100 lat

Fz
Cz
Pz

105.2
103
101.8

16.1
11.4
12.1

P200 amp

Fz
Cz
Pz

3.2
5.8
3.9

3.1
2.9
2.2

P200 lat

Fz
Cz
Pz

201.9
203.7
192.1

27.7
26.4
28.9

N100 amp

Fz
Cz
Pz

-10.2
-11.4
-6.6

N100 lat

Fz
Cz
Pz

P200 amp

P200 lat

104.9 12.6
104.5 11.2
100.7 16.5
4.7
6.1
5.4

110.7
106.1
101.2

4.1
3.2
2.9

105
4.6
3.5
186.2
184.2
185.8

3
3.8
3.1

185.9 21.4
182.6
19
187.1 27.5
Target
-7.5
3.7
-7.1
3.6
4.2
2.4

108.3
103.1
101

16.6
13.2
12.6

106.6 14.9
101.1
11
98.7 12.9

110.4
104.5
96.2

Fz
Cz
Pz

0.8
-0.4
1.5

3.7
4.7
3.3

Fz
Cz
Pz

172.4
161.7
163.2

16.1
18.6
17.4

N100 amp

Fz
Cz
Pz

-8.1
-7.5
-5.4

4.1
3.6
2.4

N100 lat

Fz
Cz
Pz

100.5
95.5
98.6

12.7
9.7
13

P200 amp

Fz
Cz
Pz

3.4
5.2
3.7

4.3
3.5
3.2

P200 lat

Fz
Cz
Pz

199.7
200.5
199.5

26.4
23.4
26

3.5
5.6
5.4

-10.6
-9.3
-4.8

4.6
4.2
3.1

-1.7
1.7
3.5

178.5 15.3
174.9 16.7
178.5 21.3

171.9
171.2
160.8

MIWIT+1
-6.2
-5.9
-4.3

3.9
4.6
3.6

19.1
18.1
18.8

1.6
3.8
3.2

3.2
3.4
3

37.2 188.7
31.2 192.8
34.6 194.7

29.9
28
33

4.1
4.5
2.7

-5.9
-5.4
-3.9

3.6
3.4
3.1

16.7 106.5
12.2 97.1
11.5 94.3

15.8
15
19.4

5.2
6.2
5.8

2.3
4
4.5

4.7
4.5
3.8

17.3 168.4
20.4 165.8
31.7 158.1

13.9
16.6
25.2

-5.5
-5.4
-4.4

3.5
3.8
3.6

-5.6
-4.4
-3.5

3.5
2.9
3.1

105.7 16.8 106.9
104 15.6 101.9
101 19.2 100.7-1

17.5
19.3
16.4

113.5
102.6
95.2

31.7
17.4
18

3.9
4.4
3.4

1.8
3
2.2

4.1
3.9
3

20.3 181.6
22.2 179.1
23.2 172.2

25.5
26.7
31.7

3.9
5.2
3.5

4.5
3.2
2.5

20.3 105.6
16.6 101.5
19 98.8

3.6
3.4
2.7

3.3
5.8
4.1

182.3 20.6
184.6
20
181.1 21.9

185.4
184.6
184.6
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Table 5.6 N200 and P300 Mean and SD to target stimuli for clinical and control
groups.

Older NC

N200
amp

Chronic Sz

Younger
NC

FESz

Mean SD Mean SD Mean SD Mean SD
Fz
-5.3
3.6
-3.9 4.4
-9.9 5.6
-5.8
4.6
Cz
-7.5
5.9
-1.7 4.8
-3.2 7.2
-0.9
5.5
Pz
-2.1 4.3
0.7 3.4
1.1 5.3
0.8
4.4

N200 lat

Fz
Cz
Pz

209.8 16.6
207.2 13.1
203.8 22.3

P300
amp

Fz
Cz
Pz

10.3
11.9
18.9

6.3
8
6.6

P300 lat

Fz
Cz
Pz

316.3
316.8
328

23.4
23.7
21.6

229.5 21.6
220.6 18.2
226.5 17.1
5.7
11.2
15.1

5.9
7
6.6

315.5 27.8
309.2 32.6
327.4 35.5

214.1 18.9 222.5
209.3 18.1 216.1
195.1 29.9 204.9
10.4 8.5
18.9 10.6
25.2 10.5

19.8
21.6
31

7.9
13.3
17.7

7.7
8.2
9.7

315.9 28.8 320.4
316 35.8 317.7
318.1 27.6 325.4

45.1
38.5
39.3
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5.5.1.1 N100 Component
5.5.1.1.1 Amplitude

N100 amplitude statistical results for chronic schizophrenia vs. older controls, and
FESz v. younger controls are summarised in Table 5.7.

Chronic schizophrenia versus older controls
For N100 amplitude there was a significant main effect for group with the
chronic schizophrenia group manifesting reduced N100 amplitude compared with
older controls. This main effect for group was further qualified by Group X Stimulus,
Group X Site and Group X Stimulus X Site interactions (see Table 5.7, values in blue
& Figure 5.3) as follows. With regard to the target, non-target comparisons,
significant group differences were observed at the central compared with the frontoparietal sites indicating that the older control group had reduced N100 amplitude to
non-target compared with target stimuli while the chronic schizophrenia group did
not. Additionally, whereas the schizophrenia group did not differ in the way they
responded to the two non-targets, controls did, with T+1 decreased compared with T1, with this pattern being specific to the central site (see Table 5.7, values in blue &
Figure 5.3).

Over group and site, targets produced larger amplitudes than non-targets,
with this effect being pronounced at the central site rather than the fronto-parietal
sites. The expected fronto-central maximum for N100 amplitude was also observed,
with both linear and quadratic contrasts yielding significant results (see Table 5.7,
values in green).
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4f (1,76)
Group
Group X Stimulus

Contrasts
Stimulus

T vs NTs
T+1 vs T-1

Group X Site
Group X Stim X Site T vs NTs
T+1 vs T-1
Stimulus
Stimulus X Site

T vs NTs
Fz vs Pz
T vs NTs
T+1 vs T-1

Site
Gender
Gender X Group
Gen X Stim X Site

T vs NT
T+1 vs T-1

Chronic Sz

FESz

30.08

.0001

6.45
9.61

6.14
15.22

.02
.0002

12.76

.0006

11.44

.001

15.78

.0002

Site

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

.01
.003

10.98 .001
3.93
.05
3.27
.07
31.32 .0001

15.37
8.96
.0000 13.04
.002 19.72
0.0001 13.37

.001
.004
.001
.001
.001

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

24.37
9.84
37.2

Cz vs Fz & Pz
Fz vs Pz

140.28 0.0001 25.86 .0001
123.65 0.0001 74.71 .0001

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Table 5.7 Summary of N100 amplitude results

5.57

0.02

8.57

0.005

3.9

.05
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Figure 5.3 N100 amplitude to target and non-target stimulus at midline sites, for all
groups.
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The main effect for gender was significant (see Table 5.7, values in pink)
with women producing larger amplitudes than men, with this effect further qualified
by a Gender X Stimulus x Site interaction. In sum, the gender difference was
maximal at frontal and parietal compared with the central site and greater for T+1
stimuli than for T-1 stimuli.

Summary: The chronic schizophrenia group did not differ in the way they responded
to targets and non-targets however, the older controls did displaying larger N100s to
targets compared to T-1, with this effect being prominent at the vertex.

FESz versus younger controls
There was a significant main effect for group, with the FESz group
manifesting reduced N100 amplitude compared with younger controls. This main
effect for group was further qualified by Group X Stimulus, Group X Site and Group
X Stimulus X Site interactions, similar to those found in the chronic group (see Table
5.7, values in blue & Figure 5.3). With regard to the target versus non-target
comparisons, significant group differences were observed at the fronto-central
compared with the parietal site indicating the younger control group had reduced
N100 amplitude to non-target compared with target stimuli, while the FESz group
did not differ in their response to target and non-target stimuli.

Over group and site, targets produced larger amplitudes than non-targets, an
effect more pronounced at the fronto-central, than parietal site (see Table 5.7, values
in green). The expected fronto-central maximum for N100 amplitude was also
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observed, with both linear and quadratic contrasts yielding significant results (see
Table 5.7, values in red).

The main effect for gender was significant with women producing larger
amplitudes than men. There no further interaction between gender and group, stimuli
or site (see Table 5.7, values in pink).

Summary: The FESz group did not differ in the way they responded between targets
and non-targets, however, the younger controls did displaying increased N100 to
targets compared with non-targets, with this effect pronounced at the fronto-central
rather than parietal sites.

5.5.1.1.2 Latency

Chronic schizophrenia versus older controls
Effects were not significant for group, or group interactions with stimuli or
site. There was a significant quadratic comparison for Group X Site, F(1,76) = 5.27,
p < .05 with earlier N100 latency for older controls compared with chronic

schizophrenia, specific to the vertex.

There was a main effect for gender with earlier latencies for females
compared to males, F(1,76) = 5.39, p < .02. This effect was maximal in latencies to
target compared with non-target stimuli, F(1,76) = 7.46, p < .01, at central cf, frontal
and parietal sites, F(1,76) = 4.05, p < .05. For the non-target contrast, females
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showed earlier latencies to T-1 compared with T+1 stimulus, with this effect
maximal at frontal compared with parietal sites. F(1,76) = 4.96, p < .05.
FESz vs. younger controls
Effects were not significant for group or group interactions with stimuli or
site for N100 latency. Nor were effects for gender significant as a main effect, or as
an interaction with group stimulus or site.

5.5.1.1.3 Relationship between N100 and age
Non-tar,Qets: N100 amplitude increased with age for non-target, T-I, and T+I,

stimuli at the central site for the younger control group, but not for the schizophrenia
group (see Table 5.8). Correlations between non-target N100 latency and age were
not significant.

Table 5.8 Pearsons two-tailed correlations between age and N100 amplitude2
Non-target
T-1
Control
Schizophrenia

Target
T+1

r = -.34, p‹.002 r = -.24, p‹.05

r = -.29, p = .01
r = -.34, p‹.01

Targets: N100 amplitude increased with age for target stimuli, at the central site for

both the control and schizophrenia groups. However, further analysis revealed that

Note that as N100 is a negative component. Hence correlations with N100 amplitude are the inverse
of the r value sign.
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these results were influenced by illness duration rather than age, because the
correlation for the schizophrenia group did not remain significant after controlling
for the effects of duration, r = -.2, p = .09, or the combination of duration and
medication, r = -.1, p = .59. Correlations between target N100 latency and age were
not significant.

5.5.1.1.4Relationship between N100 and symptomatology

N100 amplitude correlated with the disorganisation factor at the central site
across stimuli in the chronic schizophrenia group, and in the FESz group for nontarget but not target stimuli, indicating that the higher the score on the
disorganisation factor the more reduced the N100 amplitude3 ( see Table 5.8). N100
latency did not correlate with symptom factors.

Table 5.9 N100 amplitude 2-tailed Pearson correlations with Disorganisation factor.
Chronic schizophrenia
T-1

r = .42,p = .01

Tar get

r = .35, p = .03

T+1

r = .36, p = .03

FESz
r = .41, p = .02

r = .33, p = .06

5.5.1.1.5 Summary

3

Note that as N100 is a negative component. Hence correlations with N100 amplitude are the inverse

of the r value sign.
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Both chronic and FESz groups showed reduced N100 amplitude overall
compared with controls, with the reduction to target stimuli mainly contributing to
this result. Neither clinical group, showed the differential response between target
and non-target stimuli, reduced N100 amplitude to non-target compared with target
stimuli that was found in the control group. The chronic schizophrenia group did not
show the differentiation between non-target stimuli, reduced N100 amplitude to T+1
compared with T-1, displayed by the older control group. Reduced N100 amplitude
was found for males compared with females, across control and clinical groups.
However the enhanced N100 amplitudes associated with age, for non-target stimuli
was found in the control groups, but not in the clinical groups. Higher
disorganisation scores were related with reduced N100 amplitude across stimuli, but
maximally with non-target stimuli.

5.5.1.2 P200 Component
5.5.1.2.1 Amplitude

The results of the statistical analyses are summarised in Table 5.10.
Chronic schizophrenia versus older controls
There was a significant main effect for group, with the chronic schizophrenia group
demonstrating increased P200 amplitude compared with older controls. This main
effect was qualified by significant Group X Stimulus, Group X Site and Group X
Stimulus X Site interactions as described below (see Table 5.10, values in blue &
Figure 5.4). With regard to the target vs. non-target comparisons, whereas the
chronic schizophrenia group responded similarly to targend non-target stimuli, older
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controls responded differentially, with decreased P200 to target compared with nontarget stimuli, with this difference being most marked at the vertex (see Figure 5.4).

Table 5.10 Summary of results for P200 amplitude

Contrasts

4f (1,76)
Group
Group X Stimulus

Stimulus

Group X Stim X Site T vs NTs
T-1 vs T+1

Stimulus X Site

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

Site

Gender
Gender X Group
Gender X Stimulus

Gen X Stim X Site

T vs NTs
T-1 vs T+1

F

F

Cz vs Fz & Pz 3.62
Fz vs Pz
Cz vs Fz & Pz 18.87
Fz vs Pz
3.60
Cz vs Fz & Pz
Fz vs Pz

p

.001
.000
-.061
-.000
.062

p

-5.45 .022
3.90 .052
4.36

.040

3.98

.050

Cz vs Fz & Pz 25.17
Fz vs Pz
7.54
Cz vs Fz & Pz 3.62
Fz vs Pz

.000 3.81
.008 12.78
.061
-- 5.51

.05
.001

Cz vs Fz & Pz 57.16
Fz vs Pz
4.11

.000 47.79
.046 33.63

.000
.000

12.35

T vs NTs
T-1 vs T+1

Gender X Site

FESz

12.21
24.98

T vs NTs
T-1 vs T+1

Group X Site

Stimulus

Site

Chronic Sz

8.83
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

.001

.004

3.54 0.064
4.73 .033
8.32

.005

.02
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Figure 5.4 P200 amplitude to target and non-target stimulus at midline sites, for all
groups.
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Over group and site, targets produced reduced amplitudes compared with
non-targets, with this effect being most pronounced at the central site. As mentioned
above, this effect was qualified by a group interaction with the results of the older
control group contributing to these effects (see Table 5.10 values in green).
Additionally across group P200amplitude appeared to be reduced to T+1 compared
with T-1, at the central compared with frontal and parietal sites, with the results
approaching significance (p = .06). The expected centro-parital maximum for P200
amplitude was also observed, with both linear and quadratic contrasts yielding
significant results (see Table 5.10, values in red).

Although effects were not significant for gender or Gender X Group, there
were significant Gender X Stimulus and Gender X Stimulus X Site interactions as
follow (see Table 5.10, values in pink). Across groups, males demonstrated reduced
P200 amplitude to targets compared with non-target stimulus and to T-1 compared
withT+1 stimulus, with this effect maximal at the central compared with frontal and
parietal sites.

FESz versus younger controls
The main effect for group was not significant. However, there were
significant Group X Stimulus, Group X Site, and Group X Stimulus X Site
interactions for P200 amplitude as follows (see Table 5.10, values in blue and Figure
5.4). The FESz group responded similarly to target and non-target stimuli, whereas
younger controls responded differentially with decreased P200 to target compared
with non-target stimuli, with the difference being most marked at Fz (see Figure 5.4).

122

Additionally, whereas the FESz group did not differ in the way they responded to the
two non-targets, younger controls did, showing T-1 decreased compared with T+1.
As a result the FESz group demonstrated increased P200 to target stimulus compared
with younger controls and decreased P200 to T+1 stimulus compared with younger
controls (see Figure 5.4).

Over group P200 amplitude to target stimuli was reduced compared with nontarget stimuli, with this effect maximal at fronto-central compared with parietal sites,
and P200 amplitude was reduced to T-1 compared with T+1 stimuli at frontal
compared with parietal sites. As mentioned above, these effects were qualified by
group interaction with the results of the younger control group contributing to these
effects.

Significant linear and quadratic effects indicated that amplitude was maximal
centro-parietally over group and stimuli. Effects were not significant for gender or
interactions between gender and other factors such as group, stimulus or site.

5.5.1.2.2 Latency

The results of the statistical analyses are summarised in Table 5.11.
Chronic schizophrenia versus older controls
For P200 latency, there was a significant main effect for group, with the
chronic schizophrenia group manifesting earlier P200 latency compared with older
controls. This main effect for group was further qualified by Group X Stimulus and
Group X Stimulus X Site interactions as described below. With regard to the target
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vs. non-target comparisons, whereas the chronic schizophrenia group responded
similarly to target and non-target stimuli, older controls responded differentially,
with dramatically earlier P200 to target compared with non-target stimuli, the
difference being most marked at Cz (see Table 5.11, values in blue & Figure 5.5).
Thus, the finding of earlier latency in the chronic schizophrenia group compared with
older controls was specific to non-target stimuli, with P200 latency to target stimuli
prolonged in the chronic schizophrenia group compared with older controls (see
Figure 5.5).

Over group and site, targets produced earlier latencies than non-targets, with
this effect being maximal at the central site (see Table 5.10, values in green). As
mentioned earlier, this stimulus effect was more dramatic for the older control group.
There was also a main effect for site with P200 most prolonged at parietal compared
with frontal sites (see Table 5.10, values in red).

Although effects were not significant for gender or Gender X Group, there
were significant Gender X Group X Stimuli, Gender X Group X Site and Gender X
Group X Stimuli X Site interactions as follow (see Table 5.10, values in pink &
Figure 5.6). Essentially the pattern identified above, whereby the chronic
schizophrenia group responded more uniformly to both targets and non-targets, was
replicated for both males and females, with the between-group differences
(schizophrenia vs. older control) being more marked for females than they were for
males. The four-way interaction involving the site factor suggested that parietal site
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was more sensitive to between-group differences for females, while the central site
was more sensitive for males.

Table 5.11 Summary of P200 latency results
4f(1,76)
Factor
Group
Group X Stimulus

Contrasts

Stimulus

T vs NTs
T-1 vs T+1

Stimulus
Stimulus X Site

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

Site

Gender
Gender X Group
Gen X Group X Stim

Gen X Group X
Stimuli X Site

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

T vs NTs
T-1 vs T+1

3.88

65.18

p

FESz
F

.02 -.0000 3.72

Cz vs Fz & Pz
Fz vs Pz

--

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

.06

.0001 32.95 .0001

15.51 0.0002 -4.30
3.43

p

0.05 --

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

T vs NTs
T-1 vs T+1

Gen X Group X Site

F

5.62
40.50

T vs NTs
T-1 vs T+1

Group X Site
Group X Stim X Site

Site

Chronic Sz

.04

.07 --

4.37

.04 --

4.67

.03 --

3.64
4.32
5.54

.06 -.04 -.02 5.22

.02
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Figure 5.5 P200 latency to target and non-target stimuli at midline sites for chronic
schizophrenia and older controls
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Figure 5.6 P200 latency to target and non-target stimulus in males and females, for
chronic schizophrenia and older control groups
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FESz versus younger controls
Effects were not significant for Group, Group X Stimulus, Group X Site or
Group X Stimulus X Site for P200 latency. Over group and site, targets were
responded to earlier than non-targets, with this effect maximal parietally (see Table
5.10, values in green). There was a significant Gender X Group X Stimulus X Site
interaction (see Table 5.10, values in pink, Figure 5.7) indicating that males
responded earlier to targets compared with non-targets, (see Table 5.10, values in
pink, Figure 5.7), whereas females responded similarly to target and non-target
stimulus across both group. Quadratic contrasts indicated that this effect was
maximal at central compared with frontal or parietal sites.
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Figure 5.7 P200 latency to target and non-target stimulus in males and females, for
FESz and younger control groups.
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5.5.1.2.3 Relationship between P200 and age
Non-targets: Correlations between age and P200 amplitude to non-target stimuli at

the central site were not significant in the control group however there was a
positive correlation between age and P200 amplitude to T+1 stimuli, r = .24, p<.05,
for the schizophrenia group. In the control group P200 latency to T-1 and T+1 was
delayed with age progression, r = .27, p<.02 and T+1, r = .32, p‹.01, respectively,
while age and latency to non-target stimuli were not significantly correlated in the
schizophrenia group.

Targets: Correlations between target P200 amplitude and age were not significant for

the control or schizophrenia group. For P200 latency, the schizophrenia group
showed a significant correlation between age and P200 latency to target stimuli, r =
.23, p<.05 with latency increasing with age.

5.5.1.2.4 Relationship between P200 and symptomatology

Correlations between symptom factors and P200 amplitude and latency were
not significant.

5.5.1.2.5 Summary

Both control groups had earlier and reduced P200 components to targets and
delayed and increased to non-target stimuli. This differentiation was not found in the
chronic schizophrenia group. The FESz group differentiated between target and nontarget stimuli in latency, but not in amplitude. The combined schizophrenia group did
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not show prolonged P200 latency to non-target stimuli with age as the combined
control group did. Differential gender effects were found for both amplitude (present
in clinical not in control groups) and latency (present in control but not in clinical
groups).

5.5.1.3 N200
5.5.1.3.1 Amplitude

Chronic schizophrenia versus older controls
There was a significant main effect for group, F(1,78) =17.98, p < .001, with
N200 reduced in the chronic schizophrenia group compared with the older control
group. This was qualified by a significant Group X Site interaction with the quadratic
contrast, F(1,76) = 19.8, p < .0001, indicating that the group difference was maximal
at Cz (see Figure 5.8). Significant quadratic, F(1,76) = 10.73, p < .001, and linear,
F(1,76) = 132.9, p <. 0001, contrasts for site indicated N200 was maximal at frontocentral sites.

There was also a significant main effect for gender, F(1,76) = 7.6, p‹.01,
with N200 reduced in females compared to males, and a significant Gender X Group
X Site linear contrast, F(1,76) = 4.39, p‹.05, as the reduced N200 for the chronic
group was due to difference between female rather than male subjects, with this
effect specific to the frontal site.
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Figure 5.8 N200 amplitude (above) and latency (below) at midline sites for clinical
and control groups.
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FESz versus younger controls
The main effect for group was not significant, however, there was a significant
Group X Site linear contrast, F(1, 75) =6.76, p < .01, as the first episode group
demonstrated reduced P200 amplitude at the frontal compared with the parietal site.
There were significant linear, F(1,75) = 132.95, p < .001, and quadratic, F(1,75) =
10.73, p < .01, contrasts for site indicating a fronto-central maximum for N200
amplitude. Effects for gender were not significant, nor were any interaction effects
for gender with group or site significant.

5.5.1.3.2 Latency

Chronic schizophrenia versus older control
There was a significant main effect for group, F(1,76) = 5.25, p < .05, with
N200 latency prolonged in the chronic schizophrenia group compared with older
controls. This main effect was qualified by a Group X Site interaction with the
significant quadratic contrast, F(1,76) = 11.89, p <.0.001, indicating this delay was
maximal at frontal and parietal sites compared with the central site (see Figure 5.8).
Significant linear, F(1,76) = 152.75, p <.0001 and quadratic, F(1,76) = 4.52, p < .05,
contrasts for site indicated that latency was maximal frontally, plateauing at central
and parietal sites.

Effects for gender were not significant, nor were any interaction effects for
gender with group or site significant.
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FESz versus younger controls
Main effects for group were not significant. Across groups there was a
significant linear contrast, F(1,75) = 24.20, p < .0001, for site with N200 latency
prolonged at frontal compared with central and parietal sites. Site and Group did not
interact significantly.

Effects for gender were not significant, nor were any interaction effects for
gender with group or site significant.

5.5.1.3.3 Relationship between A1200 and age

N200 amplitude to target stimulus decreased with age for the combined
control group, r = .439, p < .05, but not for the combined schizophrenia group, r =
.21, p = .07. Correlations between target N200 latency and age were not significant
for the combined control or combined schizophrenia group.

5.5.1.3.4 Relationship between the A1200 and symptomatology

Correlations between N200 amplitude and latency at Fz and symptom factors
were not significant.

5.5.1.3.5 Summary

A significant reduced and prolonged N200 occurred in chronic schizophrenia
and a similar trend occurred in the FESz group (latency was significant when
extended over full topography [see topographical analysis 5.2.2], while not
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significant over midline sites). The reduction was maximal centrally in the chronic
group and frontally in the first episode group. The decrease in N200 amplitude with
age progression found in the combined control group did not reach significance in
the schizophrenia group. No gender effects or correlations with symptom factors
were found.

5.5.1.4 P300 Component
5.5.1.5 Amplitude
Chronic schizophrenia versus older controls
The chronic schizophrenia group showed an overall reduced P300 amplitude,
F(1,76) = 5.25, p<.05. This main effect was qualified by a Group X Site interaction
with the significant quadratic contrast, F(1,76) = 11.89, p <.0.001 indicating this
reduction was maximal at frontal and parietal sites compared with the central site
(see Figure 5.9) There was also a main effect for site, with linear, F(1,78) = 161.39, p
< .001 and quadratic, F(1,78) = 4.30, p <.05, contrasts indicating maximal amplitude

at the parietal site, plateauing between fronto-central sites (see Figure 5.9). Neither
the main effect for gender, nor any of its interaction effects were significant.

FESz versus younger controls
There was a significant main effect for group, F(1,78) = 5.31, p < .05 with
the FESz group manifesting reduced P300 amplitude compared with younger
controls. This main effect for group was further qualified by a Group X Site
interaction, with a significant linear contrast, F(1,78) = 4.34, p < .05, indicating that
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this reduction was maximal at the parietal compared with the frontal site (see Figure
5.9). There was also a significant linear contrast for site, with P300 amplitude
maximal at the parietal site. Effects for gender were not significant, nor were any
interaction effects for gender with group or site significant.
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Figure 5.9 P300 amplitude at midline sites.
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5.5.1.5.1 Latency

Chronic schizophrenia versus older controls
Main effects for group were not significant. Across groups, there were
significant linear, F(1,76) = 10.15, p < .01, and quadratic, F(1,76) = 14.71, p < .001,
contrasts for site, with P300 latency prolonged maximally at the parietal site (See
mean values in Table 5.6). Site and Group did not interact significantly. Effects for
gender were not significant, nor were any interaction effects for gender with group or
site significant.

FESz versus younger controls
For P300 latency there was no significant effects for group, site, group by site
interaction, or gender.

5.5.1.5.2 Relationship between P300 and age

P300 amplitude to target stimulus decreased with increases in age for both the
control group, r = -.39, p < .001, and the schizophrenia group, r = -.22, p = .05.
Although this relationship was stronger for the controls group, a Z test comparison
did not reveal a significant difference between these two correlations, z dill = -1.19, p
= 0.23. When the effects of duration of illness were taken in to account, the
correlation between age and P300 amplitude in schizophrenia did not remain
significant, r = -.12, p = .32. This analysis was also applied to the chronic
schizophrenia group alone, as the first episode group where assessed at onset. In this
analysis, again the relationship between P300 amplitude and age was no longer
significant when the correlation controlled for duration, r = -.04, p = .80.
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Increasing age has consistently been found to be associated with prolonged
P300 latency, and this prediction was supported in the current Study with P300
latency being positively correlated with age, r = .205, p = .03 (one-tailed test) in the
combined control group, but not in the combined schizophrenia group, r = -.12, p
=.432 (one-tailed test).

5.5.1.5.3 Relationship between P300 and symptomatology

There were no significant correlations between P300 amplitude or latency and the
symptom factors.

5.5.1.5.4 Summary

P300 amplitude was reduced for both the chronic and FESz groups compared with
normal controls. P300 amplitude was observed to reduce with age for both the
normal and schizophrenia groups. However the P300 reduction in the schizophrenia
group was related more to illness duration than age. P300 latency was prolonged
with age in the combined control group but not in the combined schizophrenia group.
There were no gender effects or symptom correlations for P300 amplitude or latency.
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5.5.1.6 Discriminant Function Analysis
To compare the relative accuracy of classification, schizophrenia or normal, based
on target and non-target N100, P200 components compared with target N200, P300
components this Study compared two separate stepwise discriminant function
analyses. The results of these analyses are summarised in Table 5.12, showing
improved classification from the DfA based on the earlier N100 and 200 components
to target and non-target stimuli compared with the DfA based on N200 and P300 to
targets.

Table 5.12 Discriminant function analysis classification results

Chronic
Older
schizophrenia control
1. N100 P200
Variables selected by
stepwise DA
(standardized canonical
discriminant function)
2. N200 P300
Variables selected by
stepwise DA
(standardized canonical
discriminant function)

FESz

Younger
control

82.5%
82.5%
Wilk's
2(2,76)
=
0.69,
2
x = 28.5, p = .000

82.5%
80%
Wilk's
2(3,78)
=
0.56,
2
Z = 44.81, p = .000

T P200 latency (0.62)
T-1 P200 latency (-0.49)
T-1 N100 amplitude (0.49)

T N100 amplitude (1.06)
T+1 N100 amplitude (-0.46)

75%
65%
Wilk's
42,77) = 0.82,
2
x = 15.78, p = .000
N200 latency (1.0)

62.5%
77.5%
Wilk's
41,78) = 0.79,
2
x = 18.49, p = .000
P300 amplitude (0.72)
N200 amplitude (-0.62)
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5.5.2 Topography

The effects of factors, including group and stimulus, along with their
interactions, have been examined earlier for midline sites. Hence the following
analyses focuses on main and interaction effects associated with hemisphere (left vs.
right) and region (anterior vs. posterior). Results for other factors including group
and stimulus emerging from this analysis replicate results from the earlier analysis
and will not be reported here, but details are made available in a CD Rom in
Appendix 3. Also only statistical values at .05 or above are reported below, with
more comprehensive outputs available in Appendix 3.

5.5.2.1 N100 component
5.5.2.1.1 Amplitude

Topographical head maps for N100 amplitude to target and non-target stimuli, for
control and clinical groups appear in Figure 5.10. The results of the statistical
analysis are summarised in Table 5.13.
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Figure 5.10 N100 amplitude topographical head maps for target and non-target
stimulus for clinical and control groups.
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Table 5.13 Summary of N100 amplitude results
Stimulus
Hemisphere
Hemisphere Group
Hemisphere X Stim
Hem X Grp X Stim

Location
L vs R
L vs R
T vs NTs
L vs R
T-1 vs T+1 L vs R
T vs NTs
L vs R
T-1 vs T+1 L vs R

Region
Region X Group
Region X Stim

A vs P
A vs P
T vs NTs
A vs P
T-1 vs T+1 AvsP
Region X Grp X Stim T vs NTs
A vs P
T-1 vs T+1 AvsP

Chronic Sz
F

FESz

10.51 .002 --

97.06 .000 100.75 .000
5.11 .027
7.18 .009 28.45 .000
19.61 .000

Chronic schizophrenia versus Older controls
Left versus right hemisphere
Neither the main effect for hemisphere nor its interaction with group was
significant. However, the Hemisphere X Stimulus interaction for the T+1 vs. T-1
contrast was significant indicating increased N100 amplitude to T-1 compared with
T+1 in the left compared with the right hemisphere, (see Table 5.13 values in blue &
Figure 5.11).
Anterior versus posterior
There was a significant effect for region signifying increased N100 amplitude
in the anterior compared with the posterior region and a significant Region X
Stimulus interaction, with the increase in N100 amplitude to target compared with
non-target stimulus maximal in the anterior region (see Table 5.13 values in green &
Figure 5.11).
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FESz versus Younger controls.
Left versus right hemisphere
Neither the main effect for hemisphere nor any of its interaction effects were
significant (see Table 5.13 values in blue).

Anterior versus posterior
The main effect for region was significant indicating that, N100 amplitude
increased in the anterior compared with the posterior region. This effect was
qualified, however, by Region X Group, Region X Stimulus and Group X Region X
Stimulus interactions. The critical finding was that the younger control group
responded with increased N100 amplitude to target (compared with non-target)
stimuli, where as the FESz group did not, with this group difference being observable
only in the anterior region (see Table 5.13, values in green & Figure 5.12).
Summary
Over the older control and chronic schizophrenia groups, differences between
T-1 and T+1 were more obvious in recordings over left (vs. right) hemisphere, as
N100amplitude to T-1, but not T+1, was increased in the left (vs right) hemisphere.
An increase in N100 amplitude to target compared with non-target stimuli found
across the older control and chronic schizophrenia groups, in the younger group
comparison this effect was found in the control, but not the FESz group who
responded to target and non-target stimulus similarly in the anterior and posterior
region.
5.5.2.1.2 Latency
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Topographical head maps for N100 latency to target and non-target stimuli, for
control and clinical groups appear in Figure 5.13.
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Chronic schizophrenia versus older controls
Left versus right
Effects were not significant for hemisphere or its interactions.

Anterior versus posterior
There was a significant effect for region, F(1,60) = 9.77, p <.01, with N100
latency prolonged in the anterior compared with the posterior region. This effect was
qualified by a Region X Stimulus significant contrast, F(1,60) = 11.51, p <.001
demonstrating that the regional effect on latency was maximal for the target
compared with non-target stimulus. There were no significant interactions betweengroup and region.
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Figure 5.14 N100 latency to target and non-target stimulus at anterior and posterior
regions.
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FESz versus younger controls
Left versus right
Effects were not significant for hemisphere or interactions between hemisphere and
group or stimulus.

Anterior versus posterior
There was a significant effect for region, F(1,60) = 34.98, p <.001, with N100
latency prolonged in the anterior compared with the posterior region. This effect was
qualified by a Region X Stimulus significant contrast, F(1,60) = 5.78, p <.05, for the
non-target comparison, as the region effect was maximal for the T+1 compared with
T-1 stimulus. The target vs non-target contrast was not significant. As seen in Figure
5.13, this appears to be because N100 amplitude to T+1 stimulus is also increased.
Group and region did not interact significantly.

Summary
Analysis by hemisphere and region revealed no between-group differences for N100
latency. All four groups showed a similar pattern of prolonged N100 latency to
targets (compared with non-targets) especially at anterior sites.
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5.5.2.2 P200
5.5.2.2.1 Amplitude

Topographical head maps for P200 amplitude to target and non-target stimuli, for
control and clinical groups appear in Figure 5.15. The results of the statistical
analysis are summarised in Table 5.14
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Table 5.14 Summary of P200 amplitude results
df (1,59)
Hemisphere
Hemisphere X Group
Hem X Stimulus
Hem X Stim X Grp

Region
Region X Group
Region X Stim
Grp X Reg X Stim

Stimulus

Chronic Sz
Location F
p

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

L vs R
L vs R
L vs R
L vs R
L vs R
L vs R

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

A vs P
A vs P
A vs P
A vs P
A vs P
A vs P

FESz

F

p

10.70 0.002 5.47 0.023

5.68 0.020 35.49 0.000
12.01 0.001 4.62 0.036

Chronic schizophrenia versus older controls
Left versus Right
Effects were not significant for hemisphere or interactions between hemisphere and
group. However, the Hemisphere X Stimulus interaction for the T+1 vs. T-1 contrast
was significant indicating that P200 amplitude was larger in the left compared with
the right hemisphere, to the T+1 stimulus (see Table 5.14, values in blue & Figure
5.16).

Anterior versus posterior
There was a significant effect for region, reflecting increased P200
amplitude in the posterior compared with the anterior region. This effect was
qualified by a significant Region X Stimulus contrast for the target vs. non-target
comparison, as the stimulus effect was maximal for the posterior region (see Table
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5.14 values in green & Figure 5.16). There were no significant interactions betweengroup and region.
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Figure 5.16 P200 amplitude to T-1 and T+1 stimulus, by hemisphere(left panels)
and to target and non-target stimuli by region (right panels).
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FESz versus younger controls
Left versus Right
Effects were not significant for hemisphere or interactions between
hemisphere and group. However, the Hemisphere X Stimulus interaction for the T+1
vs. T-1 contrast was significant, indicating that P200 amplitude was larger in the left
compared with the right hemisphere for the T+1 stimulus (see Table 5.14 values in
blue & Figure 5.16).

Anterior versus posterior
There was a significant effect for region, indicating increased P200 amplitude
in the posterior compared with the anterior region. This effect was qualified by a
significant Region X Stimulus contrast for the target vs. non-target comparison, as
the region effect was maximal for the target compared with the non-target stimulus
(see Table 5.14 values in green & Figure 5.16). There were no significant
interactions between group and region.

Summary
Across groups, P200 amplitude was maximal in the posterior region and
increased to the T+1 stimulus on the left compared with right hemisphere.

5.5.2.2.2 Latency
Topographical head maps for P200 latency to target and non-target stimuli,
for control and clinical groups appear in Figure 5.17. The results of the statistical
analysis are summarised in Table 5.15.
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Table 5.15 Summary of P200 latency results
Chronic Sz
1 59

4f ( , )
Hemisphere
Hemisphere X Group
Hemisphere X Stim
Hem X Stim X Grp

Region
Region X Group
Region X Stim
Reg X Grp X Stim

Stimulus

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

Location F
L vs R
L vs R
4.67
L vs R
LvsR
L vs R
LvsR

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

A vs P
A vs P
A vs P
A vs P
A vs P
A vs P

10.36

FES z

-.035
--

.002
--

6.49

4.30

.04

3.86

.05

10.86 .002
4.45

.04

.01

Chronic versus Older controls
Left versus Right
Effects were not significant for hemisphere or interactions between
hemisphere and stimulus. However, the Hemisphere X Group interaction was
significant, indicating that P200 latency delay in the older control compared with
chronic schizophrenia group was maximal in the left hemisphere (see Table 5.15,
values in blue & Figure 5.18).

Anterior versus posterior
There was a significant effect for region, with P200 latency prolonged in the
anterior compared with posterior region. This effect was qualified by a Region X
Stimulus X Group interaction with the target vs. non-target contrast significant, as
the stimulus effect was maximal in the posterior compared with anterior region (see
Table 5.15 values in blue & Figure 5.19).
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Figure 5.18 P200 latency across stimuli for chronic schizophrenia and older control
groups, by hemisphere (left panel), and to target and non-target stimulus, across
FESz and younger control groups, by hemisphere (right panel).
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Figure 5.19 P200 latency to target and non-target stimulus in anterior and posterior
regions, for chronic schizophrenia and older control groups (top panel) and across
group for FESz and younger control groups.
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FESz
Left versus right
There was a significant effect for hemisphere, signifying prolonged P200
latency in the left compared with right hemisphere. This effect was qualified by a
Hemisphere X Stimulus interaction, with the target vs. non-target contrast
significant, as the stimulus effect was maximal in the left compared with right
hemisphere (see Table 5.15 values in green & Figure 5.18). There were no
significant interactions between group and hemisphere.

Anterior versus posterior
There was a significant effect for region, indicating prolonged P200 latency
in the anterior compared with posterior region. This effect was qualified by a Region
X Stimulus interaction, with the target vs. non-target contrast significant, as the
stimulus effect was maximal in the anterior compared with posterior region (see
Table 5.15 values in blue & Figure 5.19). There were no significant interactions
between group and region.

Summary
Delayed P200 latency in the anterior (compared with posterior) region was
found over stimuli and groups. For the older controls (compared with chronic
schizophrenic) the delayed P200 latency was found in target (compared with nontarget) stimuli at anterior sites, and across stimuli on the left (compared with right)
hemisphere. In the FESz and younger control groups, delayed P200 latency was
evident to T-1 (compared with T+1) stimuli at anterior sites, and to non-target
(compared with target) stimuli on the left (compared with right) hemisphere.

155

5.5.2.3 N200 component
Topographical head maps for N200 amplitude and latency to target stimuli, for
control and clinical groups appear in Figure 5.20

Old control Chronic Sz
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Anterior versus posterior
There was a significant effect for region, F(1,70) = 23.4, p <.001, indicating
increased N200 amplitude in the anterior (compared with posterior) region. This
effect was qualified by a significant Region X Group interaction, F(1,70) = 11.51, p
<.01, suggesting that this pattern was mainly attributable to the chronic
schizophrenia group (see Figure 5.21).

FESz versus younger controls
Left versus Right
There was a significant main effect for hemisphere, F(1,59) = 4.33, p< .05,
indicating increased N200 amplitude in the right (compared with left) hemisphere in
both groups. Effects were not significant for the interaction between group and
hemisphere.

Anterior versus posterior
There was a significant effect for region, F(1,60) = 88.8, p <.001, with N200
amplitude increased in the anterior compared with posterior region, however this
effect was qualified by a significant Region X Group interaction, F(1,60) = 4.36, p
<.05, suggesting that this pattern was maximal in the young control group (see
Figure 5.21).
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Figure 5.21 N200 amplitude at anterior and posterior regions.

5.5.2.3.2 Latency

Chronic schizophrenia versus older controls
Left versus Right
Effects were not significant for hemisphere or the interaction between group
and hemisphere for N200 latency.

Anterior versus posterior
There was a significant effect for region, F(1,70) = 12.06, p <.001, with
P200 latency prolonged in the anterior compared with posterior region. Effects were
not significant for the Group X Region interaction.
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FESz versus younger controls
Left versus right
Effects were not significant for hemisphere, however, there was a Group X
Hemisphere interaction, F(1,59) = 5.38, as the younger control group were more
delayed in the left compared with the right hemisphere whereas the FESz group were
more delayed in the right compared with the left hemisphere. Hence the delay for the
FESz group was more pronounced in the right hemisphere.
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Figure 5.22 N200 latency for FESz and younger controls by hemisphere.

Anterior versus posterior
There was a significant main effect for region, F(1,59) = 67.46, p <.05, with
N200 latency delayed in the anterior compared with posterior region. Effects were
not significant for the Group X Region interaction.
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Summary
Increased anterior compared with posterior N200 amplitude was found across
all groups, however, this effect was stronger in the chronic schizophrenia group
compared with older controls and in younger controls compared with FESz group.
The FESz group showed the opposite pattern of hemisphere effects compared to their
control group, displaying delayed N200 latency in the left hemisphere.

5.5.2.4 P300 component
Topographical head maps for P300 amplitude and latency to target stimuli,
for control and clinical groups appear in Figure 5.23

Old control Chronic Sz
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5.5.2.4.1 Amplitude

Chronic schizophrenia versus older controls
Left versus Right
Effects were not significant for hemisphere, or the interaction between group
and hemisphere, for P300 amplitude, nor was there a significant Group X Site
interaction evident when the P300 amplitude analysis was restricted to T3 and T4
sites, F(1,72) = .02, p = .87.

Anterior versus posterior
The expected effect for region associated with P300 was observed, F(1,66) =
142.87, p <.001, indicating P300 amplitude was maximal in the posterior compared
with anterior region. Effects were not significant for the Group X Region
interaction.

FESz versus younger controls
Left versus Right
Effects were not significant for hemisphere or the interaction between group
and hemisphere for P300 amplitude, nor was there a significant Group X Site
interaction when the P300 amplitude analysis was restricted to T3 and T4 sites,
F(1,66) = .01, p = .92.

Anterior versus posterior
There was a significant main effect for group, F(1,60) = 88.8, p ‹.001,
indicating P300 amplitude was maximal in the posterior compared with anterior
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region. However, this effect was qualified by a significant Region X Group
interaction, F(1,60) = 4.36, p <.05, suggesting that this pattern was maximal in the
young control group (see Figure 5.24).
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Figure 5.24 P300 amplitude by region for FESz and younger control groups.

5.5.2.4.2 Latency

Chronic schizophrenia versus older controls
Left versus right
Effects were not significant for hemisphere or the interaction between group
and hemisphere for P300 latency.

Anterior versus posterior
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There was a significant effect for region, F(1,70) = 11.664, p = .001,
indicating that P300 latency was prolonged in the posterior compared with anterior
region. Effects were not significant for Group X Region interaction.
FESz versus younger controls
Left versus right
Effects were not significant for hemisphere or the interaction between group
and hemisphere for P300 latency.

Anterior versus posterior
Effects were not significant for region or the interaction between group and
region for P300 latency.

Summary
Analysis for hemisphere did not produce significant between-group results
for P300 amplitude or latency, for either of the two comparisons. A focussed
analysis, did not find smaller P300s over the left (T3) site than over the right (T4)
site in either the chronic or FESz groups (compared with normal controls). Analysis
by region, demonstrated a generally increased and delayed P300, in the posterior
(compared with anterior) region across the older control and chronic schizophrenia
groups.

5.5.3 Response time
Both the chronic schizophrenia group (mean = 405ms, SD = 10ms) and the
FESz group (mean = 367mss, SD = 9ms), showed significantly slower response
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times (df =1,78, p<.001 and df=78, p‹.01 respectively) than their normal controls
(mean = 315ms, SD = 15ms; mean = 308ms, SD = 9ms). There were no significant
differences between the chronic schizophrenia and FESz groups, or between the two
control groups. Control groups averaged 99.8% (older) and 99.9% (younger)
accuracy and the clinical groups averaged 93% (chronic schizophrenia) and 96.2%
(FESz) accuracy

5.6

DISCUSSION

Results from this Study strongly suggest that abnormalities in ERPs in
schizophrenia are not restricted to target stimuli, but occur to both target and nontarget stimuli, and are evident at both the onset of schizophrenia and the chronic state
of the illness. The results are, therefore, consistent with the hypothesis that ERP
deficits in schizophrenia are trait like and not due to secondary effects of chronic
morbidity, neuroleptics or institutionalisation. The examination of ERP responses to
target and non-target stimuli, and further to T-1 vs. T+1 non-target stimuli, produced
striking results. The chronic and FESz groups did not demonstrate the differential
N100 and P200 amplitude responses to target and non-target stimuli shown by both
older and younger control groups. In addition the chronic schizophrenia group did
not differentiate in their response to T-1 and T+1 non-target stimuli for N100
amplitude, as did the older and younger control groups. Most importantly the
stepwise discriminant function analysis demonstrated a superior classification for
both chronic and FESz using the early components to both target and non-target
stimuli in comparison to the previous focus on the P300 component elicited by target
stimuli. The inclusion of ERP components to non-target stimuli, in addition to target
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stimuli also provided evidence of differential aging effects on ERPs in schizophrenia
versus normal controls and the most robust correlation with symptom factors.

Schizophrenia versus Controls: For both the chronic schizophrenia and FESz groups,

the traditional averaged ERP to target stimuli showed decreased N100, N200 and
P300 amplitude and increased P200 amplitude when compared to their controls. The
reduced N100, N200 and P300 amplitude are consistent with previous ERP studies
with schizophrenia (Ogura et al., 1991; Boutros et al., 1997; Brown et al. 2000) and
with previously reported reduced N200 and P300 amplitude findings in FESz studies
(Demiralp et al., 2002; Hirayasu et al., 1998; Salisbury et al., 1998). Previous target
P200 amplitude findings have been mixed, however, the increased P200 amplitude in
this Study replicates findings by Ogura et al. (1991) in an unmedicated sample. P200
amplitude has been reported to reflect aspects of decision-making or stimulus
encoding (McCarley et al., 1991).

There were some differences, however between the chronic schizophrenia
and FESz groups and their respective controls. While amplitude disturbances were
common to both groups, latency deficits were specific to the chronic group, who
showed delayed P200 and N200 latencies to targets, and earlier P200 latency for
non-targets. The FESz group, in contrast, showed no significant latency differences
in comparison to their control group. One possible explanation for this pattern of
results is that the observed amplitude deficits manifest an association with more
primary aspects of the disease, whereas latency differences represent secondary or
subsequent aspects, for example, direct consequences associated with the progression
of the disease or indirect consequences of chronicity such as institutionalisation. In
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addition, the reduced P200 amplitude to T+1 stimulus found in the FESz was not
found in the chronic schizophrenia group.

Target versus non-target:

The disturbance in information processing is also

elucidated by within group comparisons. The pattern of significant differences
between targets and non-targets (smaller earlier P200 to targets versus increased
delayed P200 to non-targets), shown by the controls, was not shown either by the
chronic schizophrenia or FESz groups (see Figures 5.2 and 5.4). In the chronic
schizophrenia group, P200 amplitude and latency did not vary significantly between
target and non-target stimuli. In the FESz group, P200 amplitude either did not
differentiate at fronto-central sites, or differentiated by increasing to target
(compared with non-target) stimuli at the parietal site. This is in the opposite
direction to the control group, where P200 amplitude is reduced to target (compared
with non-target) stimuli. The FESz group, showed a shift in P200 latency between
target and non-target stimuli. Scrutiny of the waveforms (Figure 5.1) suggests that
the P200 amplitude and latency shift between targets and non-targets, shown by the
controls, may result from the overlap with the N200 components in ERPs to target
stimuli. Thus, the large and wide P200 amplitude component normally elicited by
non-target stimuli is reduced and narrowed by the negative shift associated with the
N200 component in ERPs elicited by target stimuli. It is possible that this does not
occur to the same extent in the chronic and FESz groups because their N200, and
P300 components are reduced compared to controls, and so the N200 overlap is not
so prominent in the P200 component. This would contribute to the larger P200
amplitude to targets found in the chronic schizophrenia group compared to controls.
It should be noted, however, that the P200 amplitude produced by the target stimuli
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is actually larger than the P200 amplitude produced by the non-target stimuli in the
FESz group despite the presence of the N200 component in the target elicited ERP.
Although not within the scope of this thesis, a new single trial method (Melkonian et
al., 2001) will be applied to this data to tease out the overlapping components to
investigate, amongst other questions, whether P200 differences remain when the
effects of the N200 overlap are removed.

The N100 component is correlated with specific aspects of stimulus features
(Pritchard, 1986; Naatanen and Picton, 1987), but may also reflect attention, as it is
generally larger with increasing attentional requirements (Maclean et al., 1975). It is
also affected by non-specific arousal (Rockstroh, Muller, Wagner, Cohen, & Elbert,
1994). The chronic and FESz groups, in addition to showing an overall reduction of
N100 amplitude, also failed to show the distinct pattern of N100 amplitude to target
>T-1 > T+1 stimuli found in the control groups. The stimulus features of the T+1 and
T-1 stimuli are identical. It is therefore possible that the reduction in N100 amplitude
to T+1 stimuli found in normal controls, but not in patient participants, could be due
to temporal recovery, as the T+1 stimuli follows a target that requires a cognitive and
motor response. Alternatively, it could reflect reduced attentional requirements for
T+1 stimulus due to changes in states of vigilance or preparedness, as a target
stimulus is always followed by a non-target stimulus in this paradigm. This
possibility is further explored in Study 3, employing a paradigm in which target
stimuli are equiprobably followed by target or non-target stimuli. Further support for
this proposition comes from the results of an associative learning study utilising
visual stimuli, in which the N100 amplitude evoked by a stimulus 2(S2) following a
predictive stimulus 1(S1) was reduced (Rose, Verleger, & Wascher, 2001). The
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authors interpreted this reduction as indicative of a reduced need to allocate spatial
attention to S2 because S1 had provided reliable information about S2. If this
interpretation is accurate, the results of the present Study would indicate that a
similar process applies to the auditory attentional system
The patient group's diminished discrimination between target and non-target
stimuli (and also between T-1 and T+1) suggests that they are less flexible in
differentiating and processing target and inhibiting non-target information than
controls. This pattern is consistent with Gray's (1998) model in which
"misattributions" in the match/mismatching of target: non-target information is
proposed to underlie the core positive symptoms in schizophrenia. A failure to
develop an expectancy that a non-target would follow a target could be further
evidence of this dysfunction, and may stem from the failure to make use of stored
regularities in information processing. Amongst other possibilities, it may be viewed
as a disturbance in implicit memory.

N100 amplitude was robustly correlated with the disorganisation factor for
both the chronic and FESz groups. As disorganisation increased, N100 amplitude
reduced. As predicted, this correlation was stronger for non-target stimuli in
comparison to target stimuli. Perhaps increased disorganisation in schizophrenia is
more strongly associated with the failure to inhibit, or dampen the processing of
irrelevant stimuli (non-targets) than it is related to preferential processing of relevant
stimuli (targets). These fmdings indicate that the reduced N100 amplitude in
schizophrenia is present at the onset of illness, as well as later chronic stages. This
reduction to non-target stimuli related to disorganisation, the putative core factor of
schizophrenia.
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Increased N100 amplitude to non-target stimulus and decreased and delayed
P300 component to target stimulus with age are robust findings (see 4.1.1) and were
found in the combined (younger + older) normal control group in this Study. In the
combined schizophrenia group, however, correlations were not significant between
age and both N100 amplitude and P300 latency. For P300 amplitude the correlation
only just reached significance. Further differential age effects were found for P200
latency. The control group showed prolonged P200 latency to non-target stimuli with
age, whereas the schizophrenia groups showed prolonged P200 latency to target
stimuli with age. The combined normal control group also demonstrated a decrease
in N200 amplitude with age, an effect not found in the schizophrenia groups. These
results do not suggest the accelerated ageing that would be expected with a
neurodegenerative illness. The pattern of results, including the absence of age
effects, along with the presence of similar deficits in both first episode and chronic
schizophrenia, are more consistent with a neurodevelopmental hypothesis.

Compared to the N200 and P300 components, which have been the focus of
schizophrenia research, the N100 and P200 components acquired in response to both
targets and non-targets provided a more accurate classification for both the chronic
schizophrenia group (improved from 75% to 82.5%) and the FESz group (improved
from 62.5% to 82.5%). Thus, the emphasis on extending ERP investigations to
components other than P300 in the current Study is strongly supported.

Perceptual abnormalities are an early sign of the onset of psychosis
(Chapman, 1966) and the development of investigational methods to assess this is
important. Given the current emphasis in first episode psychosis treatment on early
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identification and active treatment of young people at risk (McGlashan 2001a,
McGlashan 2001b), a method to help highlight risk prior to a psychotic episode, and
track treatment progress is necessary. For these purposes, and to avoid unnecessary
use of antipsychotic medication, it is imperative to correctly differentiate FESz
patients from normal and other non-psychotic controls. The benefit of using the
earlier components to target and non-target stimuli is illustrated by the reduction in
false positive classifications i.e. 37.5% of the controls would have been falsely
classified as FESz using the N200 and P300 components to target stimulus versus
20% using the N100 and P200 components to both target and non-target stimuli.
However, because this Study did not use a clinical control group, the specificity of
these findings needs to be examined.

Gender effects did not differ for the schizophrenia group compared with
controls for N100 amplitude and latency or P200 amplitude. However, males with
schizophrenia (both first episode and chronic) compared with females, showed
shorter P200 latency to target compared to non-target stimuli. This effect was
maximal at the central site. In addition, the reduced N200 amplitude in the chronic
schizophrenia compared with the control group arose predominantly from a
reduction in females in the schizophrenia group. These were unexpected findings, as
one might expect gender differences in schizophrenia to favour females rather than
males. Previous schizophrenia research has indicated improved outcomes for females
compared to males (Tamminga, 1997; Castle et al., 2000), suggesting that females
appear to have a less virulent form of the disorder (Flor-Henry, 1985; Andia et al.,
1995; Kulkarni, 1997).
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Overall there were few group topographical differences. The left lateralised
P300 amplitude deficit found in some studies (see Chapter 4.5) did not occur, even
when restricting the comparison to T3 and T4 electrode sites. The left lateralised
P300 deficit has been found more commonly in studies using a count response than
button press. It is possible, therefore, that the button press response used in this Study
has contributed to the absence of the lateralised P300 amplitude deficit, although
Turetsky et al. (1998) has demonstrated this lateralised deficit, using the button press.
Another possible contributing factor is that the EEG recording was not acquired from
TCP1 and TCP2 sites which were found to show a greater effect than T3 and T4 in a
meta- analysis of P300 topography studies (Jeon &Polich, 2001).

In conclusion, this Study found that:
(i)

N100 and P200 target versus non-targets differences and non-target sequence
effect differences (T-1 vs. T+1) are diminished in schizophrenia.

(ii)

In comparison to target generated P300amplitude, N100 and P200 deficts to
target and non-target stimuli show improved sensitivity for schizophrenia.

These findings led to further investigations in subsequent studies. The next Study
(Chapter 6) explores whether sequence effects on ERPs to target stimuli, as well as
non-target stimuli, are disturbed in first episode schizophrenia. It also examines
whether N100 non-target (T-1, T+1) sequence effects are found when target stimuli
are equiprobably followed by a target or non-target stimulus. Study 4 (Chapter 7)
focuses on the important issue of whether these findings are specific to first episode
schizophrenia, compared to a clinical control group (ADHD) in which P300
amplitude has also been found to be reduced.
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6 ERP SEQUENCE EFFECTS IN FIRST EPISODE SCHIZOPHRENIA

6.1

INTRODUCTION

Studies 1 and 2 (Chapters 3 & 5) suggested a problem in schizophrenia, with
either the independent processing of target and non-target stimuli, and/or the
interactional effects emerging from the ongoing processing of these two stimuli.
These findings were robust, present at the first onset of illness and also in chronic
schizophrenia, and consistent with preliminary findings in the literature. This
problem could underlie the core information processing problems in schizophrenia
and may link ERP findings to investigations using alternate methodologies, for
example, deficits in latent inhibition and Kamin Blocking in people with
schizophrenia and their first degree schizotypal and non-schizotypal relatives
(Baruch, Hemsley, & Gray, 1988; Jones, Gray and Hemsley, 1992; Martins, Jones,
Toone, & Gray, 2001). Latent inhibition is a weakening of associative learning if the
to be conditioned' stimulus is first pre-exposed a number of times without any
consequence. Similarly, in Kamin Blocking, pre-exposure to a first association
between a conditioned (CS1) and unconditioned stimulus (UCS), results in a block to
the learning of a compound stimulus (CS1 + CS2), followed by the same UCS.
Deficits on these tasks are interpreted as possibly arising from a basic impairment in
associative learning, also suggesting that the association between two stimuli are not
processed accurately in schizophrenia.

The Gray-Hemsley model (Gray, Feldon, Rawlins, Hemsley, & Smith, 1991;
Gray, 1998; Hemsley, 1993, 1994) proposes that people with schizophrenia fail to
establish appropriate response biases because they are unable to use stored memories
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of regularities based on their previous experience. This results in a failure to make
use of temporal and spatial redundancy to reduce information processing demands.
Although the Gray-Hemsley model is derived from empirical research in a different
field, it is worthwhile and intriguing to determine whether the same dysfunctional
mechanisms postulated might underlie observed ERP deficits in the auditory oddball
paradigm. To this end, the current Chapter will investigate P300 and reaction time to
target stimuli, and N100 amplitude to non-target stimuli, on tasks involving
repetition of two stimuli: target (T) and non-target (N).

As ERP deficits are found in schizophrenia at first episode (Study 2, Chapter
5) it was decided to investigate a group with first episode schizophrenia to reduce
confounding effects which may be secondary to chronic morbidity, such as
prolonged use of neuroleptic medication, or hospitalisation.

6.1.1 Sequence effects on P300 and RT

Attempts to examine the relationship between two repeating stimuli
presented in random sequence have been made in studies examining sequence
effects. In these studies, the sequential structure of stimuli preceding the target
stimuli has been consistently shown to affect target response. For example, subjects
tend to respond more quickly to the continuation of a stimulus repetition (TT), than
to its discontinuation (NT). Studies which have examined sequence effects have in
general, either used a simple RT task, where the subject is asked to respond to targets
and ignore non-targets, or a choice reaction time task (CRT), in which different
responses (e.g. left vs. right button presses) are required to targets and non-targets.
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Sequence effects were first demonstrated in reaction time (Remington, 1969)
and have been robustly replicated (Kirby, 1976, 1980; Soetens, Boer, & Heuting,
1985; Soetens, Deboek, & Hueting, 1984). It was found that RTs were influenced,
not only by the current stimulus, but also by the sequence of preceding stimuli. Two
types of sequence effects are observed in choice RT tasks. First order effects are
attributable to the immediately preceding event, whereas higher order effects are
caused by events earlier in the sequence (Kirby, 1980; Soetens, Boer, & Heuting,
1985). Both these effects are dependent on the response-stimulus interval (RSI), the
interval from the preceding response to the next stimulus presentation. For first order
effects, RTs are shorter for repetitions than alternations (TT<NT)4 at RSIs less than
500ms, and shorter for alternations than for repetitions (NT<TT) when RSIs are
longer than 500ms (Hale, 1967; Kirby, 1976; Soetens, Boer, & Heuting, 1985;
Soetens, Deboek, & Hueting, 1984). Higher order sequential effects are observed
after continued runs of stimulus repetitions or stimulus alternations (TTTT or
NTNT), or conversely discontinuations of these runs (NNNT or NTNTT), with faster
RTs to continuations than to discontinuations (Remington, 1969; Soetens Boeing, &
Hueting, 1985). At shorter RSIs, these patterns, referred to as cost-benefit patterns,
are not found; instead a benefit only pattern is found (Kirby, 1976: Soetens, Deboeck
& Hueting, 1984; Vervaeck & Boer, 1980). The cost-benefit patterns found with long
RSIs were explained by confirmations and disconfirmations of expectancies, arising

4

Various terminologies have been used for the two alternate stimuli in sequence studies, for example,

A/B, A/R, and NIT. To avoid confusion the two stimuli will be referred to as T and N in this thesis.
When used with a CRT task, T and N refer to the two alternate target stimuli, when used with a simple
RT task the T refers to the target stimuli and the N refers to the non-target stimuli.
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from the preceding sequence of stimuli. If expectancy is confirmed, RT is short, and
if it is disconfirmed, RT is long.

Squires, Wickens, Squires and Donchin (1976) demonstrated that ERPs also
reflected sequence effects. Thus, in addition to RT as an index of performance, ERPs
might also provide an index of the underlying psychophysiology. These studies, and
others (Duncan-Johnson & Donchin, 1982, Johnson & Donchin, 1980), demonstrated
that target stimuli that continue a series of repetitions (TT, TTT, TTTT, or
alternations (NT, NTN, NTNT) elicit smaller P300s and earlier RTs than target
stimuli that discontinue a sequence of repetitions ( T), or alternations
(NTNTT). Most low probability oddball studies average over sequence types,
thereby losing valuable information when sequences have been a determinant of
P300 amplitude.

A methodological issue that deserves mention, is that most of the earlier
sequence studies (Duncan-Johnson, Roth, & Kopell, 1984; Duncan-Johnson &
Donchin, 1982, Johnson & Donchin, 1980; Squires, Wickens, Squires, & Donchin,
1976) examined sequence effects in a hierarchical cumulative manner, where first
order effects, attributable to the immediately preceding event (e.g. TN), include
higher order effects, events that are earlier in the sequence (NNT, TNT, NTNT,
TTNT etc.). For example, Duncan Johnson et al., 1984 used a Group X Stimuli X
Sequence (repetition vs. alternation) X Outcome (continuing vs. discontinuing) X
Site analysis. This hierarchical cumulative approach does not facilitate analysis of
lower vs. higher order effects (NT vs. NNT vs. NNNT) which are the focus of this
Study.
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Mean ERP scores to different sequences, commonly visually presented as
"sequence trees" in sequence studies (Duncan-Johnson et al., 1984, Johnson &
Donchin, 1980; Squires,Wickens, Squires, & Donchin,1976) indicate that in addition
to the 'continuation versus discontinuation' and 'alternation versus repetition'
comparisons, there appear to be linear relationships within these series, for example,
consistent linear increases in P300 amplitude to discontinuation of repetition or DR
series (DR5>DR4>DR3>DR2>DR1) and perhaps more minimally to discontinuation
of alternations (DA3>DA2>DA1). However, because of the statistical approach
mentioned above, the significance of these possible linear relationships has not been
tested. In normal controls, RT appears to decrease within the DR series (DuncanJohnson et al., Gonsalvez et al.) and increase with the DA series (Duncan-Johnson et
al.). The P300 latency results across DR or DA series have been examined
infrequently.

As sequence manipulations resulted in effects on both RT and P300
amplitude, initial efforts sought a single explanation for both effects. For example,
the expectancy model that was used to explain the cost-benefit pattern in RT results,
was generalised to ERPs (Duncan-Johnson & Donchin, 1982, Johnson & Donchin,
1980; Squires, Wickens, Squires, & Donchin, 1976). However, the expectancy
explanation of sequence effects has now been challenged from a number of
directions. Sequential effects in RTs show properties that are not explainable by
expectancy (Soetens et al., 1985). In the stimulus repetition effect, for example,
faster RTs for repetitions than alternations with a faster stimulus presentation rate,
have been associated with an automatic facilitation or priming, rather than the
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subjective expectancy associated with slower presentation rate (Kirby, 1980;
Soetens, 1998; Soetens et al., 1985).

Studies showing evidence of dissociation between sequence dependent RT
and P300 amplitude patterns (e.g. some experimental manipulations have produced
RT and ERP results in opposite directions) have challenged the idea of a common
expectancy mechanism for RT and P300 amplitude sequence effects (Leuthold &
Sommer, 1993). The effects of "practice" (Sommer et al., 1990) and "manipulated
expectations" (Matt, Leuthold, and Sommer, 1992) have been found in RTs, but were
absent (practise), or minimal (manipulated expectancies) in P300 amplitude.
Leuthhold & Sommer (1993) found that the first order repetition effect in P300
amplitude was only observed at a 1.3 sec ISI, and not at slower presentation rates,
wheras higher order effects were unmodulated by ISI. P300 amplitude is usually
smaller, whereas RT may be longer for first order repetitions, as compared to
alternations (Sommer, Leuthold and Soetens 1999; Sommer, Leuthhold, & Matt,
1998). In higher order sequential effects, Sommer, Leuthold and Soetens (1999)
found the sequential pattern in RTs changed from cost-benefit to cost, only when RSI
was decreased from 500 to 40ms, wheras P300 consistently showed a cost-benefit
pattern at both RSIs.

Other findings have also challenged the expectancy hypothesis. Sommer,
Matt, & Leuthold (1990b) showed that conscious expectancies for a given stimulus,
as measured by subjective ratings, are barely affected by the trial sequence. The
ability to develop trial to trial expectancies would presumably rely on being able to
encode and hold in immediate memory the recent stimulus pattern, in order to
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categorise the current stimulus as locally frequent or rare, yet P300 sequence effects
have been found in groups with diminished immediate memory capacity and function
(Polich and Broderant, 1997).

The above reasons have led researchers to question the notion that expectancy
disconfirmation underpins observed variations in P300 amplitude (e.g. Verleger,
1988; Gonsalvez et al., 1999; Gonsalvez & Polich, 2002; Croft, Gonsalvez, Gabriel,
& Barry, 2003). Gonsalvez and colleagues (Gonsalvez et al., 1999; Gonsalvez &
Polich, 2002; Croft, Gonsalvez, Gabriel, & Barry, 2003) suggest an alternative
explanation for at least some sequence effects, arguing that the first order, or
stimulus mismatch versus stimulus match effect (NT vs TT), and the higher order
discontinuation of repetition ( DR) series or non-target sequence length effect (NNNT
vs. NNT vs. NT) upon P300 amplitude are the result of target-to-target interval (TTI)
rather than sequence effects. This hypothesis is explained by resource limitation, i.e.
P300 updating processes are primarily influenced by the interval between stimuli
rather than the sequence structure context effects (Gonsalvez & Polich, 2002).

6.1.1.1 DA effects on ERPs: Are they an index of cognitive processes implicated
in associative learning?
Several sequence studies have found an interesting relationship between
P300 amplitude and discontinuation of alternation ( DA) series. DA effects occur
where a preceding alternation or series of alternations is terminated by a repetition of
the penultimate stimuli, thus discontinuing the alternation pattern as in the following:
NTT (DA1); NTNTT (DA2); NTNTNTT (DA3). Although not as dramatic as DR

178

effects, DA effects have been reported in several studies (Duncan-Johnson et al.,
1984; Squires et al., 1976) in a consistent direction, with P300 amplitude increasing
with increases in the number of alternations preceding the final stimulus mismatch
(DA3>DA2>DA1). The DA effect on P300 amplitude cannot be explained by the TTI

hypothesis, as TTI remains unchanged with increases in DA series.

Previous studies have explained alternation and DA series by invoking
expectancy theory. The subject expects alternations to continue, larger numbers of
alternations increase this expectancy, leading to reduced P300 amplitude. The final
repetition violates this expectancy, leading to larger P300 amplitude (DuncanJohnson et al., 1984; Squires et al., 1976). Regardless of whether expectancy
underlies the DA effect, available evidence points to the fact that ERPs are sensitive
to pair-wise occurrences of stimuli or to the relationship between contiguous
occurrences of stimuli. The brain (consciously or unconsciously) recognises a pattern
of two alternating stimuli and responds differently when this pattern is continued
versus when it is discontinued. In addition, the number of preceding pairs appears to
influence P300 amplitude in a consistent way, leading to the intriguing prospect that
ERPs may be an objective measure of strength of associative coding. This
possibility opens up a large number of exciting research avenues with significant
clinical and theoretical implications. For example, if P300 to certain sequence types
is indicative of associate encoding strength (at least in paradigms that elicit these
sequence effects), reduced P300 may indicate poor encoding of stimulus pairs. This
may underlie the widespread P300 amplitude deficit amongst people with
schizophrenia, on oddball tasks. Poor encoding of contiguous occurrences of events
could also explain latent inhibition and Kamin blocking results, and may be a core
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cognitive deficit of schizophrenia. There are advantages in determining an objective
measure of this, including an understanding of the psychophysiology of this deficit,
as well as the provision of a biological marker for the disorder.

There is some support for the use of P300 as a correlate of associate learning
from a study which isolated associative cognitive learning from non-associative
adaptive mechanisms (Rose, Verleger, & Wascher, 2001). In this Study, amplitude
of P300 evoked by the predictive first stimulus (S1) increased linearly over blocks,
and P300 amplitudes, evoked by the second stimulus (S2) following the predictive
S 1, decreased in the course of learning with a quadratic trend, while there were no
modifications to P300 on the control task. The authors interpreted these trends as a
fast decrease in neglecting the information of S2 and a continuous increase of the
meaning of S 1.

An expectancy effect, based on paired associations, would predict that the
increase in P300 amplitude to the terminating target in DA series compared to
alternation series (which should be a decrease, according to TTI, as it immediately
follows a target) is caused by a disconfirmation of this expected association. As it
would take more than one pair to establish this association, this would be seen in
linear increases of P300 amplitude within DA series. Previous studies have used
shorter series (Duncan-Johnson et al., 1984 Squires et al., 1976) A systematic
investigation of the effects of increasing DA series, may therefore, require longer
series of stimuli than those normally used in sequence studies.
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The primary focus of this Study was to examine the effect of increasing
levels of DA series on the P300 component and RT of patients with FESz and normal
controls. The current Study predicted that, in normal controls, there would be linear
increases in P300 amplitude as a function of increases in the DA series, as suggested
by a few earlier studies (Duncan-Johnson et al., 1984 Squires et al., 1976), reflecting
appropriate associative encoding for stimulus pairs. It was hypothesised that this
P300 amplitude pattern would not occur in the FESz group, indicating a problem
with associative encoding. On the other hand, linear increases in DR series effects
were predicted to occur in both the control and FESz group, according to the TTI
hypothesis and previous findings (Duncan-Johnson et al., 1984; Gonsalvez et al.,
1995). To examine these hypotheses, a specialised version of the oddball paradigm
that included DA sequences ranging from DA1 to DA3 was developed.

6.1.2 Sequence effects on P300 and RT in schizophrenia
Sequence effects on the P300 have been well established in normal healthy
subjects. However, there has been a dearth of sequence effects studies in
schizophrenia, with only two studies (Duncan-Johnson, Roth and Kopell, 1984;
Gonsalvez et al. 1999) evident. One reason is that ERPs to each stimuli type need to
be sub-averaged separately, and signal-to-noise requirements result in lengthy
paradigms that are difficult for clinical populations, including schizophrenia, to
complete. The Duncan-Johnson et al. study investigated sequence effects in a
schizophrenia group, with a 0.5 probability CRT, where subjects responded to each
of two tones by pressing one of two buttons. Although special attention was not paid
to the DA series, the authors reported a similar overall pattern (sequence tree) of
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P300 amplitude and RT changes in both the schizophrenia and normal control
groups. The authors interpreted these ERP findings as an indication that people with
schizophrenia formulate trial to trial expectancies, with RT findings indicating that
these expectancies were applied to response preparation processes.

At first glance the above results would not appear to support the GrayHemsley model, or suggest that ERPs do not reliably index the deficit that these
models hold as central to schizophrenia. It would suggest that people with
schizophrenia accurately encode recent stimulus patterns and can categorise and
respond to the next stimulus as locally frequent or rare, i.e. make connections
between previous stimuli which then bias their response to the next incoming stimuli.
On the other hand, it could be argued that the Gray-Hemsley model refers to
"reliable" associations between stimuli, whereas the sequence effects refer to
"random" stimuli. Of importance is the fact that the Gray Hemsley model applies
more specifically to DA effects and DA effects were not examined by DuncanJohnson et al. (1984) in a comprehensive manner. Consequently the results may have
been swayed by the DR or other sequence types (where the schizophrenia group
showed a similar pattern as normal controls), which could be attributed to TTI, rather
than by the DA series.

Gonsalvez et al. (1995) examined sequence effects in schizophrenia utilising
a simple reaction time auditory oddball paradigm. Subjects responded (button press)
only to target stimuli, separated by equiprobable series of 1,3,5,7,9 or 11 non-targets
(1.3 seconds fixed ISI) with a 0.16 probability for target stimuli. Target ERPs were
subaveraged according to the number of preceding non-targets, similar to stimuli in
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DR series, but differing in extending the length of the sequence, with DR ranging

from DR1 through to DR9. Where the previously quoted studies had analysed the
statistical difference between continuation and discontinuation of sequences, this
Study examined whether P300 amplitude and RT varied in a linear way as DR series
was manipulated, ranging from DR1 to DR9. P300 amplitude increased with
increasing numbers of non-targets preceding the target in schizophrenia patients as
well as controls, however the reduction in P300 amplitude for the schizophrenia
group compared with the control group was only significant to the target stimuli
following non-target series of intermediate length (i.e. preceded by 3, 5 or 7 nontargets) and not when targets followed a short (1) or long (9) series of non-targets.
Thus both studies (Duncan-Johnson et al.; Gonsalvez et al.) indicated a linear effect
for DR series in schizophrenia, although Gonsalvez et al. was the only study to test
this statistically.
6.1.3 Sequence effects on N100 amplitude

Most sequence studies have focused on the P300 component elicited by target
stimuli. However, there are a number of studies which have found sequence effects
on N100 amplitude to non-target stimuli (Hermanutz, Cohen, & Sommer, 1981;
Hirata & Lehmann, 1990; Brown et al., 2002; Roth & Cannon, 1972; Starr,
Aquinaldo, Roe and Michalewski, 1997; Staff, Sandroni & Michalewski, 1995).
These studies all used simple RT rather than CRT tasks. Several studies (Hermanutz
et al.; Hirata & Lehmann; Starr, Aquinaldo et al.; Starr, Sandroni et al.) have found a
repetition effect demonstrating increasing N100 amplitude to non-target stimuli with
longer trains of preceding non-targets. This is the opposite pattern to P300 amplitude
to target stimuli which decreases with longer trains of preceding target stimuli (see
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6.1.1). The results of Study 2 in this thesis demonstrated another sequence effect on
N100 in normal controls; a reduction in N100 amplitude to T+1 compared to T-1, an
effect found in normal populations in some other studies (Roth & Cannon; Starr,
Aquinaldo et al., Starr, Sandroni et al.) These studies have used oddball paradigms
where target frequency is low and occurrences of TT are absent. A study that
examined changes associated with all four 2nd order sequence effects (TT NT, NN &
TN) did not find significant effects on N100 amplitude (Polich & Broderant, 1996).
This suggests that the reduction to T+1 compared to T-1 stimuli may not be found
when target stimuli may be followed by either target or non-target stimuli

Study 3 also sought to determine whether the reduction in N100 amplitude to
T+1 compared with T-1 stimuli found in the control, but not the schizophrenia group

in Study 2 (Chapter 3), was related to recovery cycle effects. If N100 amplitude
reduction to T+1 stimuli was attributable to recovery following a target, it should
also be found in the paradigm used in this study using the same ISI as in S2, but with
target probability raised to 0.5. Consequent to the probability manipulation, in Study
3, the T+1 stimulus would no longer remain predictable as it could now be either a T
or N, unlike in Study 2 where it was always an N. Therefore, if Study 3 replicated
results of Study 2 (N100 amplitude to T+1 < T-1) the recovery hypothesis would be
supported, whereas if it did not, alternative explanations would have to be
considered, for example, the predictability of the stimulus.
6.1.4 Sequence effects on N100 amplitude in schizophrenia
Only two studies have investigated sequence effects on N100 amplitude in
schizophrenia, one the published results from Study 2 of this thesis (Brown et al.,
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2002) and the other, an early study on the ERP in schizophrenia (Roth & Cannon,
1972). Roth and Cannon used an auditory oddball task with an ISI of 1 second, in 21
male subjects with schizophrenia having a similar duration of illness to the chronic
group used in Study 2 (mean of 13.6 ± 9 years since initial hospitalisation). These
researchers used rare and standard stimuli, akin to the target and non-target stimuli in
terms of probability of occurrence, except that in this study the subjects were not
instructed to make a response. Roth and Cannon found that N100 amplitude to T and
T-1 was increased, compared to T+1 and T+2 in the control group, but not the group

with schizophrenia. In Study 2 (Chapter 5), the auditory oddball paradigm required a
motor response to the target stimulus (equivalent to the rare stimuli in Roth &
Cannon's paradigm), using an ISI of 1.3 seconds with both chronic and FESz groups
(both male and female). This Study similarly found N100 amplitude increased to
target (compared with non-target) stimuli and increased to T-1 (compared with T+1)
stimuli in the control group, but not in the schizophrenia group.

In summary, both the Roth and Cannon (1972) and Brown et al. (2002)
studies indicate that the N100 amplitude reduction to T+1 stimuli sequence effect,
commonly found in normal controls, is not found in schizophrenia in an oddball
paradigm where TT occurrences do not occur. The present Study attempts to clarify
whether the reduction in N100 amplitude to T+1 is due to preparedness (probability
/expectancy) or to response recovery processes.
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6.1.5 Hypotheses:
1. DR series
There will be an increase in P300 amplitude and decrease in P300 latency and RT
with repetitions in DR series (e.g. NNNNT>NNNT>NNT) in both the normal control
and FESz groups.

2. DA series
P300 amplitude and latency and RT will increase with repetitions in DA series (e.g.
NTNTNTT>NTNTT>NTT) in the normal group but not in the FESz group.

3. Continuing (repeating) vs. discontinuing (alternating) short sequences
P300 amplitude will be increased to discontinuing (TN, NT) compared with
continuing (NN, TT) short sequences in both the normal control and FESz groups.

4. N100 amplitude
N100 amplitude to non-target T+1 (TN) will be reduced compared with N100
amplitude to non-target T-1 (NN).

6.2

MET HOD

6.2.1 Participants

6.2.1.1 Participants with FESz
Eighteen participants with FESz were recruited from community and hospital
settings through the Western Sydney First Episode Psychosis Project. Of these only
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the data from fourteen participants (11 males, 3 females) between 13 yrs and 23 yrs
(mean = 18.5 yrs; SD = 3.1 yrs) were able to be included in the analysis. Two
participants were unable to complete the paradigm, while a further two were
excluded from analysis due to a high error rate in their responses to targets. FESz
participants were defined as those young people presenting for the first time to health
services with psychotic symptoms that warranted a diagnosis of either schizophrenia
or schizophreniform disorder. Diagnosis was made by means of a consensus
conference (of at least three fully qualified psychiatrists) that drew upon the
interview by the participating psychiatrist, information from family and case
manager and the case notes. Diagnoses were made according to the Diagnostic and
Statistical Manual of Mental Disorders, 4th edition (DSM—IV: American Psychiatric
Association, 1994). Exclusion criteria were the same as for Studies 1 and 2 (Chapters
3.2.1). The majority of participants were medicated with atypical antipsychotics
alone, though a small number were also receiving antidepressant or anticholinergic
medications

6.2.1.2 Normal control participants
Fourteen normal control participants (11 male, 3 female) between 14 yrs and
24 yrs (mean = 19.7 yrs; SD = 3.4 yrs) were recruited from the community and were
gender and age matched to within 2 years with the first episode participants
exclusion criteria were the
same as for Studies 1 and 2 (see Chapter 3.2.1)
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6.3

DATA ACQUISITION

This Study was approved by Western Sydney Area Health Service and
University of Wollongong ethics' committees. Participants were seated in a reclining
chair in a quiet, dimly lit laboratory, facing a video screen and wearing a pair of
headphones. The paradigm used in this Study was an auditory oddball with target
probability set at 0.5, 612 target (1500 Hz) tones and 612 non-target (1000 Hz) tones
(with 10ms rise and fall). The tone intensity was 60 dBSPL and the fixed
interstimulus interval (ISI) was 1.3 s. The design included at least 20 occurrences of
each of the following sequences.
Repetition series: TT TTT TTTT TTTTT TTTTTT
Discontinuation of Repetition (DR) series: NT NNT NNNT
T

Alternation series: TNT NTNT TNTNT NTNTNT TNTNTNT
Discontinuation alternations (DA) series: NTT TNTT NTNTT TNINTT
NTNTNTT

Participants were asked to look at a dot on the computer screen 60 cm in front
of them, ignore the low non-target tones, and press two reaction time buttons with
the index finger of each hand to target tones. Participants were required to respond
with both hands to control for potential lateralized effects associated with unilateral
motor activity. Task instructions emphasised speed and accuracy of response
equally. EEGs were recorded on a DC based system (Synamps, equipped with a 16bit A/D converter) from 19 scalp sites according to the 10-20 International system
(Bloom, 1982) in reference to linked-ear electrodes with an amplification of 200 a
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band pass from 0 to 50 Hz and digitised at 250 Hz. Only data recorded at Fz Cz and
Pz are reported here. Horizontal EOG was recorded via electrodes placed at the outer
canthus of each eye and vertical EOG was recorded via two electrodes placed 1cm
above and below the midline supraorbital and infraorbital regions of the left eye. Eye
correction was carried out using a technique based on Gratton, Coles & Donchin
(1983). ERPs were separately sorted and averaged for each level of DR and DA as
defined above under Data Acquisition (6.3)

For sub-averaged target and non-target stimuli, N100 and P300 peaks were
measured relative to a pre-stimulus baseline of 200 ms by an automated system based
on the detection of a consistent change in the direction of the gradient of the
waveform (Haig, Gordon, Rogers & Anderson, 1995). Thus, a change from a
consistently positive to a consistently negative gradient was identified as a positive
peak, and vice versa for a negative peak, with the criteria that N100 occurred
between 80 -140ms, and P300 occurred between 250-500 ms. Peaks thus identified
were then verified through visual inspection.

6.4

ANALYSIS AND RESULTS

Amplitude, latency and RT measures were each subjected to ANOVA as
described in greater detail below.

6.4.1 ERPs
In this Study ERPs were analysed in three stages:
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(i)

ERPs associated with targets following one or more repetitions of the
non-target (NT, NNT, ..), termed discontinuation of repetition sequences
or DR-series

(ii)

ERPs to targets that followed an alternation sequence, termed
discontinuation of alternation or DA series

(iii)

ERPs to targets and non-targets reflecting all 4 possibilities of the 2nd
order sequence effects, namely continuing (NN, TI) and discontinuing
sequences (NT, TN)

Each of these stages is discussed in order. As the P300 component was the
primary interest, analyses were restricted to this component from the 3 midline
sites for DR and DA sequences, and to P300 and N100 amplitudes for continuing
vs. discontinuing sequences. Mean scores for N100 and P300 amplitudes at
midline sites for all stages of the Study appear in a consolidated Table (See Table
6.1).

6.4.1.1 Discontinuation of repetition sequence for target stimuli (DR series)
Grand average waveforms for DR sequences appear in Figure 6.1. P300
amplitude and latency from the DR series were subjected to a 2 Groups X 5
Sequences (DR levels) X 3 Sites (Fz, Cz, Pz) ANOVA with repeated measures on the
last two factors. Linear and quadratic contrasts were examined for the sequence and
site factors.
P300 amplitude: No main or interaction effects were significant for group, however,
there were significant linear, F(1,26) = 29.4, p<0.001, and quadratic, F(1,26) = 8.05,
p<.01, contrasts for DR. P300 amplitude increased as longer strings of repetitions
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were discontinued. This increase was more prominent in the first three levels,
plateauing from level 3 for the control group and from level 4 for the FESz group
(see Figure 6.2). There was a significant linear contrast for Site X DR, F(1.26) =
13.88, p < 0.001, with sequence effects maximal at Pz.

P300 latency: There were no significant effects evident for P300 latency.
First episode schizoprenia
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Figure 6.2 P300 amplitude across midline sites (left) and at Pz (right) for DR
sequences (DR1—NT; DR2=NNT; DR3=NNNT; DR4—
; DR5—NNNNNT

6.4.1.2 Discontinuation of alternation sequence for target stimuli (DA series).
Grand average waveforms appear in Figure 6.3. P300 amplitude and latency
from the DA series were subjected to a 2 Groups X 3 Sequences (DA1, DA2, DA3))
X 3 Sites (Fz, Cz, Pz) ANOVA with repeated measures on the last two factors.
Linear and quadratic contrasts were examined for sequence and site.

P300 amplitude: No main or interaction effects for group, or linear and quadratic
contrasts for DA series were significant for P300 amplitude. There was a significant
linear contrast for site, F(1,26) = 38.77, p < 0.001, with P300 amplitude increased
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from Fz to Pz. The quadratic, F(1,26) =15.69, p<.01, contrast arose as the increase
from Fz to Cz was steeper than the increase from Cz to Pz.
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effect was clearly apparent at Pz (see Figure 6.4), however, at Cz and Fz the
prolongation occurred only from DA1 to DA2, giving rise to a significant DA X Site
X Group quadratic, linear contrast F(1,26) = 11.37, p < 0.02.

450 Contr ol —M— FESz

400 -

c-) 350 -

300 -

250

DA 1

DA 2

DA 3

Sequence
Figure 6.4 P300 latency for the two groups as a function of DA series at Pz.
(DA1=NTT, DA2= NTNTT, DA3 = NTNTNTT).

6.4.1.3 Continuing (NN, TT) and discontinuing (TN, NT) series.
P300 and N100 amplitudes were separately subjected to a 2 Groups X 2
Sequences (continuation & discontinuation) X 2 Stimuli (target & non-target) X 3
Sites (Fz, Cz, Pz) ANOVA with repeated measures for the last three factors.
P300 amplitude: There were no significant main or interaction effects for group. The
main effect for sequence was significant, F(1,26) = 20.73, p < 0.001, with larger
P300 amplitudes for discontinuing sequences, as was the main effect for Site, with a
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progressively increasing P300 amplitude from frontal to central and parietal sites.
The main effect for stimulus was not significant, however there were significant
Sequence X Stimulus, F(1,26) = 5.1, p < 0.05, and Stimulus X Site F(1.4, 36.27) =
84.45, p <0.001, interactions. The Sequence X Stimuli interaction arose as P300
amplitude differences between continuing vs. discontinuing sequences were more
pronounced in non-target stimuli (NN vs TN) than in target stimuli (TT vs NT). The
Site X Stimuli interaction arose as P300 amplitude increased from frontal to parietal
sites for target stimuli, but decreased from frontal to parietal sites for non-target
stimuli (see Figure 6.6).
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Figure 6.5 Grand average ERPs to continuing and discontinuing sequences.

Control

FE Sz
9

TN

Target

Non-target

0

Target

Stimuli
Pz 9 —

NT

Non-target
Stimuli

9
NT

0

Target
Non-target
Stimuli

0

Target

Non-target
Stimuli

—*— Continuing —0— Discontinuing

Figure 6.6 Sequence X Site and Sequence X Stimuli interactions for continuing and
discontinuing sequences at Fz (top row) and Pz (bottom row) for P300 amplitude.
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N100 amplitude: Mean N100 amplitudes were consistently lower for the
schizophrenia group to TT, NT, NN and TN stimuli (see Table 6.1), however, the
main effect for group did not reach significance F(1,26) = 3.06, p = .09, nor were
there any significant interactions with group. Main effects for stimuli or sequence
were not significant, however, the Sequence X Stimuli interaction approached
significance, F(1,26) = 3.84, p = .06, as discontinuations produced increased N100
amplitude to targets but not to non-targets. No significant difference was found
between N100 amplitude to NN (T-1) and TN (T+1). There was a significant main
effect for site, F(1.34, 34.7) = 40.27, p<0.001, as N100 amplitude increased from
parietal to frontal sites. There were no significant site interactions.
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Table 6.1 Mean and standard deviation scores for P300 amplitude (amp) and latency (lat) and N100 components.

DR1
DR2
DR3
DR4
DR5
DA1

DA2
DA3
TT
NT
NN
TN
TT
NT
NA,
TN

P300 amp
P300 lat
P300 amp
P300 lat
P300 amp
P3001at
P300 amp
P300 lat
P300 amp
P300 lat
P300 amp
P300 lat
P300 amp
P300 lat
P300 amp
P300 lat
P300 amp
P300 amp
P300 amp
P300 amp
N100 amp
N100 amp
N100 amp
N100 amp

Fz
Mean SD
0.46
4.80
361.61 62.75
3.24
5.24
330.96 61.60
2.60
4.69
334.39 78.24
2.70
4.87
353.90 90.25
2.46
6.27
362.00 76.67
.56
5.49
343.05 68.52
1.13
5.33
378.89 65.97
1.39
6.32
341.73 49.94
0.33
4.72
0.61
4.91
-2.52
6.17
4.62
7.44
-5.33
2.95
-6.09
2.18
-5.78
2.51
-5.72
3.04

Control
Cz
mean
SD
5.80
3.60
348.63 68.59
8.06
4.78
334.28 57.69
9.255
4.027
345.62 66.94
8.44
5.03
332.09 64.08
9.38
6.02
320.86 39.45
5.41
4.92
351.65 64.46
6.60
3.21
384.53 68.07
6.44
5.59
373.14 62.77
5.82
4.03
6.35
3.71
3.02
5.72
5.60
6.36
-4.10
2.66
-4.64
2.15
-4.71
2.52
-4.62
2.96

Pz
mean
SD
7.72
3.41
331.47 53.00
10.13
3.81
321.11 41.25
11.93
4.17
328.00 46.06
11.37 5.28
347.93 44.91
12.70
5.88
329.43 45.60
7.24
5.72
332.29 40.82
7.96
4.76
358.30 54.42
8.76
6.44
380.01 60.05
7.22
3.8024
8.28
3.29
1.39
3.39
4.05
3.63
-2.75
2.17
-2.93
1.97
-3.75
1.84
-3.38
2.39

Fz
mean
SD
2.07
6.18
356.35 68.36
4.06
4.56
326.29 61.70
3.86
4.27
311.66 50.24
5.99
6.74
316.32 40.53
5.32
5.66
305.42 37.90
4.14
6.89
413.37 63.46
2.92
5.81
331.71 60.81
2.64
4.72
348.28 63.27
1.66
5.86
2.22
5.15
3.33
5.64
6.33
7.09
-4.44
2.50
-5.12
2.68
-4.65
2.24
-4.27
2.66

FESz
Cz
mean
SD
5.53
4.75
342.86 69.36
7.83
5.36
308.57 30.66
9.20
5.19
340.45 60.59
10.39 6.51
316.32 32.33
10.96 5.16
317.43 52.66
7.23
4.59
394.76 72.49
6.17
4.89
376.28 65.13
5.92
4.26
369.43 76.32
5.22
3.84
6.07
4.53
2.46
3.73
5.95
4.73
-2.91
1.99
-3.86
2.45
-3.49
1.73
-2.70
2.01

Pz
mean
SD
5.88
4.29
325.79 44.04
9.59
6.02
327.43 52.99
10.49 6.09
347.43 65.82
11.86 5.84
325.41 32.61
12.43
5.44
313.71 46.69
8.42
5.52
368.38 64.13
7.77
5.75
376.29 65.13
7.28
4.39
376.85 73.16
5.70
3.72
6.73
4.31
1.88
1.98
4.42
3.17
-1.82
1.42
-2.18
1.60
-1.76
1.37
1.85
1.05
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6.4.2

Response time (RT)
The mean level of accuracy was 98% for the control group and 94% for the FESz

group. Only correct responses were included in the analysis. RT data was subjected to a 2
Groups X 5 Sequences (DR series) and a 2 Groups X 3 Sequences (DA series) ANOVA,
with repeated measures for the DR and DA series, and linear and quadratic contrasts for
the within-subjects factor.

Mean RTs were consistently lower for the FESz group (see Table 6.2), however,
main effects for group did not reach significance, for DR or DA series. The larger RT
variance within the FESz group (see Table 6.2.) probably contributed to this lack of
significance. No significant Group X Sequence interaction was found for either DR or DA
series. There were no significant linear or quadratic effects for the DR series, however
there were significant linear, F(1,26) =8.9 p<0.01, and quadratic, F(1,26) = 7.6 p<0.01,
trends for the DA series, as RT increased (for both groups) from level 1 to 2 and then
plateaued between level 2 and 3 (see Fig. 6.8.).
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Figure 6.7 RT for DR and DA sequence levels.

Table 6.2 Mean and standard deviation values for RT.

Sequence type
All stimuli

Mean
339.43

Control
SD
53.39

First episode Sz
Mean
SD
370.07
89.52

DR1
DR2
DR3
DR4
DR5

338.64
343.57
319.21
340.14
331.86

61.70
61.33
50.42
65.21
57.48

373.78
380.57
365.36
382.86
370.71

102.56
102.17
106.79
114.45
91.00

DA1
DA2
DA3

357.14
386.79
383.43

55.79
76.87
67.06

391.71
435.07
421.64

106.73
101.53
84.65
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6.5

DISCUSSION

The results from the current Study underline the relevance and importance of
research on sequence effects. There has been limited research in this area in
schizophrenia (see 6.1). Against the background of previous research, this Study draws
attention to the fact that a large proportion of variance observed among single trials and
washed out through conventional averaging of targets and non-targets (across sequence
types) are due to systematic and reliable sequence effects. This Study reports results of an
in-depth examination of specific sequence types that have theoretical and clinical
significance. This is also the first time sequence effects on ERPs and RT have been
investigated in FESz.

6.5.1

DR sequences
Both normal controls and the FESz group showed the same pattern of increasing

P300 amplitude to DR series (NNNNNT> NNNNT>NNNT>NNT>NT). Previous studies
in both control (Johnson & Donchin, 1980; Squires,Wickens, Squires, & Donchin,1976)
and schizophrenia groups (Duncan-Johnson & Donchin, 1982) suggested a similar trend,
but results were not examined statistically and were examined over shorter sequence
lengths (usually a maximum length of 4-5 stimuli). Hence, this Study confirms and
extends these results by demonstrating a significant linear contrast over the DR series for
both control and FESz groups. This result is also consistent with findings in a chronic
schizophrenia group (Gonsalvez et al., 1995). P300 amplitude changes at Pz arising from
DR sequences varied dramatically (see Figures 7.1 & 7.2), suggesting that this sequence
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type has a major effect on P300 amplitude in the auditory oddball paradigm. The change
in target probability (0.5 vs. 0.15), made necessary in this Study by the sequence pattern
requirements, are the most likely explanation for differences in P300 amplitudes between
the two groups not reaching significance This is consistent with the results of previous
studies indicating that patients with schizophrenia have significantly reduced P300 only
to low probability stimuli, for example, 0.10, 0.20 and 0.30 and not to high probability
stimuli, for example, 0.50 and 0.80 (Duncan, Perlstein, & Morihasa, 1987; Mathalon and
Ford, 2002). The significant difference in P300 amplitude between the control and
schizophrenia groups found in the Duncan-Johnson et al. sequence study, which also used
a 0.50 probability, may be due to one, or a combination of variables, including task
demands (simple vs. CRT), subject variables (first episode vs. chronic schizophrenia) or
sequence structure (the current Study artificially increased certain types of sequences).

There were no significant DR series effects for P300 latency consistent with
Gonsalvez et al. (1999). The lack of significant findings for DR series effects on RT is
consistent with the observed means for DR series shown in the sequence tree in the
Duncan-Johnson et al. (1984) study; however it is in contrast to the decrease in RT over
increasing numbers of preceding non-targets found in the Gonsalvez et al. (1995) study.
It seems most likely that this difference would be explained by the differences in
probability in the two studies — low (0.15) in the Gonsalvez et al. study and high (0.5) in
the present Study and in the Duncan-Johnson et al. study.
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The absence of a DR effect on RT and P300 latency, alongside a significant linear
effect for DR on P300 amplitude, adds support to the results of other studies which argue
against a common expectancy-violation explanation for P300 amplitude, but is in
accordance with the TTI hypothesis. Gonsalvez and associates (Croft et al., 2003;
Gonsalvez et al., 1999) have argued convincingly that the consistent increase in P300
associated with increases in DR series is related to TTI and not to probability or number
of non-target occurrences between targets. The fact that both the FESz and control groups
showed similar DR sequence effects on P300 amplitude, would suggest that the temporal
mechanisms underlying P300 variance associated with this sequence type are not
impaired in this clinical group and is consistent with findings in chronic schizophrenia
groups (Duncan-Johnson et al., 1984; Gonsalvez et al., 1995).

6.5.2 DA sequences
An important aim of this Study was the search for an ERP index of associative
strength. The results of previous studies suggested that P300 amplitude associated with
DA sequences might be a useful measure. The hypothesised linear trend for increased
P300 amplitude over the DA sequence was not found in either the control group or the
group with FESz. Thus the preliminary, but promising results of previous studies were
not verified when this sequence type was examined over an extended range, and with an
adequate signal:noise ratio. One possible explanation for the discrepancies between
results may concern the magnitude of DA effects. DA effects with increasing runs of
stimuli on P300 in previous studies were quite small and not tested statistically (see
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6.1.1.1.). A visual inspection of the DA waveforms (see Figure 6.3) for the control group
in this Study shows that DA effects on P300s were in the expected direction for the
control group, but either the magnitude of the change was too small and/or the variance
too great to reach statistical significance. The magnitude of DA effects did not increase,
as expected, with extension of the DA series. In any event, the unfortunate outcome of
these negative results is that the DA effects on P300 amplitude found in this Study could
not be considered a useful index of associative strength, and thus it was not possible to
verify if an impairment of associative strength was central to and could contribute to the
widely replicated P300 deficit observed in schizophrenia.

There was, however, as hypothesised, a significant linear DA series effect for
controls on P300 latency, increasing with DA series length. As hypothesised this P300
latency increase over the DA series was not found in the group with FESz (see Figure
6.4). This effect has not been examined in previous research and is difficult to interpret
with certainty. As these findings in the control group are in the same direction as the
effects on RT, they will be discussed further after RT is examined

The hypothesised DA series effect on RT for controls was found, with both linear
and quadratic contrasts significant. While P300 latency showed a clear increase with each
DA level, RT showed an increase from DA1 to DA2 before plateauing between DA2 and
DA3. This indicates the possibility that different mechanisms may be responsible for
P300 latency and RT effects. One possible explanation is that DA effects on P300 latency
are more stimuli-related. They may be more sensitive to the preceding stimulus patterns
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and reflect more automatic, non-conscious processes and priming. In contrast, RT could
be seen as more response-related and more sensitive to conscious and controlled
strategies (Maglliero, Bashore, Coles, & Donchin, 1984; McCarthey & Donchin, 1981;
Smith, Mulder, Mulder, & Brands, 1992; Smulders, Kok, Kanemans, & Bashore, 1995;
Verlager, 1997). This notion is consistent with previous investigations that have
examined effects of practice (Somer et al., 1990) and manipulated expectancy (Matt et
al., 1992) effects on RTs but not on ERPs. The hypothesised deficit in DA series effects
on the schizophrenia group was not found. This finding provides further support for the
hypothesis that DA sequence effects on P300 latency and RT may result from different
mechanisms. The above suggestion would indicate that the schizophrenia group may
have a deficit in automatic non-conscious mechanisms engaged by the stimulus sequence,
but not in sequence effects on conscious and controlled response strategies.

6.5.3

Continuing (matches) vs. discontinuting (mismatches) stimuli
Both the FESz and the control groups showed increased P300 amplitude for

discontinued sequence, when compared to continued sequence, for target (NT>TT) and
non-target stimuli (TN>NN) in the shortened form of analysis. This is consistent with
findings in healthy controls (Broderant & Polich, 1997) and in schizophrenia (DuncanJohnson et al., 1984). However, no between-group differences emerged.
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6.5.4

Sequence paradigms in clinical settings:

This Study also shed light on the applicability of sequence paradigms in clinical
settings. The current paradigm was more difficult for this clinical population than the
shorter oddball used in Studies 1 and 2. In the previous paradigm, data from all subjects
was acceptable, whereas the longer paradigm used in the current Study had a 22%
attrition rate for the clinical population, but not for the normal controls. Some FESz
participants were unable to finish the task, falling asleep, while a further two were
excluded because of high percentage of inaccurate responses. Polich and Broderant
(1997) advocate the use of sequence effects as a sensitive means for assessing implicit
cognitive information-processing capabilities in applied/clinical testing situations, and
have proposed the use of an abbreviated format (McCarthy, Wood, Williamson, &
Spence, 1989) which would be more easily tolerated by clinical patients than traditionally
extended sequence paradigms. In this Study, although employing an extended paradigm,
the analysis of short continuing and discontinuing series (NN, TN, TT, NT), as proposed
by Polich and Broderant was also trialled. Consistent findings for sequence types
emerged over group, but no between-group differences were observed.

6.5.5

T+1 vs. T-1 sequence effects on N100 amplitude

The reduced N100 amplitude for T+1 (vs T-1) found in Study 2 was not
replicated in this Study. Hence, the hypothesis that this reduction in N100 amplitude
could be related to post-target recovery mechanisms for the T+1 stimulus was not
supported. This non-replication of reduced N100 amplitude when TT is a sequence
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variant in the paradigm, is consistent with Polich and Broderant's (1997) findings and
suggests an alternative explanation for the reduction in N100 to T+1, when TT is not a
sequence variant in the paradigm (i.e. when every target is followed by a non-target).
These findings support the possibility that mechanisms related to vigilance and
preparedness may be a more likely explanation. The sequential pattern of auditory events
is processed on an ongoing basis (Barry, de Pascalis, Hodder, Clarke, & Johnstone,
2003). The brain prepares for the next event, in the case of the T+1 stimulus, by reducing
thresholds of activation or allocating less attention, because the non-target status of this
stimulus becomes known, resulting in reduced N100 amplitude. Thus, the failure of the
schizophrenia group to demonstrate a reduced N100 to T+1 stimuli appears to be
associated with an ability to modulate attentional resources to predictable occurrences of
irrelevant (non-target) events, a dysfunction that has been hypothesised by several
information processing models (See Chapter 2.2 for details). It could also be argued that
this pattern of results is not inconsistent with the Gray-Hemsley proposal that people with
schizophrenia fail to establish appropriate response biases, because they are unable to use
stored memories of regularities based on their previous experience. However, in the past,
N100 variations have been interpreted in terms of general or more specific attentional
effects and the postulation that the N100 may reflect more specific mechanisms
implicated in the Gray- Hemsley model may be considered tentative. Further examination
of this is feasible if, within the same subjects, deficits in latent inhibition tasks are
correlated with a similar pattern of ERP deficits observed in this Study.
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7 SPECIFICITY OF TARGET AND NON-TARGET ERP DEFICITS IN FESz
COMPARED WITH CLINICAL (ADHD) AND NORMAL CONTROLS
7.1

INTRODUCTION AND RATIONALE

The current thesis identified several notable target and non-target ERP deficits in
schizophrenia; however, it is critical to determine whether these deficits are specific to
the disorder. Attention Deficit Hyperactivity Disorder (ADHD) and schizophrenia have
certain cognitive deficits in common: disturbed attention (Berger & Posner 2000; Satter
1994) reduced working memory capacity (Oie, Sunde, & Rund, 1999; Karatekin &
Asarnow, 1998; Ross, Harris, Olincy and Radant, 2000) and inhibitory dysfunction
(Barkley 1997; Liddle & Morris, 1991). Dopamine dysfunction is also implicated in these
cognitive deficits in both ADHD and schizophrenia (Nieoullon, 2002). Although ADHD
is an early onset disorder, 60% of adolescents with ADHD maintain this diagnosis into
adulthood (Biederman et al., 1996; Wender, 1995). Because of these shared deficits
adolescents and young adults with ADHD, provide a useful psychiatric control group for
exploring the specificity of ERP findings in a group with FESz. The reduced P300
amplitude observed in both these disorders makes this comparison even more compelling.

In studies investigating possible differences in the two disorders, smooth pursuit
eye movement (SPEM) abnormalities (Jacobsen, Hong, Hommer et al., 1996; Ross,
Olincy, Harris, Sullivan and Radant, 2000), failure to inhibit the P50 auditory ERP in a
paired stimulus conditioning-testing paradigm (Olincy et al., 2000) and increased eye
blinking (Jacobsen, et al., 1996), have been found to be present in schizophrenia, but not
in patients with ADHD. Some studies have found that although both groups have
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impaired performance on tasks measuring attention, working memory and inhibition, the
pattern of deficits is different. On the continuous performance test (CPT), adult ADHD
patients made more errors of omission (failure to detect the target stimulus) without
increases in commission errors (incorrectly responding to a non-target) (Holdnack,
Moberg Arnold, Gur, & Gur, 1995) while children with ADHD made significantly more
errors of commission and omission than normal children. Patients with schizophrenia, on
the other hand, have shown impaired ability to distinguish target (signal) from non-target
(noise) information, as identified by the discrimination index (Cornblatt, Lenzenweger, &
Erlenmeyer-Kimling, 1989). On the delayed oculomotor response task, used to study
inhibitory and working memory function, both ADHD and schizophrenia patients showed
disinhibition (an increased percentage of premature saccades), however, only the
schizophrenia group demonstrated decreased spatial accuracy of the remembered
saccade, purportedly a form of working memory (Ross et al., 2000). Some comparison
studies have also reported deficits, which are sensitive, but not specific for ADHD and
schizophrenia. For example, similar backward masking deficits have been found in both
ADHD and schizophrenia patients (Rund, Oie, & Sundet, 1996).

Reduced P300 amplitude in the auditory oddball paradigm has been a consistent
and sensitive finding for schizophrenia (see Chapter 2) and is also found in ADHD
(Frank, Seiden, & Napolitano, 1998; Holcomb, Ackerman, & Dykman, 1986; Johnstone
& Barry, 1996; Jonkman et al., 1997; Loiselle, Stamm, Matinsky and Whipple, 1980;
Overtoom et al., 1998 Robaey, Bretton, Dugas, & Renault, 1992; Satterfield, Schell,
Nicholas, Satterfield and Freese, 1990). Although ERPs have been acquired in auditory
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oddball paradigms for both groups, it has been difficult to compare these findings due to
the difference in ages. Most schizophrenia studies have employed adults, while most
studies with ADHD have employed children. Differences in paradigm variables, for
example, stimuli, ISI and probability, and in data acquisition procedures, also add to the
difficulty of making reliable inferences from such comparisons. The current Study has
controlled for these variables, obtaining data with the same paradigm, with age and sexmatched participants with FESz, ADHD, and normal controls.

In common with trends in schizophrenia research, ADHD studies have focused on
the P300 component elicited by target stimuli, although reduced N200 amplitude
(Satterfield, Schell, Backs, & Hidaka, 1984; Satterfield et al., 1990; Satterfield, Schell, &
Nicholas, 1994) and increased P200 amplitude (Holcomb et al., 1986; Satterfield et al.,
1994; Robaey et al.1992) to targets have also occasionally been reported in groups with
ADHD. Findings for N100 amplitude to targets have been mixed, with some studies
finding reduced N100 to targets (Loiselle et al., 1980; Satterfield et al., 1984; Satterfield
et al., 1994), but not others (Johnstone & Barry, 1996; Lazzaro, Gordon, Whitmont,
Meares, & Clarke, 2001). Barry, Johnstone & Clarke (2003) suggest an age-specific
effect, in ADHD and control groups with N100 differentiation occurring between 7-9
years and possibly also again at 12-14 and 16-18 years.

Few studies have investigated ERPs to non-target stimuli. Johnstone and Barry
(1996) and Winsberg, Javitt and Silipo (1997) found no significant deficits in people with
ADHD with regard to N100 or P200 measures to non-target stimuli. If the N100
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amplitude deficit pattern to target and non-target stimuli found in chronic and FESz
groups in Study 2 is a non-specific attentional dysfunction, the ADHD group should
display similar abnormalities. Given that the literature on cognitive deficits in ADHD
does not suggest a failure to use context in information processing, the ADHD ERP
findings discussed above, and the theoretical and empirical reasons, outlined in Chapter
4, for expecting deficits to target and non-target stimuli in schizophrenia, it was important
to determine whether the N100, P200 and P300 component deficits to target and nontarget stimuli (T-1 & T+1) found in Study 2 would also be present in the ADHD group.
7.1.1

Hypotheses

a) N100 and P200 components
1. N100 amplitude will be increased to target compared with non-target stimuli in
the clinical (ADHD) and normal controls, but not in the FESz group.
2. N100 amplitude will be increased to T-1 compared with T+1 stimuli in the
clinical (ADHD) and normal controls, but not in the FESz group.
3. N100 latency will be delayed to non-target compared with target stimuli in the
clinical (ADHD) and normal controls, but not in the FESz group.
4. P200 amplitude will be increased and prolonged to non-target compared with
target stimulus in the clinical (ADHD) and normal controls, but not in the FESz
group.
5. P200 amplitude will be increased and prolonged to T-1 compared with T+1
stimuli in the clinical (ADHD) and normal controls, but not in the FESz group.
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b) N200 and P300 component (target stimuli)
1. N200 amplitude will be reduced in the FESz group compared to the clinical and
normal controls.
2.

P300 amplitude will be reduced in the FESz group compared to the clinical and
normal controls.

3. P300 amplitude will be reduced in the clinical (ADHD) control group compared
with the normal control group.

7.2
7.2.1

METHOD

Participants

Participants with ADHD
Twenty males diagnosed with ADHD aged between 13 and 26 years, with a mean
age of 17 years (SD = 4.29 years), were referred by paediatricians, clinical psychologists
and psychiatrists to participate in this Study. All patients were subsequently interviewed
using a semi-structured interview based on DSM-IV criteria for ADHD (American
Psychiatric Association, 1994). All participants had been free of stimulant treatment for a
period of 2 weeks or longer prior to testing. Patients with a history of neurological
disorder or substance abuse were excluded from the Study.

Participants with FESz and normal controls
A subset of twenty male participants from the FESz group, along with their
matched pairs from the normal control group, was included in this Study. The selection of
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this subset from the original sample of 40 subjects used in Study 2 (see Chapter 5.2.1)
was based on age matching within two years to the ADHD participants. The FESz group
aged between 14 and 28 had a mean age of 18.9 years (SD = 2.88years), and the normal
controls aged between 14 and 29 had a mean age of 18.45 (SD = 3.87).

7.2.2

Data Acquisition and Procedure

Procedures for data acquisition were the same as Study 2 (Chapter 5.3). This
Study was approved by the ethics' committees of the University of Wollongong and the
Western Sydney Area Health Service.

7.3

ANALYSIS

7.3.1Midline ERPS

N100 and P200 amplitudes and latencies were submitted separately to 3-way
ANOVAs. The design incorporated 3 groups (FESz, ADHD [clinical control] and normal
controls) by 3 stimuli (T-1, T, T+1) by 3 electrode sites (Fz, Cz, Pz), with repeated
measures for site and stimulus factors. For the group factor, two specific contrasts were
conducted:(i) FESz vs. ADHD and normal controls, to determine if the FESz group was
different from the 2 control groups, and (ii) ADHD vs. normal controls to determine if
the clinical control group differed from the normal control group. For the stimulus factor,
two specific planned contrasts were carried out: (i) target vs. non-targets (T vs. T-1/T+1)
to examine whether the target status influenced ERP components and (ii) between nontargets (T-1 vs. T+1) to examine whether the sequential position of the non-target
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affected ERP components. For the site factor, linear and quadratic contrasts were
examined, the linear contrast purporting to examine reduced amplitudes at parietal sites
(Fz vs Pz) and the quadratic contrast purporting to test the frequently observed maximal
amplitudes at central sites (Cz vs. Fz+Pz).

N200 and P300 components were reliably observed only to the target stimulus
and were therefore subjected to a group (FESz, ADHD, normal controls) by site (Fz, Cz,
Pz) ANOVA repeated measures design. Similar linear and quadratic contrasts as
described above were conducted for the site factor. The Statistical Package for Social
Sciences 10.0 program (SPSS Inc., 1999) was used in all analyses.

As a result of the above contrasts all comparisons were based on a single degree
of freedom, obviating the need to employ statistical procedures to correct for alpha (e.g.
Bonferroni) or sphericity effects (e.g., Greenhouse-Geisser).

7.3.2

Discriminant function analysis
The purpose of conducting a discriminant function (DA) analysis was to

determine the accuracy with which the ERP measures could correctly classify persons
with and without schizophrenia. Hence two groups were defined: the schizophrenia group
and the non-schizophrenia group (the two control groups combined). Component
amplitude and latency measures on which the clinical and control groups were
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significantly different in ANOVA results were entered into three separate stepwise
disciminant function analyses in the following manner:

1. N100 and P200 component amplitude and latency for target, T-1 and T+1 stimuli.
Where the number of significant differences exceeded the number of variables
permissible under subject-to-variable ratio recommendations, and differences were
observed at more than one site, then only the site at which the component has maximal
between stimuli differences for amplitude/latency was entered (E.g., Cz for P200).

2. All significant target N200 and P300 amplitude and latency at midline sites.

3. Variables chosen from the stepwise Dfas described in 1 and 2 where then entered into
a third stepwise Dfa

7.4

RESULTS

The same ERP waveforms are presented in Figure 7.1 to accentuate betweengroup differences and in Figure7.2 to accentuate within group differences. Mean and
standard deviation amplitude and latency values are presented in Tables 7.1 and 7.2
respectively. A small percentage (2% for controls and 3% for FESz and ADHD) of ERP
measures were identified as outliers (greater or less than one and a half the interquartile
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range from the upper and lower quartile). All results below are based on data with
outliers; however results remained significant following removal of outliers. All
significant results appear in Tables 7.2 — 7.4 or are reported in text. Statistical values for
non-significant results are not reported, but are attached (see Appendix 3, CD-Rom).
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Figure 7.1 ERPs to T-1, Target and T+1 stimulus for normal control, ADHD and FESz
groups
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Figure7.2 ERP waveforms to T-1, Target and T+1 stimuli, superimposed to show within
group differences, for control ADHD and FESz.
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Table 7.1 N100 and P200 mean and standard deviation amplitude and latency scores
FESz
Mean
SD

Normal control
Mean
SD

ADHD
Mean
SD

N100 amplitude

Fz
Cz
Pz

-6.05
-5.14
-3.79

2.73
2.41
2.21

T-1
-7.39
-7.87
-5.42

4.21
4.61
3.28

-7.74
-6.48
-4.08

4.69
4.72
2.11

N100 latency

Fz
Cz
Pz

108.53
103.74
96.29

22.66
21.99
18.99

110.76
105.48
98.92

19.56
13.57
16.14

111.40
99.60
96.60

14.64
10.37
10.96

P200 amplitude

Fz
Cz
Pz

1.51
4.07
2.96

3.82
3.89
3.41

2.29
5.70
3.88

4.24
4.98
3.93

0.15
4.97
3.89

4.06
4.09
3.08

P200 latency

Fz
Cz
Pz

196.17
199.03
200.54

35.54
32.99
38.57

27.81
25.28
33.14

188.67
183.71
176.46

34.22
32.00
35.44

N100 amplitude

Fz
Cz
Pz

-4.95
-4.47
-3.22

182.97
178.57
184.35
Tar get
3.55
-10.93
2.34
-9.47
2.02
-4.88

4.56
5.33
3.34

-9.66
-8.29
-4.46

5.56
6.55
2.96

N100 latency

Fz
Cz
Pz

107.56
95.31
92.87

18.39
18.04
19.66

114.50
106.28
96.39

16.07
11.52
19.65

117.17
103.96
91.00

18.87
17.23
18.62

P200 amplitude

Fz
Cz
Pz

3.02
4.33
5.16

5.98
5.37
4.51

-1.66
1.63
3.08

5.31
7.57
6.33

-2.86
2.98
4.45

5.05
6.08
3.82

P200 latency

Fz
Cz
Pz

168.32
161.55
156.11

15.54
17.38
22.97

176.14
171.56
156.00

16.31
17.47
28.94

172.13
170.05
161.36

16.57
19.83
24.26

N100 amplitude

Fz
Cz
Pz

-5.36
-3.91
-3.23

2.97
2.38
2.51

-4.74
-5.05
-4.33

3.74
4.35
4.04

-5.23
-4.82
-4.03

3.69
4.66
3.73

N100 latency

Fz
Cz
Pz

122.07
104.27
92.99

39.49
16.06
16.18

107.02
101.66
97.00

14.34
14.86
14.62

110.45
95.88
94.80

16.47
12.20
12.59

P200 amplitude

Fz
Cz
Pz

1.64
3.26
2.57

3.57
3.61
3.35

4.62
6.97
4.83

4.11
4.42
3.40

4.02
7.52
6.11

5.44
4.28
3.00

P200 latency

Fz
Cz
Pz

185.55
180.28
163.23

26.80
28.73
33.65

184.98
185.40
190.80

21.00
20.77
21.41

197.24
198.39
202.69

22.04
24.15
26.08
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Table7.2 N100 and P200 mean and standard deviation amplitude and latency scores

Normal control

N200 amplitude

Fz
Cz
Pz

FESz
Mean
SD
-5.4408 5.1813
-0.4826 6.30042
1.28895 4.70631

N200 latency

Fz
Cz
Pz

222.659 21.9944 217.299 20.9499 216.96 17.5089
214.915 18.7223 211.082 13.3428 215.091 18.3824
203.918 34.9195 194.642 26.1287 202.477 23.742

P300 amplitude

Fz
Cz
Pz

9.82375 8.60497 9.8305 7.93304 4.0376 7.64664
16.4389 8.86339 20.3025 9.87283 11.9716 9.54835
20.8744 9.67486 27.8976 10.4392 19.969 9.93474

P300 latency

Fz
Cz
Pz

325.466 54.8732 320.179 29.1231 318.784 22.2235
322.769 40.9583
317.4 29.4018 309.208 47.9957
327.576 40.7367 325.393 24.945 316.51 40.3415

ADH D
Mean
SD
Mean
-10.496 6.81705 -10.605
-3.8156 9.12753 -2.5057
0.66085 6.37969 1.78905

SD
6.95912
7.90954
5.93713
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7.4.1

N100 Component

7.4.1.1 Amplitude

The results of the statistical analyses are summarised in Table 7.3

FESz versus clinical (ADHD) and normal controls

There was a significant main effect for group, with N100 amplitude reduced in
the FESz group compared with the clinical (ADHD) and normal control groups. This
main effect for group was further qualified by Group X Stimulus, Group X Site and
Group X Stimulus X Site interactions as follows (see Table 7.3, values in blue & Figure
7.3). With regard to the target vs. non-target comparisons, significant group differences
were observed at frontal rather than parietal sites, so that the control and ADHD groups
demonstrated reduced N100 amplitude to the non-target compared with target stimuli,
while the FESz group demonstrated similarly reduced amplitudes to all stimuli.
Additionally the ADHD and normal control group appeared to have reduced amplitude to
T+1 compared with T-1, at the frontal rather than parietal sites, with the results
approaching significance (p = .06), whereas the FESz group had similarly reduced
amplitudes for both non-targets (see Figure 7.3). Hence, the reduction in N100 amplitude
in the FESz group compared with normal and clinical controls was most prominent to
target compared with non-target stimuli.

Over group and site, targets produced larger amplitudes than non-targets and T+1
produced larger amplitudes than T-1, with this effect being pronounced at the fronto-
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central rather than parietal sites (see Table 7.3, values in green & Figure 7.3). As
mentioned above, this effect was qualified by a group interaction with the results of the
ADHD and normal control groups (but not the FESz group) contributing to these effects.

The expected fronto-central maximum for N100 amplitude was also observed,
with both linear and quadratic contrasts for site yielding significant results (see Table 7.3,
values in red).
Table 7.3 Summary of N100 Amplitude results

FESz vs ADHD+NC
41(1,58)
Stimulus
Group
Grp X Stim

T vs NTs
T-1 vs T+1

Stimulus
Stim X Site

T vs NTs
T-1 vs T+1
T vs NTs
T-1 vs T+1

Site

F
5.91
9.96

p
.02
.003

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

4.33

.04

18.47

.000

3.46

.06

5.31
13.07

T vs NTs
T-1 vs T+1

Grp X Site
Grp X Stim X
Site

Site

ADHD vs NC

df (1,38)
F

p

.03
.001

19.76
16.19

.0001
.0001
.0001
.04
.003
.002
.0001

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

6.02
4.54

.02
.04

51.22
4.76
9.80

Cz vs Fz & Pz
Fz vs Pz

5.88
45.77

.02
.0001

10.85
44.90
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Figure 7.3 N100 amplitude to target and non-target stimuli for all groups.

222

Clinical (ADHD) versus normal controls

Neither main effects for group nor interaction effects were significant. Over group
and site, targets produced larger amplitudes than non-targets and T+1 produced larger
amplitudes than T-1, with this effect being pronounced at the fronto-central rather than
parietal sites (see Table 7.3, values in green & Figure 7.3). This effect was qualified by a
Stimulus X Site interaction with the target vs. non-target effect occurring at frontal
compared with parietal sites, and the non-target effect, showing both linear and quadratic
contrasts, being maximal at fronto-central compared with parietal sites.

The expected fronto-central maximum for N100 amplitude was also observed,
with both linear and quadratic contrasts for site yielding significant results (see Table 7.3,
values in red).

Summary: The results yielded an interesting pattern of deficits that appear to be specific
to schizophrenia. Specifically, the FESz group did not differ in the way they responded
between targets and non-targets, or between the two non-targets, while the normal
control and ADHD groups demonstrated decreased N100 amplitude to non-targets
compared with targets (maximal at fronto-central sites) and decreased N100 amplitude to
T+1 compared with T-1 (maximal at fronto-central sites).
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7.4.1.2 Latency

FESz versus clinical (ADHD) and normal controls
N100 latency effects were not significant for group, however, there was a
significant Group X Stimulus interaction for the target vs. non-target contrast, F(1,58) =
5.63, p < 0.05, as non-targets produced more prolonged latencies than targets in the
clinical (ADHD) and normal control group, while the FESz group showed the opposite
pattern. As a result, compared with the control groups, the FESz group showed delayed
latency to target rather than non-target stimuli.

Over groups there was a significant linear contrast for site, F(1,58) = 55.49, p <
0.001, with N100 latency prolonged at frontal compared with parietal sites.

Clinical controls (ADHD) versus normal control
Effects were not significant for group or interactions with group for the ADHD
vs. normal controls comparison. There was a Stimuli X Site interaction for the target vs.
non-target comparison, F(1,38) = 4.41, p < 0.05, indicating prolonged N100 latency to
target compared with non-target stimuli at frontal, rather than parietal sites. There was a
main effect for site, with the significant linear contrast, F(1,38) = 50.4, p < 0.001,
showing N100 latency prolonged at frontal compared with parietal sites.
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Summary: Targets (vs. non-targets) produced a delayed N100 in the FESz group, but had
the opposite effect for the two control groups who responded similarly, suggesting that
this latency effect might be specific to schizophrenia.

7.4.2

P200 component

7.4.2.1 Amplitude
The results of the statistical analyses are summarised in Table 7.4

FESz versus clinical (ADHD) and normal controls

Main effects for group were not significant, although Group X Stimuli, Group X
Site and Group X Stimuli X Site interactions were significant. With regard to the target
vs. non-target comparisons, the control and ADHD groups demonstrated reduced P200
amplitude to the target compared with non-target stimuli, especially at the frontal site
(vs. parietal) while the FESz group had similar amplitudes to both stimuli types (see
Table 7.4, values in blue & Figures 7.4 and 7.5). Additionally the ADHD and normal
control group showed enhanced amplitude to T+1 (vs. T-1) across sites, whereas the
FESz group did not differ in the way that they responded to the two non-targets (see
Table 7.4, values in blue & Figure 7.4).

Over the three groups, the Stimulus X Site interactions (linear and quadratic) for
the target vs. non-target comparison were significant, suggesting stimuli-based
topographical shifts, with targets producing maximal amplitude parietally and non-
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targets centrally(see Table 7.4, values in green & Figure 7.5). For the non-target
comparison, a quadratic contrast indicated the reduced P200 amplitude to T-1 compared
withT+1 stimulus was maximal at the vertex (see Table 7.4, values in green).

Across groups and stimuli, the expected centro-parietal maximum for P200
amplitude was also observed, with both linear and quadratic contrasts yielding significant
results (see Table 7.4, values in red).

Table 7.4 Summary of P200 amplitude results
FESz vs ADHD+NC ADHD vs NC
df(1,58)
df (1,38)
Stimulus

Group
Grp X Stim

Site

11.18 .001
5.71
.02
Grp X Site
Cz vs Fz & Pz 5.57
.02
Fz vs Pz
Grp X Stim X T vs NTs
Cz vs Fz & Pz
Site
Fz vs Pz
4.30
.04
T-1 vs T+1 Cz vs Fz & Pz
Fz vs Pz
Stimulus
Stimulus X
Site

Site

T vs NTs
T-1 vs T+1

T vs NTs
T-1 vs T+1
T vs NTs

14.44
14.23

Cz vs Fz & Pz 5.96
Fz vs Pz
11.08
T-1 vs T+1 Cz vs Fz & Pz
3.98
Fz vs Pz
Cz vs Fz & Pz 45.71
Fz vs Pz
24.36

.02
.002 27.05
.05
4.62

.001
.001
.0001
0.04

.0001 51.64 .0001
.0001 26.62 .0001
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7
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Figure 7.4 P200 amplitude to target and non-target stimuli for all groups across midline
sites.

Clinical control (ADHD) versus normal control
Effects were not significant for group nor were any interaction effects significant
with group for the ADHD vs. normal controls comparison.

Over groups, there was a significant main effect for stimulus for both the target
vs. non-target contrast and the non-target contrast, T-1 vs.T+1, with target stimuli
producing reduced amplitude compared with the non-target stimuli and T-1 producing
reduced amplitude compared with T+1. Across groups, the expected centro-parietal
maximum for P200 amplitude was also observed, with both linear and quadratic contrasts
yielding significant results.
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Summary: The reduced P200 amplitude found frontally, to target compared with nontarget stimuli, which was present in the ADHD and normal controls, was not found in the
FESz group. Hence, these P200 amplitude deficits also appear to be specific to FESz.

10

Normal controls

10
8

Amplitude uV

6
4
2
0
-2
-4

Site
10 -

-6

First episode schizophrenia

86:L

--T-1 —0— T

T+1

-2 -4 -6 -

Site

Figure 7.5 P200 amplitude to target and non-target stimuli (T-1 & T+1) for all groups.
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7.4.2.2 Latency
The results of the statistical analyses are summarised in Table 7.5.

FESz versus clinical (ADHD) and normal controls
Effects were not significant for group, however, Group X Stimulus and Group X
Stimulus X Site interactions were significant as follows. With regard to the non-target
comparisons, significant group differences were observed at parietal rather than frontal
sites, so that the control and ADHD groups demonstrated earlier P200 latency to T-1
compared with T+1 stimuli, while the FESz group showed the reverse pattern (see Table
7.5 values, in blue & mean scores in Table 7.1).

Across group, latency was earlier to targets than non-targets and this effect was
maximal at Pz (see Table 7.5, values in green & mean scores in Table 7.1). The main
effect for site was also significant; the significant linear contrast indicated latency was
earliest at Pz.

Clinical control (ADHD) versus normal control
Effects were not significant for group nor were any interaction effects significant
with group for the ADHD vs. normal controls comparison.

Over group, there was a significant main effect for stimulus for both the target vs.
non-target contrast and the non-target contrast, T-1 vs.T+1, with target stimuli producing
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earlier latency compared with the non-target stimuli and T-1 producing earlier latency'
compared with T+1.
Table 7.5 Summary of P200 latency results
FESz vs ADHD+NC ADHD vs NC
df (1,58)
df (1,38)
F

p

T vs NTs
T-1 vs T+1

16.13

.001

Cz vs Fz & Pz
Fz vs Pz
Grp X Stim X T vs NTs
Cz vs Fz & Pz
Site
Fz vs Pz
T-1 vs T+1Cz vs Fz & Pz
Fz vs Pz

11.32

.001

Stimulus
Group
Grp X Stim

Site

Grp X Site

Stimulus
Stim X Site

Site

T vs NTs
T-1 vs T+1
T vs NTs

53.17 .0001 33.70 .0001
5.20
.03

Cz vs Fz & Pz
Fz vs Pz
T-1 vs T+1Cz vs Fz & Pz
Fz vs Pz

Cz vs Fz & Pz
Fz vs Pz

9.61

.003

6.68

.01

4.52

.04

4.09

.056

This effect for both contrasts was qualified by an interaction with site, indicating that the
difference was maximal parietally (see Table 7.5, values in green). Across group, the
expected centro-parietal maximum for P200 amplitude was also observed, with both
linear and quadratic contrasts yielding significant results (see Table 7.5, red).
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Summary: T+1 stimuli produced delayed latency in the two control groups, but not in the
FESz group, an effect maximal at the parietal site.

7.4.3 N200 component

7.4.3.1 Amplitude

FESz versus clinical (ADHD) and normal controls

Main Effects were not significant for group. However, there was a Group X Site
interaction with a significant linear contrast, F(1,58) = 6.94, p = 0.01, indicating that the
FESz showed reduced frontal N200 amplitude compared with normal and clinical
(ADHD) controls. Significant linear, F(1,58) = 95.01, p < .0001, and quadratic, F(1,58)
= 7.94, p < .01, contrasts for site indicated that N200 amplitude was maximal frontally
with marked reductions at centro-parietal sites.

Clinical control (ADHD) versus normal control

Effects were not significant for group or group X site interaction. Significant
linear, F(1,38) = 99.64, p < 0.001, and quadratic, F(1,38) = 4.97 p < .05, contrasts for
site indicated that N200 amplitude was maximal frontally.

Summary: There was a frontal reduction in N200 amplitude specific to the FESz group.
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7.4.3.2 Latency

FESz versus clinical (ADHD) and normal controls
Effects were not significant for group or Group X Site interaction. Significant
linear, F(1,58) = 24.91, p < 0.001, and quadratic, F(1,58) = 4.36 p < .05, contrasts for
site indicated that N200 latency was prolonged fronto-centrally.

Clinical control (ADHD) versus normal control
Effects were not significant for group or Group X Site interaction. Significant
linear, F(1,58) = 25.13, p < 0.001, and quadratic, F(1,58) = 9.58 p < .01, contrasts for
site indicated that N200 latency was prolonged fronto-centrally.

7.4.4

P300 component

7.4.4.1 Amplitude

FESz versus clinical (ADHD) and normal controls
The main effect for group was not significant, however, there was a main effect
for site, with the expected parietal maximum for P300 amplitude being observed for the
linear contrast, F(1,58) = 138.53, p < .001. This result was qualified by a significant
Group X Site interaction with the linear contrast, F(1,58) = 6.23, p < 0.01, indicating that
this pattern was maximal for the control (clinical + ADHD) group compared with the
FESz group (see Figure 7.6).
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Clinical (ADHD) versus normal controls
There was a significant main effect for group, F(1,38) = 7.88, p < .01 with P300
amplitude reduced in the ADHD group compared with normal controls (see Figure 7.6).
Across group, the expected parietal maximum for P300 amplitude was also observed,
with a significant linear contrast, F(1,38) = 145.57, p < .001, for site.

Summary: Over sites, the ADHD group demonstrated reduced P300 amplitude compared
with normal controls. The FESz group did not demonstrate a significantly reduced P300
amplitude when compared to the combined (clinical + normal ) control group. The
conventionally observed enhancement of P300 amplitude from frontal to parietal sites
was more pronounced for the combined control groups when compared with the FESz
group.

35 30 25 20 15 10 50

Pz

Cz
Site

Control —0— First episode Sz

A

—

—

ADHD

Figure 7.6 P300 amplitude for all groups at midline sites.
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7.4.4.2 Latency
Effects for group, site and group by site interactions were not significant for P300 latency
in either of the group comparisons.

7.4.5

Discriminant function analysis (DA)

The results of the three stepwise DAs are presented in Table 7.6
Table 7.6 Results of stepwise discriminant function analyses

% Correctly classified
Variables entered
in stepwise DA

FESz

ADHD and
Variables included by
normal controls stepwise DA *

1. N100, P200
T, T-1, T+1

85%
82.5%
Wilk's 43,58) = .555,
X2 = 33.28, p<.001

T+1 P200 latency (-0.71)
T-1 P200 latency (0.43)
T N100 amplitude (.67)

2. N200, P300

65%
55%
Wilk's
41,58) = .869,
2
x = 8.06, p<.01

T N200 amplitude (1.0)

85%
82.5%
Wilk's 43,58) = .555,
x2 = 33.28, p<.001

T+1 P200 latency (-0.71)
T-1 P200 latency (0.43)
T N100 amplitude (.67)

T

3.Combined
stepwise variables
from 1 and 2

* standardised canonical discriminant function co-efficients in brackets
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Entering the same target and non-target N100 and P200 components as those used
in the DA in Study 2 (see 7.3.2) 17.5% of the clinical + normal control group, i.e. three
normal controls and four ADHD controls, would have been incorrectly classified as
belonging to the schizophrenia group (false positives), while 15%, 3 people with FESz,
would have been inaccurately identified as belonging to the clinical and normal control
group (false negatives). However, when only N200 and P300 components to target
stimuli were used, the accuracy rate was dramatically reduced with 45% of the clinical +
normal control group, (10 normal controls & 8 ADHD controls) being incorrectly
classified.

When the critical variables selected by the two stepwise analyses (i. N100, P200
& ii. N200, P300) above were combined and entered into a stepwise DA the results were
identical to the N100, P200 analysis. In other words, the later components (N200, P300)
derived from the target stimuli failed to enhance the classification accuracy derived from
the earlier components (N100, P200).

7.5

DISCUSSION

The results yielded several distinctive findings for both N100 and P200 amplitude
and latency for the FESz group, compared to the clinical (ADHD) and normal control
group, supporting the possibility that these results are specific to schizophrenia. In

235

contrast, reduced P300 amplitude was not found to be specific for the FESz group and
also occurred in ADHD.

Results supported the hypothesis that the pattern of N100 and P200 deficits found
in schizophrenia compared with normal controls would not be found in the ADHD group.
The ADHD patients showed a similar pattern of N100 amplitude differences as the
normal controls for both the target vs. non-target comparison, with non-targets producing
decreased N100 amplitude compared with targets. In addition, for the non-target, T-1 vs.
T+1 comparison, T+1 produced reduced N100 amplitude compared with T-1 for both
control groups. The patients with FESz, however, did not show this N100 amplitude
differentiation, either between target and non-target stimuli, or between non-target, T-1
and T+1, stimuli. N100 amplitude was reduced overall in the FESz group compared to
the control and ADHD group.

This difference in N100 amplitude findings between the first episode and ADHD
groups would seem to indicate that the N100 amplitude deficits in FESz are not simply
the result of non-specific attentional deficits, as one would expect to find the pattern of
deficits in the ADHD group if this was so. The results of Study 3 (Chapter 6) suggest that
the lack of differentiation between T-1 and T+1 stimulus in FESz is not simply the result
of a disturbed recovery following the response to the target stimulus. Additionally, Study
3 indicated that normal controls no longer produce differentiated N100 amplitude to T-1
and T+1 stimuli, when T+1 stimuli are not predictable. In combination, these results
suggest that the FESz group were not able to make use of past regularities, i.e. a target
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will always be followed by a non-target to establish appropriate response biases, i.e.
reduced allocation of attention to T+1 stimuli reflected in a reduction in N100 amplitude.
The results could also suggest a heightened state that allows even predictable irrelevant
stimuli, such as T+1, to capture attentional resources.

Similarly, for P200 amplitude, the ADHD and normal control groups showed a
differentiation between stimuli, with a P200 amplitude reduction to target, compared to
non-target stimuli. This pattern was not found in the FESz group, as target stimuli
produced increased P200 amplitude, compared to non-target stimuli. This increase in
P200 amplitude to targets in the FESz group is intriguing as this is generally thought to
be precluded by the effects of the overlapping N200 component elicited by target stimuli.
While the ADHD group showed increased P200 amplitude to T+1 compared with T-1
stimuli, the FESz group did not differentiate between non-target stimuli. The FESz group
showed the same pattern of differentiation for P200 latency elicited to target vs. nontarget stimuli, (earlier to target) as the normal control and ADHD groups. In addition, the
comparison between non-target stimuli produced opposing results between the first
episode and control groups with P200 latency elicited by T+1 stimuli prolonged
compared with T-1 stimuli in the control group, but earlier in the first episode group.

P300 amplitude was reduced in FESz, compared to normal controls, in Study 2
(Chapter 5), however, in the current Study, the FESz group did not demonstrate a
significantly reduced P300 amplitude when compared to the combined (clinical +
normal) control group. This is because, across topography, the ADHD group
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demonstrated reduced P300 amplitude compared with normal controls, a finding
consistent with previous studies (Frank et al., 1998; Holcombe et al., 1986; Johnstone &
Barry, 1996; Jonkman et al., 1997; Loiselle et al 1980; Overtoom et al., Robaey et al.,
1992; Satterfield et al., 1990). These findings have a number of important implications.
Firstly, they reinforce doubts about the utility of P300 amplitude as a marker for
schizophrenia because of its problems with specificity. Secondly, it may have theoretical
implications for the reduction in P300 amplitude found in schizophrenia. For example, it
may be associated with a generic impairment common to many psychopathologies, such
as a working memory deficit. Alternatively, it may be sensitive to several different
mechanisms in different psychiatric groups, each resulting in diminished P300. As might
be expected from these findings, results from the discriminant function analysis
demonstrated that patients with FESz were not accurately classified using N200 and P300
amplitude, when the control group included people with ADHD. As no left (compared
withright) temporal deficit was found in the first episode group, it is unlikely that this
would have increased the specificity of the P300 findings. The finding that P300
amplitude reduction is not specific to schizophrenia, challenges its usefulness as a
biological marker for schizophrenia.

The discriminant analysis indicated that the P300 deficit is not specific for
schizophrenia while deficits in N100, P200 components were specific for schizophrenia
when compared with the combined group of controls and patients with ADHD. The most
compelling evidence for this was that only the N100 and P200 variables were chosen in
the stepwise DA which combined, the variables chosen in the individual stepwise
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analyses for (i) N100 and P200 and (ii) N200 and P300. This finding highlights the
possibility that N100 and P200 components to target and non-target stimuli may provide
a more useful biological marker for genetic research than the traditional focus on P300
amplitude.

An obvious limitation of this Study was the lack of female participants. This was
a consequence of the all-male ADHD group, as ADHD is much more common in males
than females. It would be important to replicate these findings in a larger study, with
equal female and male participants included.

This Study has demonstrated the benefits of using non-target, in addition to target
ERPs, and in further separating ERPs elicited by non-target stimuli into those occurring
immediately before the target stimulus (T-1), and those occurring immediately after the
target stimulus. It was the distinct pattern of ERP responses to N100 and P200 elicited by
T-1, target and T+1 stimuli found in the FESz group compared to the control and ADHD
groups, that allowed the accurate discrimination of patients with FESz from a
combination of normal and psychiatric, (ADHD) control groups.
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8 THESIS CONCLUSIONS AND IMPLICATIONS

8.1

MAJOR FINDINGS AND IMPLICATIONS

This thesis has emphatically demonstrated the importance of looking beyond the
P300 component in schizophrenia research. This is in contrast to earlier ERP research
which focussed on the P300, because of its assumed association with critical cognitive
variables and the robustness of the P300 amplitude reduction finding in schizophrenia.

The first major finding was that the early ERP components elicited by both nontarget and target stimuli were disturbed in schizophrenia. ERPs to non-target stimuli
showed reduced N100 amplitude and delayed P200 latency, while ERPs to target stimuli
showed reduced and earlier N100 and increased P200 amplitude. A related finding, also
revolving around the N100 and P200 components was the lack of differentiation between
early ERP responses elicited by target and non-target stimuli in schizophrenia. Study 1
demonstrated that both of these deficits were reliably found in a large sample of patients
with schizophrenia and their matched controls. In Study 2, these initial findings were
extended with results indicating that the pattern of deficits also occurred among first
episode schizophrenia participants.

The presence of these early deficits in both FESz and chronic schizophrenia
suggests that they are more likely to be trait deficits, rather than transient state markers
associated with severity of psychopathology, or other effects of illness or
institutionalisation. Although reduced N100 amplitude to non-target stimuli in
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schizophrenia has been found in some previous studies, the current series of studies that
has tested large numbers of patients, in early and later stages of schizophrenia, and has
used normal and clinical control groups, constitutes the most most comprehensive and
compelling data-set about early ERP deficits in schizophrenia known to be reported.

These findings have important empirical implications for schizophrenia research.
They indicate the importance of systematic analysis of N100 and P200 ERPs elicited by
non-target stimuli. Secondly, they show that an examination of the relationship between
these components elicited by non-target and target stimuli yields valuable information,
and, therefore, should be included in the analysis.

A third major finding was that differences in the ERP response to non-target
stimuli which occur before and after the target stimuli (T-1 & T+1) evident in the normal
controls, was notably absent in both the first episode and chronic schizophrenia groups.
The N100 reduction to T+1 compared with T-1 stimuli found fronto-centrally in normal
controls was not present in chronic schizophrenia and was minimal in FESz (Study 2,
Chapter 5). The N100 amplitude reduction associated with T+1 and observed in normal
controls is consistent with findings of other oddball studies in the literature (Hirata &
Lehman, 1989; Starr, Sandroni, & Michalewski, 1995; Starr et al., 1997) in which the
target stimuli is always followed by a non-target stimuli by design or by virtue of low
probability. The reason for this finding among normal controls has remained unclear,
with the results being consistent with either response recovery or stimulus predictability
hypotheses. However, Study 3 demonstrated that the effect disappeared when the non-
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target status of the stimulus was not predictable, thereby ruling out the recovery
hypothesis. Thus these studies confirm the T+1 effect on N100 amplitude in normals and
more convincingly link it to the predictable occurrence of a task-irrelevant (non-target)
stimulus.

The reduced N100 amplitude to T+1 stimuli finding has important empirical
implications for ERP research for schizophrenia and as well as in normal and other
clinical groups. From an empirical perspective, it demonstrates that it is important not to
average ERPs to all non-target stimuli in the auditory oddball paradigm as certain nontarget stimuli may have different functional significance. Among other possible
interpretations, these findings could be seen to support a deficit in associative learning in
schizophrenia and can be seen as support for the cognitive model proposed by Gray,
Hemsley and others (Gray et al., 1991; Gray, 1998; Hemsley, 1996), that people with
schizophrenia fail to establish appropriate response biases because they are unable to use
stored memories of regularities based on their previous experience. An alternative
possibility is that patients with schizophrenia, like normal controls, are aware that T+1
are non-target occurrences, but are unable to prevent these irrelevant stimuli from
automatically capturing valuable attentional resources.

A fourth, and perhaps the most important finding of this thesis, is the improved
sensitivity and specificity of deficits in the N100 and P200 components elicited by target
and non-target stimuli when compared to the N200 and P300 measures. These results
were both robust and reliable and the superior classification associated with the earlier
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components between schizophrenia and normal control subjects in Study 2 were
replicated in Study 4 between FESz and both clinical (ADHD) and normal controls.
In Study 4, N100 and P200 components elicited to target and non-target stimuli,
utilising a stepwise DfA, enabled correct identification of 85% of the FESz subjects, and
82.5% of the combined (clinical + normal) controls. On the other hand, the use of N200
and P300 components to target stimuli in a stepwise DfA resulted in correctly classifying
65% of the FESz group and 55% of the combined (clinical+normal) control group. These
classification rates appear impressive. If replicated, they have important empirical
implications for genetic studies searching for a psychophysiological endophenotype.
Currently reduced P300 amplitude has been considered as a likely endophenotype or
biological marker for genetic studies with schizophrenia. However the results of Study 4
(Chapter 7) indicate that the N100, P200 components may be a superior biological
marker than P300.

This thesis also examined the relationship between symptom factors and ERP
components elicited by target and non-target stimuli. The most robust relationship was
the negative correlation between the magnitude of N100 amplitude and the
disorganisation factor, which is seen as a core feature of schizophrenia. This correlation
was maximal for N100 amplitude to non-target stimuli. This suggests the possibility that
the N100 amplitude to non-target stimuli may be related to the unique pathology of
schizophrenia. In contrast, no significant correlations were found between symptom
factors and P300 amplitude in this Study, and the results of previous investigations have
been mixed and difficult to replicate.
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The finding that people experiencing their first episode of schizophrenia have
psychophysiological disturbances of a similar severity to those who have experienced
schizophrenia over a number of years also has treatment and theoretical implications.
With regard to treatment this finding emphasizes the need for an early and
comprehensive intervention in schizophrenia. One further advantage of having the
chronic schizophrenia group in addition to the FESz group was that it allowed for an
exploration of differential age effects on ERPs to target and non-target stimuli between
the two groups. The schizophrenia group did not show an exacerbation of the normal age
effects on ERP components, providing an additional argument against the notion that
schizophrenia is a neurodegenerative disorder.

Finally, preliminary evidence suggested that the P300 amplitude was sensitive to
alternating sequences of stimuli within the oddball task, and systematically increased or
decreased depending on whether these alternations discontinued or continued. Study 3
examined the proposal that, in these circumstances, reliable P300 changes to DA series
would be a reliable index of associative strength in normal controls and would be
impaired in schizophrenia. The results failed to confirm that such a pattern occurred in
normals, hence the hypothesis could not be confirmed in schizophrenia. In any case, the
study examined DR and DA effects in a comprehensive way in first episode
schizophrenia, thereby contributing to the very limited research in this area. The finding
that manipulations of the DR series has comparable effects on both normal controls and
schizophrenia groups, suggests that the temporal determinants (such as target-to-target
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intervals) that underpin these amplitude changes in normals, are not critical to the
impairment in schizophrenia.

8.2

LIMITATIONS AND FUTURE DIRECTIONS

There are a number of study limitations. The participants with FESz, had
commenced medication at the time of testing, so that while they had not had an extended
time on medication and while medication was a covariate in the statistical analysis, it
would be preferable to have tested these participants drug naïve and to have withdrawn
the chronic schizophrenia participants from medication. This is difficult to achieve
because of the serious ramifications of withholding medication for people with
schizophrenia. However one possible way to overcome this would be to have a laboratory
on the psychiatric admission ward, with the EEG recording a standard part of the initial
neuropsychiatric battery prior to medication. At any rate, previous research has indicated
that ERP component deficits are not due to the effects of medication (see Chapter 2.4.1)
and as all significant results remained unchanged even after co-varying for medication, it
appears very unlikely that the results were due to medication effects.

The thesis necessarily employed a cross-sectional rather than longitudinal design.
Future investigation, following subjects from their first episode of schizophrenia in a
longitudinal study, would provide important information on ERP deficits over the course
of the illness.
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Study 4 demonstrated the specifity of target and non-target N100, P200 deficits in
first episode and chronic schizophrenia. However in addition to the need for replication
of these findings, it would also be important to demonstrate that these deficits were
present in people prior to the onset of their schizophrenia illness and more prevalent in
family members, to be able to consider these deficits as biological markers.

The ADHD group provided an appropriate clinical control group to examine
initially the specificity of schizophrenia deficits as both groups have cognitive and P300
reduction deficits in common. Future investigations might extend this research by
including additional psychiatric control groups to provide a more detailed examination of
the specificity of the findings. A further limitation to Study 4, was the lack of female
participants, due to the constraints of an all male ADHD group, thus limiting
generalisation of findings to a male population. Further investigation, with adequate
numbers of female participants, is required.

The ERP topographical analysis in Study 2 although providing a high temporal
resolution of brain activity, is limited in its spatial resolution. The neural basis of deficits
in schizophrenia could be further explored using neuroimaging techniques, such as event
related (er) fMRI, allowing for much greater spatial resolution of cortical and sub-cortical
areas. For example, an erfMRI study by Kiehl and Liddle (2001) has been able to
demonstrate reduced activations, both in strength and extent, in right lateral frontal
cortex, thalamus, bilateral anterior superior temporal gyrus, anterior and posterior
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cingulate, associated with target processing in schizophrenia compared to normal
controls.

Study 4 clarified answers to competing hypotheses arising from the N100
amplitude reduction to T+1 stimuli found in Study 2. However, probability differences in
paradigms existed between the two studies - 0.5 in Study 3 and 0.3 in Study 2, which may
have affected results. This difference arose, in part, from the constraints imposed by
having the target stimuli followed equiprobably by target and non-target stimuli, and by
by the sequence requirements of Study 3. However a previous study (Polich &
Bondurant, 1997) did not find N100 amplitude non-target sequence effects in normal
participants, when examining these effects in paradigms with 0.33 and the other with 0.67
target probabilities. This suggests that the probability difference between the two studies
is unlikely to have affected findings.

8.3

CONCLUSION

This thesis provides a thorough investigation of target and non-target N100 and P200
components, in contrast to target N200 and P300 components, from the first onset of
schizophrenia, through chronic duration, and in comparison with both healthy controls
and ADHD. The results present compelling evidence that N100 and P200 components to
target and non-target stimuli are impaired in both the early and chronic manifestations of
schizophrenia and demonstrate the importance of investigating non-target in addition to
target ERPs in schizophrenia. In contrast to reduced P300 amplitude, deficits in these
early components to both target and non-target stimuli show superior sensitivity and
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specificity for schizophrenia, and hence may serve as potentially useful biological
markers for the disorder.
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10 APPENDICES

10.1

APPENDIX 1- CHLORPROMAZINE EQUIVALENT

This table shows the dosage estimates used to calculate the Chlorpromazine equivalent
medication levels in patients in this thesis (Lambert, 1998).

ORAL MEDICATIONS 100 CHLORPROMAZINE
EQUIVALENTS
Haloperidol
Trifluoperazine
Pimozide
Pericyazine
Fluphenazine
Thioridazine
Respiridone
Olanzapine
Clozapine
Thiothixene

2
5
1.5
10
2
100
1.5
3
75
4

Depot Injections (2 Weekly)

300 Chlorpromazine
Equivalents per Day

Fluphenazine Decanoate
Haloperidol Decanoate
Zuclopenthixol Decanoate
Flupenthixol Decanoate

25
50
200
40
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Abstract
Objectives: Event-related potential (ERP) abnormalities to target stimuli are reliably found in schizophrenia. However, as people with
schizophrenia are thought to have difficulty discerning the relevance of incoming sensory stimuli it is also important to examine ERPs to nontargets. To differentiate between potential trait markers of the disease and deficits that might be associated with the consequence of illness
chronicity, this study investigated ERPs to both target and non-target stimuli in groups of people with either first episode or chronic
schizophrenia (CSz).
Methods: Using an auditory oddball paradigm, ERPs to target, non-target before target (Nt before) and non-target after target (Nt after)
stimuli were analysed for 40 patients with CSz, 40 patients with first episode schizophrenia (FESz) and two groups of normal controls
matched for age and sex with their patient counterparts.
Results: The FESz group showed the same pattern of amplitude disturbance as the CSz group to both targets (reduced N100, N200, P300
and increased P200) and non-targets (reduced N100) compared to controls. Both CSz and FESz groups also failed to show the changes to the
P200—N200 component between targets and non-target stimuli that was exhibited by controls (smaller earlier P200 to targets vs. increased
delayed P200 to non-targets) or the reduction in N100 amplitude of ERPs to the Nt after stimuli compared with ERPs to the Nt before stimuli.
Previous literature has focussed on the sensitivity of P300 deficits in classifying persons into schizophrenia and non-schizophrenia groups.
This study demonstrated improved accuracy in the classification of patients with schizophrenia from controls using discriminant analysis of
target and non-target N100 and P200 components.
Conclusions: The results suggest that ERP disturbances are evident at the time of first referral to mental health services and may be a
potential trait (rather than secondary effect) of the illness. It is important to include both target and non-target stimuli processing, and their
interrelationship in future research. Crown Copyright © 2002 Published by Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Schizophrenia; First episode schizophrenia; Event-related potential; Non-target

1. Introduction
Numerous studies have found deficits in event-related
potentials (ERPs) of patients with schizophrenia, linked to
target stimuli in an auditory oddball paradigm, most notably
a reduction in P300 amplitudes (for reviews see Pfefferbaum
et al., 1989; Pritchard, 1986; Ford et al., 1992; Jeon and
Polich, 2000). Most of these studies have investigated
ERPs in chronic patients, however, an important emerging
issue is whether these deficits are trait-like and therefore
present at the onset of illness (Salisbury et al., 1998; Ford,
* Corresponding author. Tel.: +61-2-9845-6835; fax: +61-2-9635-7734.
E-mail address: kerrib@psych.usyd.edu.au (K.J. Brown).

1999; Frodl-Bauch et al., 1999; Mathalon et al., 2000;
Blackwood, 2000). This is particularly important because
ERP deficits observed in patients with chronic schizophrenia (CSz) may be secondary effects of chronic morbidity,
neuroleptic medication or other changes associated with
chronic mental illness (e.g. hospitalisation). If established
as a trait, ERP deficits could be useful in identifying 'at risk'
individuals and would provide potential for the implementation of preventative strategies.
Although there is now some evidence that reduced P300
amplitude is a stable trait marker in schizophrenia (Mathalon et al., 2000; Blackwood, 2000), with evidence for
genetic association (Blackwood et al., 2001; Weisbrod et
al., 1999), there have been studies which have not found
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reduced P300 in the undiagnosed family members of people
diagnosed with schizophrenia (Friedman et al., 1988) and in
a study that looked at the predictive validity of the P300,
Squires-Wheeler et al. (1993) did not find P300 amplitude
reduction predictive of subsequent schizophrenic breakdowns. However, in the Squires-Wheeler et al. study
(1993), as might be expected, because of the relatively
low incidence of schizophrenia even among relatives of
schizophrenics, there were no more than 6 subjects classified as having a schizophrenic breakdown and only one
classified with schizophrenia disorder (this subject's P300
amplitude was reduced one and a half standard deviations
below the mean for the normal group). Hence, the reliability
of these findings is questionable, and the importance of
using alternative methods to determine whether ERP deficits observed among chronic schizophrenics is trait-like is
further highlighted. One such method comprises the
comparison of ERP deficits early (first presentation) and
late (CSL) in the developmental course of schizophrenia.
Reduced mismatch negativity (MMN) amplitude has also
been found in non-psychotic first degree relatives of patients
with schizophrenia (lessen et al., 2001) suggesting that
earlier components (N100 and P200) should also be investigated. There have been few studies investigating auditory
oddball ERP deficits in people with first episode schizophrenia (FESz). Salisbury et al. (1998) and Hirayasu et al. (1998)
have both found reduced P300 amplitude to target stimuli in
this group. ERPs to non-target stimuli (and their relationship
with target ERPs) remain unexplored in FESz.
There are both theoretical and empirical indications for
investigating possible ERP disturbances to non-target
stimuli in addition to target stimuli in people with schizophrenia. Current models of information processing deficits
in schizophrenia (e.g. Frith, 1995; Gray, 1998; Hemsley,
1996) suggest a disturbance at the 'comparator' level in
the match/mismatch between incoming stimuli and stored
memories of past regularities or similarly, a failure in the
inhibitory effect of context (Servan-Schreiber et al., 1996).
These models highlight the need to examine the processing
of irrelevant or context information in addition to relevant
information in people with schizophrenia. Houghton and
Tipper's (1996) model of 'normal' selective attention
proposes that, in addition to the excitatory feed back loop
elicited by target stimuli, selective attention involves an
inhibitory feedback loop elicited by non-target stimuli.
There is evidence from negative priming tasks indicating
a disturbance of this inhibitory process in schizophrenia
(Beech et al., 1989, 1991). In the auditory oddball paradigm,
where subjects are asked to respond to target and not to nontarget stimuli, ERPs to non-targets may provide insight into
this inhibitory process, and should be investigated along
with ERPs to targets. As the auditory oddball paradigm
comprises target events that often follow a series of nontarget occurrences, a comparison of ERPs elicited by targets
and those elicited by non-targets immediately preceding and
following the target stimuli might capture the effects of
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cognitive processes during the putative comparator stage
(P200—N200) and immediately before (N100) and after
(P300) such processing.
Further evidence of the significance of non-target stimuli
for information processing emerges from studies, showing
that the same stimuli are processed differently when they
appear as a non-target in the auditory oddball task than
when they are used in a passive listening condition
(Garcia-Larrea et al., 1992; Yordanova et al., 2001). There
is also evidence that ERPs to non-targets before (Nt before)
and after (Nt after) the target stimuli, in normals, may
involve different brain states (as indicated by different
scalp topographical distributions for the two types of nontargets) and should be averaged separately (Hirata and
Lehmann, 1990). ERPs to Nt after stimuli may also provide
insight into the possibility of a disturbance in temporal
recovery (Roth and Cannon, 1972) or refractoriness in
N100 (Shelley et al., 1999), which has been suggested in
schizophrenia. Additionally, there is the possibility of an
expectancy effect associated with the Nt after stimuli, as a
target stimulus is always followed by a non-target stimulus
in the oddball design used in this study. For these reasons, in
our study, we have examined separately Nt before and Nt
after the target stimuli.
Reported findings in non-target ERPs in people with schizophrenia include reduced N100 amplitude (Roth et al.,
1980; Pfefferbaum et al., 1989; Ogura et al., 1991; Boutros
et al., 1997; Laurent et al., 1999; Brown et al., 2000); both
increased (Pfefferbaum et al., 1989; Ogura et al., 1991) and
reduced (Roth and Cannon, 1972; Roth et al., 1980; McCarley et al., 1991) P200 amplitude; earlier P200 latency
(Brown et al., 2000) and less difference between target
and non-target N100/P200 components (Brown et al.,
2000). Studies by Brown et al. (2000) and Roth and Cannon
(1972) indicate the importance of examining the group by
stimuli interaction, as patterns of differences between ERPs
to target and non-target stimuli found in normal controls
may not be present in schizophrenia. There is also complimentary evidence of a disturbance of target/non-target
discrimination from single trial ERP analysis showing
people with schizophrenia had fewer P300s to targets and
more P300s to non-targets compared with controls (Roschke
et al., 1996; Wagner et al., 2000).
Previous literature has focussed on the sensitivity of the
P300 component in schizophrenia. For example, Ford et al.
(1992) established criterion P300 amplitude, above which
one can rule out a diagnosis of schizophrenia. Boutros et al.
(1997), however, found that non-target N100 and P200
components were also sensitive measures and recently
Ford et al. (2001) proposed that N100 amplitude reduction
to targets and non-targets may have greater specificity for
schizophrenia than P300 reduction (in that study while P300
amplitude was sensitive to schizophrenia-like symptoms
found both in schizophrenic and in epileptic patients, with
interictal CSz-like features, only N100 was specific to those
symptoms in schizophrenia alone). We investigated the
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sensitivity of the N100 and P200 components elicited by
non-targets and targets and compared this with the P300
component to targets in discriminating CSz and FESz
groups from their respective normal control groups. Following Gray's (1998) model and our (Brown et al., 2000)
previous finding that there is less difference between target
and non-target N100 and P200 scores in a schizophrenia, we
decided to also investigate the sensitivity of the within
group differences for stimuli (where these differed between
the groups) by subtracting target and non-target scores.
2. Methods
2.1. Participants
2.1.1. Participants with chronic schizophrenia

Forty people (28 males, 12 females) with CSL, aged
between 23 and 51 years of age, with a mean age of 36.0
years (SD = 7.1 years) were recruited from hospital and
community health centres. All participants had been diagnosed with schizophrenia for at least 4 years (range 4-34
years) with a mean duration of illness of 14.3 years
(SD = 7.0 years). All were medicated, with 20 subjects on
typical antipsychotics (mostly depot preparations), 7 on
atypical antipsychotics and 13 on clozapine. The mean
dose of medication was 520 chlorpromazine equivalents
(SD = 423). Diagnosis was made by concordance between
the case file diagnosis and diagnosis based on Section G
(schizophrenia and psychotic disorders) of the Composite
International Diagnostic Interview (World Health Organisation, 1992), or by concordance between diagnosis made by
two psychiatrists according to the Diagnostic and Statistical
Manual of Mental Disorders (3rd edition revised) (DSM-IIIR) (American Psychiatric Association, 1987). Exclusion
criteria were a recent history of substance abuse, past history
of substance dependence, mental retardation, other neurological disorders including epilepsy and head injury
(defined as an injury requiring hospital observation for at
least 4 h or unconsciousness for more than 1 h).
2.1.2. Participants with first episode schizophrenia

Forty people (26 males, 14 females) with FESz aged
between 14 and 26 years (mean = 19.6 years;
SD = 3.2 years), were recruited from community and
hospital settings through the Western Sydney First Episode
Psychosis Project. FESz participants were defined as those
young people presenting for the first time to health services
with psychotic symptoms that warranted a diagnosis of
either schizophrenia or schizophreniform disorder. Diagnosis was made by means of a consensus conference (of at
least 3 fully qualified psychiatrists) that drew upon the interview by the participating psychiatrist, information from
family and case manager and the case notes. Diagnoses
were made according to the Diagnostic and Statistical
Manual of Mental Disorders (4th edition) (DSM-IV) (Amer-

ican Psychiatric Association, 1994). Exclusions were the
same as for the chronic group. The majority of participants
were medicated with atypical antipsychotics alone
(M = 250 chlorpromazine equivalents: SD = 202), though
a small number were also receiving antidepressant or anticholinergic medications. Four participants were on no medication.
2.1.3. Positive and negative symptom scale (PANSS)

Schizophrenic symptoms were rated for both CSz and
FESz groups using the Positive and Negative Syndrome
Scale (PANSS, Kay and Opler, 1987). The CSz group had
a mean total score of 78.5 (SD = 18.7) and the FESz group
75.2 (SD = 15.1). Mean (SD) subscale scores for the CSz
group were: positive, 20.3 (SD = 6.5); negative, 20.6
(SD = 6.5); and general, 37.6 (SD = 8.3); and for the
FESz group: positive, 17.2 (SD = 5.7); negative, 19.5
(SD = 6.2); and general, 38.7 (SD = 6.9).
2.1.4. Normal control participants

Normal control participants for the two groups were
recruited from the community and were gender and age
matched to within 2 years for clinical subjects under the
age of 25 years and to within 5 years for those over the
age of 25 years. The rationale for closer age matching of
the younger subjects derived from research indicating
maturational changes in the electroencephalogram (EEG),
occurred up to early adulthood (Neidermeyer, 1999).
Control group 1 with a mean age of 36.7 years (SD = 7.6)
was compared with the CSz group and control group 2 with
a mean age of 19.65 years (SD = 3.86) was compared with
the FESz group. Persons with a recent history of substance
abuse, or past history of substance dependence, epilepsy,
other neurological disorders, mental retardation or head
injury were excluded from the sample.
2.2. Data acquisition

Participants were seated in a reclining chair in a quiet,
dimly lit laboratory, facing a video screen and wearing a
pair of headphones. A conventional auditory oddball paradigm was employed, consisting of 40 target tones (1500 Hz
with 15% probability and 247 background (1000 Hz) tones
both lasting 50 ms (with 10 ms rise and fall). The tone intensity was 60 dBSPL and the fixed interstimulus interval (ISI)
was 1.3 s. Participants were asked to look at a dot on the
computer screen 60 cm in front of them, ignore the low
(background) non-target tones and press two reaction time
buttons (with the index finger of each hand, to counterbalance motor activity) when they identified a task relevant
target tone. Task instructions emphasised speed and accuracy of response equally. EEGs were recorded on a DC
based system (Synamps, equipped with a 16 bit A/D converter) from 19 scalp sites according to the 10-20 International
system (Bloom, 1982) in reference to linked-ear electrodes
with an amplification of 200, a band pass from 0 to 50 Hz
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chronic schizophrenia — control 1 —

FESz — control 2 —

Fig. 1. Grand average waveforms for all groups, to each stimuli at midline
sites. Both chronic and first episode Sz groups show reduced N100, N200
and P300 and increased P200 amplitude to targets compared with controls
and decreased N100 amplitude with Nt before. Chronics showed delayed
P200 latency to targets and earlier P200 latency to non-targets and delayed
N200 latency to targets.

and digitised at 250 Hz. Only data recorded at Fz, Cz and Pz
are reported here. Horizontal electro-oculogram (EOG) was
recorded via electrodes placed at the outer canthus of each
eye and vertical EOG was recorded via two electrodes
placed 1 cm above and below the midline supraorbital and
infraorbital regions of the left eye. Eye correction was
carried out using a technique based on Gratton et al.
(1983). Within the block comprising target and non-target
tones, in 33 instances, targets occurred both immediately
before and after the target tone and the responses to these
33 targets, 33 non-targets before (Nt before), and 33 nontargets after (Nt after) were averaged separately (in 7
instances the non-targets were immediately preceded by
and followed by a target and hence were simultaneously
both Nt before and Nt after, and so were excluded). For
targets N100, P200, N200 and P300 peaks were measured
relative to a prestimulus (200 ms) baseline by an automated
system based on the detection of a consistent change in the
direction of the gradient of the waveform (Haig et al., 1995).
Thus a change from a consistently positive to a consistently
negative gradient was identified as a positive peak, and vice
versa for a negative peak (Haig et al., 1995). In addition, the
criteria that N100 occurred between 80 and 140 ms, P200
between 150 and 240 ms, N200 between 200 and 280 ms
and P300 between 250 and 500 ms. Peaks thus identified
were then verified through visual inspection. N100 and
P200 peaks in averaged ERPs to non-targets before and
after were ascertained according to the same method.
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2.3. Analysis
2.3.1. Midline ERPs

N100 and P200 amplitudes and latencies were submitted
separately to a to a 3-way analysis of variance (ANOVA)
repeated measures design, incorporating two groups (schizophrenic vs. controls) X 3 electrode sites (Fz, Cz, Pz) X 3
stimuli (Nt before, target and Nt after) with repeated
measures for electrode and stimulus factors. When sphericity assumptions were violated, the Greenhouse—Geisser
correction was employed and the degrees of freedom (df)
values were appropriately adjusted. N200 and P300 components were reliably observed only to the target stimulus and
were therefore subjected to a group (schizophrenia vs.
controls) X site (Fz, Cz, Pz) ANOVA repeated measures
design. These analyses were done separately for the CSz
group vs. control 1 group and FESz group vs. control 2
group. The Statistical Package for Social Sciences 9.0
program (SPSS Inc., 1999) was used in all analyses. Significant main and interaction effects based on multiple df were
further analysed by post-hoc comparisons with Bonferroni
adjusted alpha level. ERP components were also submitted
to a 3-way ANOVA repeated measures for chronic vs. FESz
groups and for control 1 vs. control 2 group. Medication and
age (used when comparing FESz and CSz groups, because
between groups, ages differed markedly in this analysis)
were used as covariates.
2.3.2. Discriminant function analysis (dfa)

Dfa was performed in two stages. Stage 1 related to amplitudes and latencies of components derived conventionally, and
stage 2 related to N100 and P200 difference score amplitudes
and latencies. Component amplitude and latency measures on
which the clinical and control groups were significantly different were entered into a stepwise dfa for the CSz and FESz
groups and their controls separately in the following manner.
2.3.2.1. Stage I.

1. N100 and P200 component amplitudes and latencies for
target, Nt before and Nt after. Where the number of
significant differences exceeded the number of variables
permissible
under
subject-to-variable
ratio
recommendations, and differences were observed at more
than one site, then only the site at which the component has
maximal amplitude/latency was entered (e.g. Cz for P200).
2. All target P300 amplitudes and latencies at midline sites.
3. Variables arrived at by the stepwise procedure above
combined with significant N200 differences. Fisher
classification functions from the CSz dfa were then
applied to the FESz group to test the robustness of the dfa
replicated in an independent sample.
2.3.2.2. Stage 2. Consistent with some current theories,
critical dysfunctions in schizophrenia could relate to
mechanisms that are called into play when switches from
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chronic Sz

bolt
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first episode Sz
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Fig. 2. Superimposed grand average waveforms for ERPs to target, Nt
before and Nt after stimuli for each group at Cz. Arrows on control graphs
refer to N100 amplitude reduction and P200 amplitude and latency shift
between targets and non-targets. These patterns are not found in the CSz
group and only the P200 latency shift is found in the FESz group.

one stimulus to another occur, such as when a target follows
a non-target or vice versa. Such processes may be best
captured by difference scores rather than by ERP peaks
derived independently for target and non-target stimuli.
Difference scores were computed and these values were
entered into a dfa to determine whether these measures
would be as sensitive as conventionally derived measures
to predict group membership.
2.3.3. Reaction time

Reaction times for CSz vs. control, FESz vs. control, CSz
vs. FESz, and control 1 vs. control 2 were compared by t test.
3. Results
ERP waveforms are presented in Fig. 1(between group)
and Fig. 2 (within group) and amplitude and latency values
in Table 1. A small percentage (between 1 and 2.5% in each
group) of ERP measures were identified as outliers (greater
or less than one and a half the interquartile range from the
upper and lower quartile). All results subsequently are based
on data with outliers; however, results remained significant
following removal of outliers and covarying for medication
(chlorpromazine equivalents).
3.1. ERPs
3.1.1. N100
3.1.1.1. CSz vs. controls. There were significant main
effects for group, F(1,78) = 25.33, P < 0.001, the CSz
group showing reduced N100 amplitudes overall; stimulus
F(2, 77) = 10.69, P < 0.001, larger N100 amplitude to target
than non-target stimuli and site, F(1.63, 126.94) = 130.34,
P < 0.001, with N100 amplitude maximal fronto-centrally.
There was also a significant group X stimulus X site interaction, F(2.83, 220.97) = 2.89, P < 0.05. The interaction arose

because N100 amplitudes were significantly larger for target
stimuli than for Nt after stimuli, for the control, but not the CSz
group (site interactions can be seen in Tables 1 and 2). There
was a significant stimuli X group interaction,
F = (2, 77) = 4.38, P < 0.05, for N100 latency which
arose because N100 amplitude for Nt after stimuli was significantly earlier than for target or Nt before stimuli in the control,
but not the CSz group, and a main effect for site,
F = (1.63)130.34, P < 0.001 with earliest latency at Pz.
3.1.1.2. FESz vs. control. There were significant main
effects for group, F(1,78) = 9.57, P < 0.01, the FESz
group showing reduced N100 amplitudes overall;
stimulus, F(1.82,142.34) = 15.83, P < 0.001, larger N100
amplitude to target than non-target stimuli and site,
F(1.39,108.73) = 76.42; P < 0.001, with N100 amplitude maximal fronto-centrally. There was also a
significant group X stimulus X site interaction F(2.75, \
215.09) = 15.376, P < 0.001. The interaction arose
because there were N100 amplitude changes as a function
of stimuli (target > Nt before > Nt after) in fronto-central
sites for the control, but not the FESz group.
3.1.2. P200
3.1.2.1. CSz vs. control. There was a significant group X
stimulus X site interaction F(3.32, 258.73) = 7.86, P
0.001 for P200 amplitude. The CSz group had significantly
larger P200 amplitude for target stimuli than controls which
explains the main effect for group, F(1,78) = 12.21,
P = 0.001. The interaction arose because there was a stimulus effect, significantly reduced P200 amplitude to target
than to non-target stimuli, found in controls but not in the
chronic group which explains the main effect for stimulus
F(2,77) = 11.21, P < 0.001. Site interactions can be seen
in Table 1. There was a significant stimulus X group interaction F(2, 77) = 119.75, P < 0.001 for P200 latency. The
CSz group was delayed for target, but earlier for non-target
stimuli when compared with controls.
3.1.2.2. FESz vs. control. There was a group X stimulus
interaction F(1.82,140.12) = 8.57, P G 0.001 and
group X site interaction F(1.69, 129.97) = 3.86, P < 0.001
for P200 amplitude. The FESz group had larger P200
amplitude than controls for target stimuli and smaller
P200 amplitude than controls for Nt after stimuli. The
stimulus interaction arose from a stimuli effect found in
controls but not in FESz, where P200 amplitude to target
stimuli was smaller than P200 amplitude to non-target
stimuli. Site effects can be seen in Table 1.
3.1.3. N200/P300
3.1.3.1. CSz vs. control. There were significant main effects
for group for N200 amplitude, F(1, 78) = 16.35, P < 0.001,
and latency, F(1, 78) = 31.88, P < 0.001, with amplitudes
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Table 1
N100 and P200 means (SDs) for CSz and controls (a), FESz and controls (b) and N200 and P300 values for all groups (Oa
Target
Control 1

Non-target before

Non-target after

CSz

Control 1

CSz

Control 1

CSz

-7.5(3.7)*
-7.1(3.6)*
4.2(2.4)*
106.6(14.9)
101.1(11.0)
98.7(12.9)
3.5(4.6)*
5.6(4.2)*
5.4(3.1)*
178.5(15.3)
174.9(16.7)*
178.5(21.3)*

-9.1(2.6)
-10.2(3.4)
-6.2(2.7)
105.2(16.1)
103.0(11.4)
101.8(12.1)
3.2(3.1)
5.8(2.9)
3.9(2.2)
201.9(27.7)
203.7(26.4)
192.1(28.9)

-5.6(4.2)*
-5.9(3.5)*
-3.5(2.1)*
104.9(12.6)
104.5(11.2)
100.7(16.5)
4.7(4.1)*
6.1(3.2)
5.4(2.9)
185.9(21.4)*
182.6(19.0)*
187.1(27.5)

-8.1(4.1)
-7.5(3.6)
-5.39(2.4)
100.5(12.7)
95.5(9.7)
98.6(13.0)
3.4(4.3)
5.2(3.5)
3.7(3.2)
199.7(26.4)
200.5(23.4)
199.5(26.0)

-6.2(4.5)
-5.9(3.2)1
-4.3(2.5)
105.7(16.8)
104.0(15.6)*
101.0(19.2)
3.9(3.6)
5.2(3.4)
3.5(2.7)
182.3(20.6)*
184.6(20.0)*
181.1(21.9)*

FESz
-5.9(3.6)*
-5.4(3.4)*
-3.9(3.1)
106.5(15.8)
97.1(15.0)
94.3(19.4)
2.3(4.7)*
4.0(4.5)
4.5(3.8)
168.4(13.9)
165.8(16.6)
158.1(25.2)

Control 2
-7.5(4.0)
-7.7(3.9)
-5.2(2.7)
110.7(20.3)
106.1(16.6 )
101.2(19.0)
1.5(3.9)
4.6(4.6)
3.5(3.6)
186.2(37.2)
184.2(31.2)
185.8(34.6)

FESz
-6.3(2.8)
-5.5(2.8)*
-4.0(2.5)*
105.6(19.1)
101.5(18.1)
98.8(18.8)
1.6(3.2)
3.8(3.4)
3.2(3.0)
188.7(29.9)
192.8(28.0)
194.7(33.0)

Control 2
-5.5(3.5)
-5.4(3.8)
-4.4(3.6)
106.9(17.5)
101.9(19.3)
100.1(16.4)
3.3(3.9)
5.8(4.4)
4.1(3.4)
185.4(20.3)
184.6(22.2)
184.6(23.2 )

FESz
-5.6(3.5)
-4.4(2.9)
-3.5(3.1)
113.5(31.7)
102.6(17.4)
95.2(18.0)
1.8(4.1)
3.0(3.9)*
2.2(3.0)1
181.6(25.5)
179.1(26.7)
172.2(31.7)

CSz
-3.9 ± 4.4
-1.7 ±4.8*
0.7 ± 3.4*
229.5 ± 21.6*
220.6 ± 18.2*
226.5 ± 17.1*
5.7 ± 5.9*
11.2 ± 7.0
15.1 ± 6.6*
315.5 ± 27.8
309.2 ± 32.6
327.4 ± 35.5

Control 2
-9.9 ± 5.6
-3.2 ± 7.2
1.1 ± 5.3
214.1 ± 18.9
209.3 ± 18.1
195.1 ± 29.9
10.4 ± 8.5
18.9 ± 10.6
25.2 ± 10.5
315.9 ± 28.8
316.0 ± 35.8
318.1 ± 27.6

FESz
-5.8 ± 4.6*
-0.9 ± 5.5
0.8 ± 4.4
222.5 ± 19.8
216.1 ± 21.6
204.9 ± 31.0
7.9 ± 7.7
13.3 ± 8.2*
17.7 ± 9.7*
320.4 ± 45.1
317.7 ± 38.5
325.4 ± 39.3

(a) N100 and P200 means for CSz and controls

N100 amp

N100 Lat

P200 amp

P200 lat

Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz

-10.2(3.0)
-11.4(3.8)
-6.6(3.1)
108.3(16.6)
103.1(13.2)
101.0(12.6)
0.8(3.7)
-0.4(4.7)
1.5(3.3)
172.4(16.1)
161.7(18.6)
163.2(17.4)

(b) N100 and P200 means for FESz and controls

N100 amp

N100 lat

P200 amp

P200 lat

Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz

Control 2
-10.6(4.1)
-9.3(4.5)
-4.8(2.7)
110.4(16.7)
104.5(12.2)
96.2(96.2)
-1.7(5.2)
1.7(6.2)
3.5(5.8)
171.9(17.3)
171.2(20.4)
160.8(31.7)

(c) N200 and P300 values for all groups

N2 Amp

N2 Lat

P3 Amp

P3 lat

a

Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz

Target
Control 1
-5.3 ± 3.6
-7.5 ± 5.9
-2.1 ± 4.3
209.8 ± 16.6
207.2 ± 13.1
203.8 ± 22.3
10.3 ± 6.3
11.9 ± 8.0
18.9 ± 6.6
316.3 ± 23.4
316.8 ± 23.7
328.0 ± 21.6

1

.P < 0.05, *P < 0.01, Bonferroni adjusted alpha level.

for the CSz group being reduced and latencies being delayed.
The reduction in N200 amplitude was prominent at both Cz
and Pz but not at the Fz site as indicated by the group X site
interactions, F(2, 77) = 10.15, P < 0.001. The CSz group
showed an overall reduced P300 amplitude demonstrated by
a significant main effect for group, F(1, 78) = 5.87, P < 0.05,
with the reduction being prominent in both Fz and Pz sites but
not at the Cz site as indicated by the site X group interaction
effect, F(1.82, 141.83) = 5.19, P < 0.01. There was also a
main effect for site, F(1.82, 141.83) = 105.60, P < 0.001,
with P300 amplitude maximal at Pz.

3.1.3.2. FESz vs. control. There was a significant

group X site interaction for N200, F(1.73) = 6.76,
P < 0.01, with the FESz group showing reduced N200
amplitude at Pc. The FESz group showed an overall
reduced P300 amplitude demonstrated by a significant
main effect for group, F(1,78) = 7.51, P < 0.01, with the
reduction being prominent at Cc and Pc sites as indicated by
the group X site interaction F(1.53) = 6.05, P < 0.01.
There was also a main effect for site,
F(1.53, 119.00) = 140.21,
P < 0.001,
with
P300
amplitude maximal at Pz.
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Table 2
Significant within-group differences for target (T), non-target before (Nt-b) and non-target after (Nt-a) stimuli'

N100 amp

N100 tat

P200 amp

P200 lat

a

Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz
Fz
Cz
Pz

P < 0.01 for all except for

1

Control 1

CSz

T
T
T
T
T

> Nt-a
> Nt-b > Nt-a
> Nt-a t
> Nt-a t
> Nt-a, Nt-b > Nt-a

T>Nt-b

T
T
T
T
T
T

<
<
<
<
<
<

Nt-b,
Nt-b,
Nt-b,
Nt-b,
Nt-b,
Nt-b,

T
T
T
T
T
T

<
<
<
<
<
<

Nt-a
Nt-a
Nt-a
Nt-a
Nt-a
Nt-a

Control 2

FESz

T > Nt-b > Nt-after
T > Nt-b > Nt-after

1

T < Nt-b and Nt-a, Nt-b < Nt-a
T < Nt-b 1 and Nt-a
T > Nt-a
T < Nt-a
T Nt-a l
T < Nt-b and Nt-a

T > Nt-a
1
T < Nt-b and Nt-b
1
T < Nt-a < Nt-b
T < Nt-b, Nt-a < Nt-b

indicates P < 0.05, Bonferroni adjusted alpha level.

3.1.3.3. CSz vs. FESz. For target P300 amplitude, significant

differences found between the two control groups (which
did not remain significant after effects of age were
partialled out) were not found between the CSz and FESz
groups. Thus, not only did the group with FESz show
reduced P300 amplitude when compared with their
controls, but also the age related differences in P300
amplitude that one might have expected to find when
compared with the CSz group were not apparent.
3.2. Discriminant function analysis
3.2.1. Stage 1
3.2.1.1. N100, P200. Stepwise discriminant analysis with
significant between group target and non-target variables
was able to accurately classify 85% of the CSz group and
77.5% of their control group, Wilk's A(3,78) = 0.51,
X2 =51.52, P < 0.001, using only the following variables,
with standardised canonical discriminant function coefficients in brackets: target P200 amplitude (0.50), Nt before
N100 amplitude (0.63) and Nt before P200 latency (-0.54).
For the FESz group this procedure accurately classified
77.5% of the clinical group and 75% of their controls,
Wilk's A(1,78) = 0.722, X2 = 25.30, P < 0.001, using
only target N100 amplitude (1.00).
3.2.1.2. P300. Stepwise discriminant analysis with all

midline P300 components was able to correctly identify
70% of the CSz group and 77.5% of their control group,
Wilk's A(3, 78) = 0.72, X2 = 25.32, P < 0.001, using P300
amplitude at Pc (1.03), Cc (-1.35) and Fz (1.01). Similarly,
72.5% of the FESz group and 57.5% of their controls,
Wilk's A(1,78) = 0.88, x2 = 10.235, P = 0.001, were
able to be correctly identified using P300 amplitude at Pc
(1.00).
3.2.1.3. All components. Stepwise discriminant analysis

using the variables from the analysis previously and
adding significant between group N200 variables (again so

as not to exceed the subject to variable ratio these were
limited to the maximal N200 site Fz) was able to
accurately classify 90% of the CSz group and 75% of
their controls, Wilk's A(4, 78) = 0.48, X2 =55.27,
P < 0.001, using Nt before N100 amplitude (0.51), Nt
before P200 latency (-0.50), target P300 amplitude
(-0.33) and target P200 amplitude (0.53). For the FESz
group 77.5% of the clinical group and 72.5% of their
controls, Wilk's A(2, 78) = 0.67, X2 =31.12, P < 0.001
using target N100 amplitude (0.85) and target P300
amplitude (-0.48). Discriminant analysis applying the
Fisher classification functions of the CSz group stepwise
analysis to the independent FESz group was not able to
classify better than chance, however, accurately classified
67.5%
of the FESL but only 28% of their controls, Pearson
2
X ( 1 , 7 9 ) = 0.17, P = 0.63.
3.2.2. Stage 2
3.2.2.1. N100, P200 difference scores. Stepwise discriminant analysis with difference scores based on within group
analysis (Table 2) were able to correctly identify 77.5% of
the CSz group and 70% of the controls, Wilk's
A(2, 78) = 0.64, x2 = 34.66, P < 0.001, using Nt after
minus target P200 amplitude (0.53) and Nt before minus
target P200 latency (0.68). Similarly, 75% of the FESz
group and 66.7% of their control group were able to be
classified using the same two variables, Nt after minus target
P200 amplitude (0.98) and Nt before minus target P200
latency (-0.68).
3.3. Reaction time

Both the CSz group (mean = 0.41 s, SD = 0.11) and the
FESz group (mean = 0.35 s, SD = 0.01), showed significandy slower reaction times (df = 78, P < 0.001 and
df = 78, P < 0.01, respectively) than their normal controls
(mean = 0.35 s, SD = 0.01; mean = 0.31 s, SD = 0.04).
There were no significant differences between the CSz
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and FESz groups, or the two control groups. Control groups
averaged 99.8% (1) and 99.9% (2) accuracy, with the CSz
group 93% and the FESz 96.2% accuracy.
4. Discussion
These results suggest that abnormalities in ERPs to both
target and non-target stimuli are evident at the onset of schizophrenia, trait-like and not due to secondary effects of chronic
morbidity, neuroleptics or institutionalisation. For both the
CSz and FESz groups the traditional averaged ERP to target
stimuli showed decreased N100, N200 and P300 amplitudes
and increased P200 amplitude when compared with their
controls. The reduced N100, N200 and P300 amplitudes are
consistent with the previous ERP studies with schizophrenia
(Ogura et al., 1991; Boutros et al., 1997; Brown et al., 2000)
and with the reduced P300 findings in the FESz studies (Salisbury et al., 1998; Hirayasu et al., 1998). Previous target P200
amplitude findings have been mixed, however, our increased
P200 amplitude finding replicates that of Ogura et al. (1991) in
an unmedicated sample. P200 amplitude has been reported to
reflect aspects of decision making or stimulus encoding
(McCarley et al., 1991).
There were some differences between the CSz and FESz
groups and their respective controls. While amplitude
disturbances were common to both groups, latency deficits
were specific to the chronic group who showed delayed
latencies for P200 and N200 components to targets and
earlier P200 latency for non-targets, with the FESz group
showing no significant difference in latency from their
control group. One possible explanation for this pattern of
results could be that the amplitude deficits observed manifest consequences of the disease itself, whereas the course of
illness may have effects on speed of processing specific
types of information. Considering latency impairments
seen in CSz were restricted to targets, this would suggest
that processing delays affected stimulus changes (infrequent
target stimuli) but not non-target stimuli. In addition, the
reduced P200 amplitude to Nt after stimuli found in the
FESz was not found in the CSz group. However, the degree
of similarity between the CSz and FESz groups is emphasised by their direct comparison, where no significant differences in ERP components remained after covarying for age.
Interestingly, the P300 decrement with age observed in
comparisons between the Normal control groups was not
observed in comparisons between CSz and FESz groups.
Among other interpretive possibilities, this pattern of results
may indicate that P300 amplitude deficits may be a more
sensitive index early in the schizophrenic process, and such
a pattern of results was observed in the dfa where the P300
amplitude deficits was one of only two valuable discriminators for FESz, whereas it was significant, but did not rate
that highly for the CSz group.
The disturbance in information processing is also elucidated by a comparison of within group analysis, where the
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controls have a pattern of significant differences between
targets and non-targets (smaller earlier P200 to targets vs.
increased delayed P200 to non-targets) while both CSz and
FESz groups failed to show this pattern (see Fig. 2 and Table
2). In the CSz group P200 amplitude and latency did not
vary significantly between target and non-target stimuli and
in the FESz, while they do show a shift in P200 latency
between target and non-target stimuli, the P200 amplitude
either does not vary significantly (Fz, Cz) or is increased
(Pz) (i.e. varies in the opposite direction to the controls). It
appears that the P200 amplitude and latency shift between
targets and non-targets found in the controls results mainly
from the overlap with the N200 components in ERPs to
target stimuli. Thus the large P200 amplitude component
normally elicited by non-target stimuli is foreshortened by
the negative shift for the N200 component in ERPs elicited
to target stimuli. It is possible that this does not occur to the
same extent in the CSz and FESz groups because their N200
and P300 components are reduced compared with controls
and so the N200 overlap is not so prominent in the P200
component which would contribute to the larger P200
amplitude to targets found in the CSz group when compared
with controls. We intend to use a new single trial method
developed by our lab (Melkonian et al., 2001) to tease out
the overlapping components to clarify this and investigate
among other questions, whether any P200 differences
remain when the effects of the overlap are removed.
The N100 component is correlated with specific aspects
of stimulus features (Pritchard, 1986; Naatanen and Picton,
1987) but may also reflect attention, being generally larger
with greater attentional requirements ( Maclean et al., 1975)
and is also affected by non-specific arousal (Rockstroh et al.,
1994). We found that, in addition to the overall reduction of
N100 amplitude in the CSz and FESz groups, they also
failed to show the distinct pattern of Nt before > Nt after
N100 amplitude found in the control groups. As the stimulus
features of the Nt after and Nt before stimuli are identical, it
is possible that the reduction in N100 amplitude to Nt after
stimuli found in normal controls, but not in patient participants, could be due to temporal recovery (as the Nt after
stimuli follow a target that requires a cognitive and motor
response) or to a reduced attentional requirement for Nt
after stimuli due to expectancy (the expectancy may occur
because, in this paradigm, a target stimuli is always
followed by a non-target). These two possibilities will be
further explored by averaging blocks of trials across the
paradigm and single trial analysis to see if the reduction
in Nt after N100 is consistent across the paradigm which
would indicate temporal recovery, or if decreases occur
across the course of the paradigm indicating the development of expectancy.
The patient group's diminished discrimination between
targets and non-targets (and also between Nt before and Nt
after) suggests that they are less flexible in differentiating
and processing target and inhibiting non-target information
than controls. This pattern of findings is consistent with
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Gray's (1998) model in which `misattributions' in the
match/mismatching of target: non-target information is
proposed to underlie the core positive symptoms in schizophrenia. A failure to develop an expectancy that a non-target
would follow a target could be further evidence of this
dysfunction and may be viewed, among other possibilities,
as a disturbance of implicit memory.
Compared with the P300 component, which has been the
focus of schizophrenia research, the N100, P200 components
acquired in response to both targets and non-targets gave a
more accurate classification for both the CSz group (improved
from 70 to 85%) and the FESz group (improved from 72.5 to
77.5%). Thus, the current study's emphasis on extending ERP
investigations to components other than P300 is vindicated.
The combination of N100 and P200 components derived from
Nt before stimuli and P300 components derived from target
stimuli produce the best classification rates for the CSz group,
whereas the best classification rates for the FESz group
involved the combination of N100 and P300 amplitudes
both derived from target stimuli.
Perceptual abnormalities are an early sign of the onset of
psychosis (Chapman, 1966) and the development of an
investigational means to assess this would be of great
importance. With the current emphasis on first episode
psychosis treatment on early identification and active treatment of young people at risk (McGlashan, 2000; McGlashan, 2001), an investigational means to help highlight risk
prior to a psychotic episode and track treatment progress is
important. For these purposes and to avoid unnecessary use
of antipsychotic medication it is imperative to be able to
correctly differentiate FESz from normal and other nonpsychotic controls. Forty-two and a half percent of the
controls would have been falsely classified as FESz using
the P300 component vs. 25% using the N100 and P200
components to both target and non-target stimuli.
Some final caveats should be mentioned here. In this
paper we limited our participants to those with a diagnosis
of FESz (for comparison with the chronic group and specificity to schizophrenia), we still need to analyse data we
have collected from first episode psychosis (FEP) patients
who attracted diagnoses other than FESz to see if these
findings are applicable across FEP. In addition, our data
indicate that these disturbances are present at the time of
the first episode, it is yet to be determined if they are present
prior to the first episode and also if they are specific to
psychosis when compared with other young clinical groups
(e.g. attention deficit hyperactivity disorder — ADHD).
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1
1.1

STUDY 1
N100 amplitude
Contrasts

Df (1,78)
Group
Group X Stimulus
Group X Site

T vs NT

Group X Stimulus X Site

T vs NT

Stimulus
Stimulus X Site

T vs NT
T vs NT

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Site

1.2

53.09
25.02
22.45
259.51
130.56

0.000
0.000
0.000
0.000
0.000

N100 latency
Contrasts

Df (1,78)
Group
Group X Stimulus
Group X Site
Group X Stimulus X Site

Stimulus
Stimulus X Site
Site

Sz vs Control
F
p
30.83
0.000
1.74
0.191
19.31
0.000
0.53
0.468
1.29
0.259
0.67
0.416

Cz vs Fz & Pz

Sz vs Control
F
p
2.88772 0.093242
9.761876 0.002502
0.087288 0.768439

Fz vs Pz
Cz vs Fz & Pz

1.587763
0.364497

0.211403
0.547771

Fz vs Pz

0.002516

0.960123

Cz vs Fz & Pz

2.90436
2.108543

0.092321
0.150489

Fz vs Pz
Cz vs Fz & Pz

16.19872
2.155114

0.000131
0.146117

Fz vs Pz

3.160987

0.079315

T vs NT

T vs NT

T vs NT
T vs NT
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1.3

P200 amplitude
Contrasts

Df (1,78)
Group
Group X Stimulus
Group X Site
Group X Stimulus X Site

T vs NT

T vs NT

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Stimulus
Stimulus X Site

T vs NT
T vs NT

Site

0.57

0.4529

Cz vs Fz & Pz

16.13
39.01

0.0001
0.0000

Fz vs Pz
Cz vs Fz & Pz

9.96
34.37

0.0023
0.0000

2.52

0.1165

Fz vs Pz

1.4

P200 latency
Contrasts

Df (1,78)
Group
Group X Stimulus
Group X Site

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Sz vs Control
F
p
5.16
18.77
0.10
0.42
3.32
0.34

0.026
0.000
0.749
0.521
0.072
0.559

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

53.24
1.69
0.11
2.15
6.34

0.000
0.197
0.736
0.146
0.014

T vs NT

Group X Stimulus X Site

T vs NT

Stimulus
Stimulus X Site

T vs NT
T vs NT

Site

Sz vs Control
F
p
5.25659 0.024559
19.80
0.0000
10.00
0.0022
0.83
0.3653
22.69
0.0000
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1.5

N200 amplitude

Df (1,78)
Group
Group X Site
Site

1.6

Site

Site

Contrasts
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Sz vs Control
F
p
7.18
0.01
1.82
0.11
7.55

0.009
0.919
0.181
0.742
0.007

Contrasts
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Sz vs Control
F
p
4.44
13.03
2.64
7.87
119.41

0.038
0.001
0.108
0.006
0.000

P300 latency

Df (1,77)
Group
Group X Site
Site

0.010
0.000
0.042
0.000
0.000

P300 amplitude

Df (1,77)
Group
Group X Site

1.8

Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Sz vs Control
F
p
6.88
18.97
4.29
18.12
39.52

N200 Latency

Df (1,78)
Group
Group X Site

1.7

Contrasts

Contrasts
Cz vs Fz & Pz
Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

Sz vs Control
F
p
1.83
0.88
2.75
5.68
11.68

0.181
0.351
0.101
0.020
0.001
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2

STUDY 2

2.1

Midline Site

2.1.1

N100 amplitude

Df (1,76)
Group
Group X Stimulus

Contrasts
Stimulus

Site

T vs NTs
T-1 vs T+1

Group X Site

Cz vs Fz & Pz
Fz vs Pz

Group X Stimulus X Site

Stimulus
Stimulus X Site

6.14

0.015

1.95

0.167

15.22

0.000

10.98

0.001

1.57

0.214

3.93

0.051

3.27

0.074

T-1 vs T+1

Fz vs Pz
Cz vs Fz & Pz
Fz vs Pz

0.72
11.44
0.01

0.398
0.001
0.905

31.32
1.11
0.90

0.000
0.295
0.345

Cz vs Fz & Pz

15.78
1.60
24.37

0.000
0.210
0.000

15.37
8.96
13.04

0.000
0.004
0.001

9.84

0.002

19.72

0.000

37.20

0.000

13.37

0.000

0.29

0.595

2.18

0.144

Cz vs Fz & Pz

140.28

0.000

25.86

0.000

Fz vs Pz

123.65

0.000

74.71

0.000

T vs NTs

5.57
2.78
0.07

0.021
0.100
0.792

3.90
0.73
0.11

0.052
0.396
0.743

T-1 vs T+1

0.31

0.578

0.01

0.915

Cz vs Fz & Pz

0.10

0.749

0.01

0.930

Fz vs Pz

0.07

0.787

1.32

0.254

Cz vs Fz & Pz

0.00

0.967

3.12

0.081

Fz vs Pz

0.02

0.886

0.31

0.579

Cz vs Fz & Pz

0.09

0.762

0.00

0.948

Fz vs Pz

0.31

0.579

0.01

0.932

T vs NTs

1.07

0.305

0.22

0.643

T-1 vs T+1

0.43

0.515

1.47

0.230

Cz vs Fz & Pz

1.17

0.283

1.09

0.299

Fz vs Pz

0.00

0.970

1.62

0.208

Cz vs Fz & Pz

8.57

0.005

0.18

0.673

Fz vs Pz

0.07

0.787

0.00

0.999

Cz vs Fz & Pz

0.00

0.957

0.08

0.776

Fz vs Pz

2.34

0.130

0.06

0.814

T vs NTs
T-1 vs T+1
T vs NTs

Group X Gender X Site
T vs NTs
T-1 vs T+1

T vs NTs
T-1 vs T+1

Gender X Site

0.003

0.001

Site

Gender X Stimulus X Site

9.61

12.76

Cz vs Fz & Pz
Fz vs Pz

Gender X Stimulus

0.253

Cz vs Fz & Pz

T-1 vs T+1

Grp X Gender X Stim X Site

1.33

FESz vs controls
F
p
6.45
0.013

T vs NTs

Fz vs Pz

Gender
Group X Gender
Group X Gender X Stimulus

Csz vs controls
F
p
30.08
0.000
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2.1.2

N100 amplitude/age correlation

T-1 N100 amplitude

control
r
-0.336

p
0.002

Schizophrenia
r
p
-0.114
0.316

T N100 amplitude

-0.287

0.010

-0.337

0.002

T+1 N100 amplitude

-0.238

0.034

-0.200

0.076

2.1.3

N100 amplitude? Symptom correlation

T-1CzN100 amplitute

TCzN100 amplitute

T+1CzN100 amplitute

2.1.4

Reality distortion
Psychomotor poverty
Disorganisation
Reality distortion
Psychomotor poverty
Disorganisation
Reality distortion
Psychomotor poverty
Disorganisation

CSz
r
0.12
0.07
0.42
0.24
0.07
0.36
0.17
0.16
0.36

p
0.47
0.7
0.01
0.16
0.68
0.03
0.3
0.36
0.03

FESz
r
0.26
0.29
0.4
0.02
0.13
0.22
-0.11
0.15
0.32

p
0.14
0.09
0.02
0.91
0.46
0.22
0.53
0.4
0.06

N100 latency
Contrasts

Df (1,76)

Stimulus

Site

Group
Group X Stimulus

Stimulus X Site

F

F

Sig.

Sig.

0.542

1.86

0.18

T vs NTs

2.79

0.099

0.17

0.68

T-1 vs T+1

2.65

0.108

0.65

0.42

Cz vs Fz & Pz

5.27

0.025

0.47

0.49

Fz vs Pz

0.26

0.610

0.09

0.77

Cz vs Fz & Pz

4.05

0.048

0.10

0.75

Fz vs Pz

0.21

0.651

3.01

0.09

Cz vs Fz & Pz

0.55

0.459

0.78

0.38

Fz vs Pz

0.42

0.519

0.18

0.67

T vs NTs

0.01

0.937

0.03

0.86

T-1 vs T+1

2.89

0.093

2.26

0.14

Cz vs Fz & Pz

1.47

0.229

0.15

0.70

Fz vs Pz

2.18

0.144

0.70

0.41

Cz vs Fz & Pz

1.82

0.181

0.81

0.37

Fz vs Pz

0.16

0.691

1.17

0.28

T vs NTs
T-1 vs T+1

Stimulus

FESz vs control

0.38

Group X Site
Group X Stimulus X Site

CSz vs control

T vs NTs
T-1 vs T+1
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Site

Cz vs Fz & Pz

1.05

0.310

0.91

0.34

16.95

0.000

26.76

0.0000

T vs NTs

5.39
0.02
0.83

0.023
0.885
0.365

0.55
0.46
0.80

0.46
0.50
0.37

T-1 vs T+1

0.23

0.634

0.46

0.50

Cz vs Fz & Pz

3.02

0.086

0.72

0.40

Fz vs Pz

0.11

0.739

0.48

0.49

Cz vs Fz & Pz

0.03

0.859

0.02

0.88

Fz vs Pz

0.12

0.732

1.70

0.20

Cz vs Fz & Pz

0.19

0.661

0.14

0.71

Fz vs Pz

1.51

0.223

0.01

0.90

T vs NTs

7.46

0.008

0.55

0.46

T-1 vs T+1

0.09

0.766

1.36

0.25

Cz vs Fz & Pz

4.05

0.048

1.15

0.29

Fz vs Pz

0.90

0.345

0.00

0.98

Cz vs Fz & Pz

0.47

0.497

0.23

0.63

Fz vs Pz

4.96

0.029

0.00

0.98

Cz vs Fz & Pz

3.15

0.080

0.48

0.49

Fz vs Pz

1.25

0.268

0.72

0.40

Fz vs Pz
Gender
Group X Gender
Group X Gender X Stimulus
Group X Gender X Site
Group X Gender X Stimulus X Site

T vs NTs
T-1 vs T+1

Gender X Stimulus
Gender X Stimulus X Site

T vs NTs
T-1 vs T+1

Gender X Site

2.1.5

N100 latency/age correlations

T-1 N100 latency
T N100 latency
T+1 N100 latency

control
r
-0.08

0.5

Schizophrenia
r
p
0.07

0.51

0.07

0.56

0.18

0.11

-0.16

0.16

0.1

0.37

p
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2.1.6

N100 latency/symptom correlations
CSz
r

T-1CzN100 latency

TCzN100 latency

T+1CzN100 latency

2.1.7

Reality distortion
Psychomotor poverty
Disorganisation
Reality distortion
Psychomotor poverty
Disorganisation
Reality distortion
Psychomotor poverty
Disorganisation

0.01
0.02
0.12
0.01
-0.06
0.05
-0.01
-0.1
-0.09

p
0.96
0.89
0.49
0.93
0.73
0.76
0.96
0.57
0.6

FESz
r
-0.13
0.08
0.13
0.15
0.01
0.28
-0.19
-0.01
-0.12

p
0.48
0.66
0.46
0.4
0.94
0.12
0.28
0.94
0.49

P200 amplitude
Contrasts

Df (1,76)

Stimulus

Site

Group
Group X Stimulus

24.98

0.000

5.45

0.022

0.48

0.489

3.90

0.052

Cz vs Fz & Pz

3.62

0.061

2.62

0.109

Fz vs Pz

0.36

0.548

4.36

0.040

18.87

0.000

0.67

0.415

Fz vs Pz

3.60

0.062

3.98

0.050

Cz vs Fz & Pz

0.42

0.519

0.97

0.328

Fz vs Pz

0.57

0.452

0.01

0.935

12.35

0.001

0.88

0.352

2.26

0.137

0.48

0.493

25.17

0.000

3.81

0.055

Fz vs Pz

7.54

0.008

12.78

0.001

Cz vs Fz & Pz

3.62

0.061

0.53

0.471

Fz vs Pz

0.16

0.693

5.51

0.022

57.16

0.000

47.79

0.000

4.11

0.046

33.63

0.000

T vs NTs

1.94
0.19
0.63

0.168
0.666
0.431

0.50
0.79
3.10

0.481
0.376
0.082

T-1 vs T+1

0.27

0.605

0.45

0.503

Cz vs Fz & Pz

1.06

0.307

0.02

0.883

Fz vs Pz

2.12

0.149

0.01

0.934

Cz vs Fz & Pz

0.55

0.459

0.04

0.836

T vs NTs

T vs NTs

Cz vs Fz & Pz

T vs NTs
T vs NTs
T-1 vs T+1

Site

Cz vs Fz & Pz

Cz vs Fz & Pz
Fz vs Pz

Group X Gender X Stimulus X Site

p
0.675

T-1 vs T+1

Gender
Group X Gender
Group X Gender X Stimulus

F

p

0.18

T-1 vs T+1

Stimulus X Site

F

0.001

Group X Site

Stimulus

FESz vs. control

12.21
T-1 vs T+1

Group X Stimulus X Site

CSz vs. control

T vs NTs
T-1 vs T+1
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Fz vs Pz

2.18

0.144

0.00

0.949

Cz vs Fz & Pz

0.38

0.537

0.03

0.868

Fz vs Pz

1.43

0.235

0.46

0.498

T vs NTs

8.83

0.004

1.06

0.306

T-1 vs T+1

0.90

0.346

0.00

0.982

Cz vs Fz & Pz

4.73

0.033

1.65

0.203

Fz vs Pz

0.11

0.736

0.10

0.753

Cz vs Fz & Pz

8.32

0.005

0.53

0.469

Fz vs Pz

0.12

0.726

0.07

0.798

Cz vs Fz & Pz

1.91

0.171

0.06

0.805

Fz vs Pz

3.54

0.064

0.07

0.788

Group X Gender X Site
Stimulus X Gender
Gender X Stimulus X Site

T vs NTs
T-1 vs T+1

Gender X Site

2.1.8

P200 amplitude/age correlations

T-1 P200 amplitude

control
r
0.11

T P200 amplitude
T+1 P200 amplitude

2.1.9

0.33

Schizophrenia
r
p
0.22

0.05

-0.16

0.16

0.14

0.2

0.07

0.56

0.24

0.03

p

P200 amplitude/ symptom correlations

T-1CzP200 amplitute

TCzP200 amplitute

T+1CzP200 amplitute

Reality distortion
Psychomotor poverty
Disorganisation
Reality distortion
Psychomotor poverty
Disorganisation
Reality distortion
Psychomotor poverty
Disorganisation

CSz
r
-0.14
-0.21
-0.02
0.14
0.17
0.2
0.09
0.25
0.05

p
0.42
0.2
0.91
0.39
0.31
0.23
0.6
0.14
0.77

FESz
r
0.01
0.09
0.06
-0.02
-0.1
-0.03
-0.15
-0.29
-0.12

p
0.96
0.59
0.74
0.93
0.58
0.86
0.39
0.09
0.5

2.1.10 P200 latency
Contrasts
Df(1,76)

Stimulus

Site

Group
Group X Stimulus

FESz vs control

F

F

Sig.

Sig.

5.62

0.020

0.00

0.994

40.50

0.000

3.72

0.058

0.02

0.886

0.73

0.395

Cz vs Fz & Pz

0.04

0.845

0.29

0.590

Fz vs Pz

0.74

0.394

0.03

0.871

T vs NTs
T-1 vs T+1

Group X Site

CSz vs control
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Group X Stimulus X Site

T vs NTs

Cz vs Fz & Pz

3.88

0.053

0.02

0.881

Fz vs Pz

0.36

0.548

1.00

0.321

Cz vs Fz & Pz

0.90

0.345

0.01

0.936

Fz vs Pz

2.09

0.153

0.18

0.677

65.18

0.000

32.95

0.000

0.01

0.926

1.76

0.189

15.51

0.000

2.28

0.135

Fz vs Pz

0.09

0.762

4.30

0.042

Cz vs Fz & Pz

0.08

0.784

0.00

0.959

Fz vs Pz

3.43

0.068

1.43

0.236

Cz vs Fz & Pz

0.02

0.892

0.62

0.433

Fz vs Pz

4.37

0.040

2.45

0.121

T vs NTs

0.50
0.14
4.67

0.482
0.707
0.034

2.45
0.81
0.30

0.121
0.372
0.586

T-1 vs T+1

0.54

0.465

0.10

0.755

Cz vs Fz & Pz

5.54

0.021

5.22

0.025

Fz vs Pz

2.55

0.114

2.24

0.139

Cz vs Fz & Pz

2.42

0.124

0.21

0.646

Fz vs Pz

1.81

0.183

1.56

0.216

Cz vs Fz & Pz

3.64

0.060

0.06

0.806

Fz vs Pz

4.32

0.041

0.46

0.498

T vs NTs

0.42

0.517

1.74

0.191

T-1 vs T+1

0.04

0.847

4.15

0.045

Cz vs Fz & Pz

0.00

0.960

0.17

0.679

Fz vs Pz

0.04

0.848

0.22

0.638

Cz vs Fz & Pz

0.05

0.820

0.84

0.362

Fz vs Pz

0.94

0.336

0.94

0.336

Cz vs Fz & Pz

1.03

0.314

0.66

0.419

Fz vs Pz

1.13

0.291

1.04

0.312

T-1 vs T+1

Stimulus

T vs NTs
T-1 vs T+1

Stimulus X Site

T vs NTs

Cz vs Fz & Pz

T-1 vs T+1

Site

Gender
Group X Gender
Group X Gender X Stimulus
Group X Gender X Stimulus X Site

T vs NTs
T-1 vs T+1

Group X Gender X Site
Stimulus X Gender
Gender X Stimulus X Site

T vs NTs
T-1 vs T+1

Gender X Site

2.1.11 P200 latency/age correlation

T-1 P200 latency
T P200 latency

control
r
0.32
-0.07

p
0
0.53

Schizophrenia
r
p
-0.15
0.23

0.17
0.04
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T+1 P200 latency

0.27

0.01

0.12

0.31

2.1.12 P200 latency/symptom correlation

T-1CzN100
latency

TCzN100 latency

T+1CzN100
latency

Reality distortion
Psychomotor
poverty
Disorganisation
Reality distortion
Psychomotor
poverty
Disorganisation
Reality distortion
Psychomotor
poverty
Disorganisation

CSz
r
-0.33

0.05

FESz
r
-0.26

-0.2

0.23

0.09

0.61

-0.17
-0.1
-0.13

0.32
0.55
0.44

0.02
0.12
0.14

0.91
0.5
0.45

-0.13
0.08

0.43
0.66

0.1
0.02

0.59
0.89

-0.12

0.49

0

0.99

0.15

0.37

0.02

0.9

p

p
0.14

2.1.13 N200 amplitude

Df (1,76)CSz, (1,75) FESz
Group
Group X Site

Contrasts
Cz vs Fz & Pz
Fz vs Pz

Site

Gender
Group X Gender
Group X Gender X Site
Gender X Site

CSz vs control
F
Sig.
17.98
0.0001
19.80
0.0000

FESz vs control
F
Sig.
2.52
0.1170
0.32
0.5742

0.86

0.3576

10.58

0.0017

Cz vs Fz & Pz

20.90

0.0000

10.73

0.0016

Fz vs Pz

60.71

0.0000

132.95

0.0000

Cz vs Fz & Pz

7.60
0.49
0.06

0.0073
0.4859
0.8149

0.00
0.14
0.39

0.9531
0.7135
0.5350

Fz vs Pz

4.39

0.0396

0.71

0.4026

Cz vs Fz & Pz

0.42

0.5184

0.06

0.8101

Fz vs Pz

2.33

0.1309

1.07

0.3033
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2.1.14 N200 amplitude/ age correlations

2.1.15 N200 amplitude/ symptom correlations

2.1.16 N200 latency

Contrasts
Df (1,76)CSz, (1,75)FESz
Group
Group X Site

Site

Cz vs Fz & Pz

Gender X Site

FESz vs. controls
F
Sig.
2.49
0.1191
0.10
0.7575

Fz vs Pz

0.01

0.9355

0.00

0.9956

Cz vs Fz & Pz

4.52

0.0368

2.11

0.1504

152.75

0.0000

24.20

0.0000

Cz vs Fz & Pz

2.78
0.07
0.40

0.0997
0.7878
0.5301

1.03
0.20
0.47

0.3136
0.6556
0.4949

Fz vs Pz

2.90

0.0927

0.23

0.6357

Cz vs Fz & Pz

0.29

0.5895

1.44

0.2337

Fz vs Pz

0.00

0.9609

0.08

0.7817

Fz vs Pz
Gender
Group X Gender
Group X Gender X Site

CSz vs. controls
F
Sig.
5.25
0.0248
11.89
0.0009

2.1.17 P300 amplitude

DF (1,76)
Group
Group X Site

Site

Contrasts
Cz vs Fz & Pz

Gender X Site

FESz vs control
F
p
5.31
0.0240
0.47
0.4941

Fz vs Pz

0.01

0.9355

4.38

0.0396

Cz vs Fz & Pz

4.52

0.0368

1.83

0.1801

152.75

0.0000

148.54

0.0000

Cz vs Fz & Pz

2.78
0.07
0.40

0.0997
0.7878
0.5301

0.04
0.20
0.01

0.8451
0.6550
0.9035

Fz vs Pz

2.90

0.0927

1.15

0.2868

Cz vs Fz & Pz

0.29

0.5895

0.01

0.9285

Fz vs Pz
Gender
Group X Gender
Group X Gender X
Site

CSz vs control
F
p
5.25
0.0248
11.89
0.0009
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Fz vs Pz

0.00

0.9609

0.92

0.3403

2.1.18 P300 latency
CSz vs control
DF (1,76)
Group
Group X Site

Site

Gender
Group X Gender
Group X Gender X Site
Gender X Site

FESz vs control

Contrasts
Cz vs Fz & Pz

0.18
3.18

0.6705
0.0786

0.41
1.72

0.526
0.194

Fz vs Pz

0.05

0.8317

0.76

0.387

Cz vs Fz & Pz

14.71

0.0003

1.24

0.269

Fz vs Pz

10.15

0.0021

1.25

0.268

Cz vs Fz & Pz

0.61
0.27
1.15

0.4367
0.6100
0.2875

0.01
0.02
1.71

0.936
0.883
0.194

Fz vs Pz

0.90

0.3447

1.93

0.169

Cz vs Fz & Pz

0.08

0.7738

0.01

0.915

Fz vs Pz

0.48

0.4922

0.49

0.487

2.1.19 Age/ERP correlations
Combined control
groups

Combined
Schizophrenia
groups
AGE

AGE
T-1CzN100 amplitude
T-1CzN100 latency
T-1CzP200 amplitude
T-1CzP200 latency
TCzN100 amplitude
TCzN100 latency
TCzP200 amplitude
TCzP200 latency

Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation

-0.34
0.00
-0.08
0.50
0.11
0.33
0.32
0.00
-0.29
0.01
0.07
0.56
-0.16
0.16
-0.07

-0.11
0.32
0.07
0.51
0.22
0.05
-0.15
0.17
-0.34
0.00
0.18
0.11
0.14
0.20
0.23
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TFzN200 amplitude
TFzN200 latency
TPzP300 amplitude
TPzP300 latency
T+1CzN100 amplitude
T+1CzN100 latency
T+1CzP200 amplitude
T+1CzP200 latency

Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed
Pearson Correlation
Sig. (2-tailed

0.53
0.44
0.00
0.01
0.91
-0.39
0.00
0.20
0.07
-0.24
0.03
-0.16
0.16
0.07
0.56
0.27
0.01

0.04
0.21
0.06
0.18
0.10
-0.22
0.05
0.02
0.86
-0.20
0.08
0.10
0.37
0.24
0.03
0.12
0.31

2.1.20 Symptom/ERP correlations

T-1CzN100 amplitute
T-1CzN100 latency
T-1CzP200 amplitude
T-1CzP200 latency
TCzN100 amplitute
TCzN100 latency
TCzP200 amplitude

Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)

chronic schizophrenia
RD
PP
D
0.12
0.07
0.47
0.70
0.01
0.02
0.96
0.89
-0.14
-0.21
0.42
0.20
-0.33
-0.20
0.05
0.23
0.24
0.07
0.16
0.68
0.01
-0.06
0.93
0.73
0.14
0.17
0.39
0.31

0.42
0.01
0.12
0.49
-0.02
0.91
-0.17
0.32
0.36
0.03
0.05
0.76
0.20
0.23

first episode schizophrenia
RD
PP
D
0.26
0.29
0.14
0.09
-0.13
0.08
0.48
0.66
0.01
0.09
0.96
0.59
-0.26
0.09
0.14
0.61
0.02
0.13
0.91
0.46
0.15
0.01
0.40
0.94
-0.02
-0.10
0.93
0.58

0.40
0.02
0.13
0.46
0.06
0.74
0.02
0.91
0.22
0.22
0.28
0.12
-0.03
0.86
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TCzP200 latency
TFzN200 amplitude
TFzN200 latency
TPzP300 amplitude
TPzP300 latency
T+1CzN100 amplitute
T+1CzN100 latency
T+1CzP200 amplitude
T+1CzP200 latency

2.2

Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)

-0.10
0.55
0.22
0.20
0.03
0.86
0.19
0.25
-0.09
0.58
0.17
0.30
-0.01
0.96
0.09
0.60
0.08
0.66

-0.13
0.44
-0.08
0.64
-0.01
0.97
0.07
0.66
-0.12
0.47
0.16
0.36
-0.10
0.57
0.25
0.14
-0.12
0.49

-0.13
0.43
-0.11
0.52
0.19
0.25
0.15
0.37
0.05
0.77
0.36
0.03
-0.09
0.60
0.05
0.77
0.15
0.37

0.12
0.50
-0.07
0.69
-0.03
0.88
-0.16
0.37
-0.07
0.70
-0.11
0.53
-0.19
0.28
-0.15
0.39
0.02
0.89

0.14
0.45
-0.03
0.84
0.00
0.98
-0.20
0.26
-0.10
0.56
0.15
0.40
-0.01
0.94
-0.29
0.09
0.00
0.99

Topography

2.2.1

N100 amplitude

2.2.1.1 Hemisphere (left/right)

Df (1,60) CSz, (1,59) FESz
Group
Group X Hemisphere
Group X Stimulus

Stimulus

Hemisphere
L vs R

T vs NTs
T-1 vs T+1

Group X Hem X Stim

Hemisphere
Stimulus

Chronic Sz
F
p
21.101
0.000
1.696
0.198
0.687
0.411

FESz
F
12.970
0.812
17.313

p
0.001
0.371
0.000

1.098

0.299

0.992

0.323

T vs NTs

L vs R

2.346

0.131

0.021

0.886

T-1 vs T+1

L vs R

0.014

0.905

0.169

0.683

L vs R

0.768
28.356

0.384
0.000

0.106
12.157

0.746
0.001

7.554

0.008

15.695

0.000

T vs NTs
T-1 vs T+1

0.10
0.59
-0.02
0.92
0.07
0.68
-0.26
0.14
0.01
0.95
0.32
0.06
-0.12
0.49
-0.12
0.50
0.02
0.90
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Hemisphere X Stimulus

T vs NTs

L vs R

0.000

0.986

3.383

0.071

T-1 vs T+1

L vs R

10.506

0.002

0.532

0.469

FESz
F
11.500
5.108
12.448

Sig.
0.001
0.027
0.001

2.2.1.2 Region (anterior/posterior)

Df (1,60) C&FESz
Group
Group X Region
Group X Stimulus

Stimulus

Region
A vs P

T vs NTs

Chronic Sz
F
Sig.
22.330
0.000
2.047
0.158
0.873
0.354

T-1 vs T+1
Grp X Reg X Stim

Region
Stimulus

0.529

0.470

A vs P

1.050

0.310

19.612

0.000

T-1 vs T+1

A vs P

1.239

0.270

1.077

0.303

A vs P

97.062
16.762

0.000
0.000

100.750
7.611

0.000
0.008

4.438

0.039

5.659

0.021

T-1 vs T+1

2.2.2

0.382

T vs NTs

T vs NTs

Region X Stim

0.775

T vs NTs

A vs P

7.185

0.009

28.445

0.000

T-1 vs T+1

A vs P

0.040

0.843

0.118

0.732

N100 latency

2.2.2.1 Hemisphere (left/right)

Df (1,60) CSz, (1,59) FESz
Group
Group X Hemisphere
Group X Stimulus

STIMULI
1,60

HEM
L vs R

T vs NTs
T-1 vs T+1

Group X Hem X Stim

Hemisphere
Stimulus
Hemisphere X Stimulus

CSz
F
0.824
0.413
1.289

0.368
0.523
0.261

FESz
F
4.552
1.275
1.347

0.376

0.542

0.200

0.657

p

p.
0.037
0.263
0.250

T vs NTs

L vs R

0.819

0.369

1.139

0.290

T-1 vs T+1

L vs R

0.040

0.843

0.001

0.974

L vs R
T vs NTs

3.752
4.573

0.057
0.037

0.245
0.103

0.622
0.749

T-1 vs T+1

4.254

0.044

4.637

0.035

T vs NTs

L vs R

0.081

0.777

0.592

0.445

T-1 vs T+1

L vs R

2.329

0.132

1.814

0.183
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2.2.2.2 Region (anterior/posterior)
Df (1,60) C & FESz
Group
Group X Region
Group X Stimulus
Grp X Reg X Stim

Region
Stimulus

Stimulus

Region

T vs NTs

0.461
2.538
1.442

0.500
0.116
0.235

2.941
0.009
0.143

Sig.
0.092
0.924
0.707

T-1 vs T+1

0.176

0.676

1.544

0.219

A vs P

2.2.3

Sig.

F

T vs NTs

A vs P

0.122

0.728

2.031

0.159

T-1 vs T+1

A vs P

1.290

0.261

1.107

0.297

A vs P

9.768
4.921
1.012

0.003
0.030
0.319

34.976
4.706
1.038

0.000
0.034
0.312

T vs NTs

A vs P

11.511

0.001

2.448

0.123

T-1 vs T+1

A vs P

0.948

0.334

5.777

0.019

T vs NTs
T-1 vs T+1

Region X Stim

F

P200 amplitude

2.2.3.1 Hemisphere (left/right)

Df (1,59)CSz, (1,56) FESz
Group
Group X Hemisphere
Group X Stimulus

Contrasts
Stimulus

Hemisphere
L vs R

T vs NTs
T-1 vs T+1

Group X Hem X Stim

Hemisphere
Stimulus

FESz vs control
F
p
0.84
0.363
0.75
0.390
3.35
0.072

1.11

0.297

3.50

0.067

T vs NTs

L vs R

0.00

0.971

0.22

0.643

T-1 vs T+1

L vs R

0.09

0.759

0.05

0.828

L vs R

0.05
25.87

0.818
0.000

2.04
3.13

0.159
0.082

0.31

0.580

0.91

0.343

T vs NTs
T-1 vs T+1

Hemisphere X Stimulus

CSz vs control
F
p
9.34
0.003
0.00
0.947
1.34
0.251

T vs NTs

L vs R

3.16

0.081

0.00

0.949

T-1 vs T+1

L vs R

10.70

0.002

5.47

0.023
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2.2.3.2

Region (anterior/posterior)

Df (1,59) C & FESz
1,59
Group
Group X Region
Group X Stimulus
Grp X Region X Stimulus

Region
Stimulus
Region X Stim

2.2.4

Contrast
Stimulus
Region

T vs NT
T-1 vs T+1
T vs NT
T-1 vs T+1

T vs NT
T-1 vs T+1
T vs NT
T-1 vs T+1

A vs P
A vs P
A vs P

CSz vs control
F
p
8.82
0.01
0.30
0.10
0.25
1.08

A vs P
A vs P
A vs P
A vs P
A vs P

5.68
2.86
3.47
12.01
0.21

0.004
0.927
0.588
0.755
0.618
0.303
0.020
0.096
0.067
0.001
0.648

FESz vs control
F
p
0.437
0.511167
3.10
0.083
3.50
0.066
2.12
0.151
0.38
0.542
0.60
0.443
35.49
0.05
0.12
4.62
0.78

0.000
0.830
0.735
0.036
0.380

P200 latency

2.2.4.1 Hemisphere
Df (1,59)CSz, (1,56) FESz
Group
Group X Hemisphere
Group X Stimulus
Group X Hemisphere X Stimulus

Hemisphere
Stimulus
Hemisphere X Stimulus

Contrasts
Stimulus
Hemisphere
L vs R
T vs NT
T-1 vs T+1
T vs NT
T-1 vs T+1

L vs R
L vs R
L vs R

T vs NT
T-1 vs T+1
T vs NT
T-1 vs T+1

L vs R
L vs R

CSz vs control
F
Sig.
8.701195 0.004554
4.67
0.035
20.27
0.000
2.89
0.094
0.57
0.454
0.35
0.555
0.28
45.89
2.01
3.38
0.03

0.599
0.000
0.161
0.071
0.865

FESz vs control
F
p
2.61
0.112
0.99
0.325
2.79
0.100
4.65
0.035
0.60
0.441
0.32
0.575
4.30
10.16
29.15
3.86
0.42

2.2.4.2 Region
Df(1,59) C & FESz

Contrasts

CSz vs control

FESz vs control

0.043
0.002
0.000
0.055
0.518
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Stimulus
Group
Group X Region
Group X Stimulus

Region
A vs P

T vs NTs
T-1 vs T+1

Group X Region X Stimulus

Region
Region X Stimulus
Stimulus

p

F

p

7.77
0.82
17.38

0.007
0.370
0.000

3.17
1.47
2.48

0.080
0.230
0.121

2.13

0.150

4.13

0.047

T vs NTs

A vs P

6.49

0.013

3.82

0.055

T-1 vs T+1

A vs P

1.68

0.201

0.08

0.775

T vs NTs

A vs P
A vs P

10.36
3.41

0.002
0.070

10.86
4.45

0.002
0.039

T-1 vs T+1

A vs P

0.01

0.904

0.62

0.435

46.14

0.000

25.21

0.000

2.27

0.137

11.45

0.001

T vs NTs
T-1 vs T+1

2.2.5

F

N200 and P300 components

2.2.5.1 Hemisphere (left/right) and region (anterior/posterior)

N200
anplitude

N200 latency

P300
amplitude

P300 latency

Source
Hemisphere
Group
Hemisphere X Group
Region
Group
Region X Group
Hemisphere
Group
Hemisphere X Group
Region
Region X Group
Hemisphere
Group
Hemisphere X Group
Region
Region X Group
Hemisphere

Contrast
L vs R
L vs R
A vs P
A vs P
L vs R
L vs R
A vs P
A vs P
L vs R
L vs R
A vs P
A vs P
L vs R

Csz vs control
df
F
1,70
0.01
0.15
0.74
1,70
23.44
0.05
11.59
1,70
1.69
21.89
0.02
1,70
12.07
0.05
1,70
0.04
12.24
1.31
1,70
153.28
0.45
1,70
1.76

p
0.906
0.700
0.393
0.000
0.821
0.001
0.198
0.000
0.895
0.001
0.822
0.844
0.001
0.257
0.000
0.506
0.189

FESz vs control
df
F
p
1,59
4.33 0.042
1.44 0.235
0.10 0.755
1,60
88.80 0.000
0.80 0.314
4.36 0.041
1,59
0.00 0.979
5.32 0.025
5.38 0.024
1,60
88.80 0.000
4.36 0.041
1,63
0.39 0.535
2.5 0.117
0.04 0.843
1,63 160.18 0.000
4.97 0.029
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1,70

0.35
1.22
11.66
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P300 Amplitude

Df(1,26)
Group
Group X DR

Contrasts
DR

Group X DR X Site

Linear
Quadratic

DR
DR X Site

Site

Linear
Quadratic

Group X Site

Linear
Quadratic
Linear
Quadratic

Site

L vs R
A vs P
A vs P

Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

FESz vs controls
F
p
0.16
0.690
2.13
0.156
0.08
0.780
2.93
0.099
0.06
0.816
0.04
0.838
1.10
0.304
0.50
0.485
0.47
0.500
29.40
8.05
13.90
0.26
0.16
0.02
82.73
20.47

0.000
0.009
0.001
0.614
0.692
0.889
0.000
0.000

0.553
0.274
0.001
0.057

1,63

4.53
3.43
0.85
0.40

0.037
0.069
0.360
0.530
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P300 latency

Df(1,26)

Contrasts
DR

Group
DR

Linear
Quadratic
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Quadratic

Group X DR
Group X Site
Group X DR X Site

Linear
Quadratic

DR X Site

Linear
Quadratic
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Linear
Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

FESz vs controls
F
Sig.
1.10
0.303
2.18
0.152
0.33
0.573
1.70
0.204
0.26
0.612
1.13
0.298
0.12
0.735
2.52
0.125
5.83
0.023
0.20
0.658
3.63
0.068
2.41
0.133
1.55
0.224
11.50
0.002
0.97
0.333
0.36
0.555
0.19
0.666

RT

Df(1,26)
Group
DR

Contrasts

F

Linear
Quadratic
Linear
Quadratic

DR X Group

3.2

Site

p
0.21
0.36
0.19
0.14
0.59

0.061
0.552
0.664
0.708
0.448

DA

3.2.1
Df(1,26)
Group
DA
Group X DA
Group X Site

P300 amplitude
Contrasts
DR

Site

Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

FESz vs controls
F
Sig.
0.26
0.613
0.01
0.917
0.00
0.958
1.82
0.189
0.29
0.597
1.63
0.213
1.42
0.245
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Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

0.03

0.859

0.02
0.13
1.14
0.32
0.02
0.01
0.48
38.60
17.22

0.888
0.726
0.296
0.574
0.884
0.905
0.493
0.000
0.000

P300 Latency

Df(1,26)

Contrasts
DA

Group
DA

Site

Linear
Quadratic
Linear
Quadratic

Group X DA
Group X Site
Group X DA X
Site

Linear
Quadratic

DA X Site

Linear
Quadratic
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Linear

RT

Linear
Quadratic
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Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

FESz vs control
F
p
0.12
0.732
1.00
0.326
0.30
0.591
2.41
0.133
3.91
0.059
0.19
0.669
1.31
0.262
0.30
0.591
0.14
10.28
0.03
6.67
0.01
0.46
0.14
0.51
2.96

0.715
0.004
0.870
0.016
0.915
0.504
0.711
0.480
0.097
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GROUP
DA

Contrasts
Linear
Quadratic
Linear
Quadratic

Group X DA

3.3

3.3.1

FESz vs control
F
p
1.83
0.188
8.89
0.006
7.59
0.011
0.04
0.848
0.53
0.472

Continuing (NN, TT) and discontinuing (TN, NT) series.

P300 amplitude

Df (1,26)
Group
Sequence
Stimulus

Contrasts
Sequence

Stimulus

Site

cont vs discont
T vs N

Group X Sequence
Group X Stimulus
Group X Site

cont vs discont

Group X Sequence X Stimulus
Group X Sequence X Site

cont vs discont
cont vs discont

Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

0.00
3.83
0.06
0.07
0.17
1.22
2.37
2.13
0.11
0.26
4.12

0.983
0.061
0.808
0.788
0.686
0.280
0.136
0.157
0.742
0.615
0.053

Linear
Quadratic
Linear
Quadratic

3.63
0.57
0.00
1.12
3.47

0.068
0.456
0.980
0.300
0.074

T vs N
Linear
Quadratic

Group X Stimulus X Site

T vs N

T vs N

Group X Sequence X Stimulus X Site

cont vs discont

T vs N

Sequence X Stimuli
Sequence X Site

cont vs discont
cont vs discont

T vs N

Sequence X Stimulus X Site

cont vs discont

T vs N

FESz vs Controls
F
p
3.06
0.092
1.21
0.282
0.07
0.793
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T vs N

Site
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4.54
0.47
47.41
0.01

0.043
0.498
0.000
0.916

N100 amplitude

Df (1,26)
Group
Sequence
Stimulus

Contrasts
SEQ

STIM

T vs N
cont vs discont

Group X Sequence X Stimulus
Group X Sequence X Site

cont vs discont
cont vs discont

Linear
Quadratic
Linear
Quadratic
Linear
Quadratic

0.983
0.061
0.808
0.788
0.686
0.280
0.136
0.157
0.742
0.615
0.053

Linear
Quadratic
Linear
Quadratic
Linear
Quadratic
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3.63
0.57
0.00
1.12
3.47
4.54
0.47
47.41

0.068
0.456
0.980
0.300
0.074
0.043
0.498
0.000

Linear
Quadratic
T vs N

T vs N

Group X Sequence X Stimulus X Site

cont vs discont

T vs N

Sequence X Stimuli
Sequence X Site

cont vs discont
cont vs discont

T vs N

Sequence X Stimulus X Site

cont vs discont

T vs N
T vs N

FESz vs Controls
F
Sig.
3.06
0.092
1.21
0.282
0.07
0.793
0.00
3.83
0.06
0.07
0.17
1.22
2.37
2.13
0.11
0.26
4.12

T vs N

Group X Stimulus X Site

Stimulus X Site

SITE

cont vs discont

Group X Sequence
Group X Stimulus
Group X Site

Site

Linear
Quadratic
Linear
Quadratic
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N100 amplitude

Stimulus

Site

Group
Grp X Stim

0.02

0.30

0.589

T vs NTs

9.96

0.003

0.27

0.605

T-1 vs T+1

1.79

0.187

0.77

0.385

Cz vs Fz & Pz

4.33

0.042

0.86

0.360

Fz vs Pz

1.89

0.174

0.35

0.558

Cz vs Fz & Pz

0.16

0.691

0.12

0.729

T vs NTs

Fz vs Pz
T-1 vs T+1

Stimulus

18.47

0.000

3.85

0.057

Cz vs Fz & Pz

0.01

0.904

0.87

0.357

Fz vs Pz

3.46

0.068

0.51

0.480

5.31

0.025

19.76

0.000

13.07

0.001

16.19

0.000

3.58

0.064

3.20

0.082

T vs NTs
T-1 vs T+1

Stimulus X Site

ADHD vs NC
df (1,38)
F
p

5.91

Grp X Site
Grp X Stim X Site

FESz vs ADHD+NC
df (1,58)
F
p

T vs NTs

Cz vs Fz & Pz
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T-1 vs T+1

Site

Fz vs Pz

3.46

0.068

51.22

0.000

Cz vs Fz & Pz

0.01

0.904

4.76

0.035

Fz vs Pz

3.46

0.068

9.80

0.003

Cz vs Fz & Pz

5.88

0.018

10.85

0.002

45.77

0.000

44.90

0.000

Fz vs Pz
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N100 Latency

FESz vs ADHD+NC
df (1,58)
Stimulus

Site

Group
Grp X Stim

0.06

0.81

0.48

0.49

T vs NTs

5.63

0.0210

0.01

0.9247

T-1 vs T+1

2.71

0.1050

0.08

0.7768

Cz vs Fz & Pz

0.06

0.8074

2.92

0.0957

Fz vs Pz

0.30

0.5839

1.50

0.2289

Cz vs Fz & Pz

1.92

0.1708

0.69

0.4125

Fz vs Pz

3.28

0.0754

0.19

0.6653

Cz vs Fz & Pz

0.47

0.4965

0.13

0.7202

Fz vs Pz

3.65

0.0611

0.12

0.7264

T vs NTs

1.04

0.3120

1.85

0.1822

T-1 vs T+1

0.06

0.8073

2.28

0.1393

Grp X Site
Grp X Stim X Site

T vs NTs
T-1 vs T+1

Stimulus

ADHD vs NC
df (1,38)
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Stimulus X Site

T vs NTs
T-1 vs T+1

Site

Cz vs Fz & Pz

0.03

0.8631

1.14

0.2932

Fz vs Pz

0.14

0.7121

4.41

0.0425

Cz vs Fz & Pz

6.02

0.017

0.81

0.3752

Fz vs Pz

4.54

0.037

0.02

0.8989

Cz vs Fz & Pz

2.74

0.1032

1.96

0.1694

55.49

0.0000

50.40

0.0000

Fz vs Pz
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P200 amplitude
FESz vs ADHD+NC
df (1,58)
Stimulus

Site

Group
Grp X Stim

0.18

0.67

0.00

0.99

11.18

0.0015

0.20

0.657

5.71

0.0201

1.37

0.249

Cz vs Fz & Pz

5.57

0.0216

0.95

0.3353

Fz vs Pz

3.34

0.0728

3.00

0.0912

Cz vs Fz & Pz

0.06

0.8050

0.65

0.4239

Fz vs Pz

4.30

0.0426

0.12

0.7274

Cz vs Fz & Pz

0.20

0.6535

0.04

0.8457

Fz vs Pz

0.57

0.4549

0.03

0.8529

T vs NTs

1.58

0.2144

14.44

0.0005

T-1 vs T+1

2.97

0.0904

14.23

0.0006

T vs NTs
T-1 vs T+1

Grp X Site
Grp X Stim X Site

T vs NTs
T-1 vs T+1

Stimulus

ADHD vs NC
df (1,38)
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T vs NTs

Cz vs Fz & Pz
Fz vs Pz

T-1 vs T+1

Site
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5.96

0.0177

2.80

0.1022

11.08

0.0015

27.05

0.0000

Cz vs Fz & Pz

3.98

0.0508

1.83

0.1837

Fz vs Pz

2.32

0.1335

4.62

0.0381

Cz vs Fz & Pz

45.71

0.0000
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Fz vs Pz

24.36

0.0000

26.62

0.0000
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FESz vs ADHD+NC
df (1,58)
Stimulus

Site

Group
Grp X Stim

0.29

0.59

0.97

0.330

0.78

0.3820

1.45

0.236

16.13
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0.00
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Cz vs Fz & Pz

0.37

0.5444

0.24624
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Fz vs Pz
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0.3122
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Cz vs Fz & Pz

3.72

0.0586
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Fz vs Pz

1.45

0.2337

1.84

0.182

Cz vs Fz & Pz

0.55

0.4627
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0.465

11.32

0.0014
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0.0000

33.70

0.000
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0.028
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T vs NTs
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Grp X Stim X Site
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Fz vs Pz
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ADHD vs NC
df (1,38)

Cz vs Fz & Pz
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Fz vs Pz
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0.014

Cz vs Fz & Pz
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0.4728
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Fz vs Pz

1.94

0.1685
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0.040

Cz vs Fz & Pz

0.48

0.4897

0.01

0.939

Fz vs Pz

9.61

0.0030
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Cz vs Fz & Pz
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Fz vs Pz
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0.0318
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ADHD vs NC
df (1,38)
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0.6982
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Cz vs Fz & Pz
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p
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Fz vs Pz

0.00

0.9818
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0.2966

Cz vs Fz & Pz

4.36

0.0412

9.58

0.0037
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Site
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df (1,38)
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Fz vs Pz
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Cz vs Fz & Pz
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0.1406
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Fz vs Pz
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p
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Fz vs Pz
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